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This report describes the Baltic Pharma Load model (BPL) and the estimated environmental loads 
and concentrations of selected active pharmaceutical ingredients (APIs). The BPL model was 
developed as a part of the project Clear Waters from Pharmaceuticals (CWPharma) funded by the 
EU’s Interreg Baltic Sea Region Programme. The calculation model uses national sales statistics as 
the driving parameter and takes into account selected differences in country-specific practices in e.g. 
waste management and sewer network coverage. The GIS-based model was compiled as a series of 
command scripts using the computing language and environment R (R Core Team 2020) and a 
calculation grid covering the entire Baltic Sea drainage basin. The calculation grid divides the Baltic 
Sea Region (BSR) into one square kilometer grid cells, with each grid cell containing the background 
information required for the calculations. Most of the country-specific input data used in the 
calculations was collected in parallel activities of the project CWPharma. These datasets included 
e.g. national sales statistics (Ek Henning et al. 2020) and waste management practices (Mehtonen et 
al. 2020). 
The calculation method used in the BPL is based on the equations suggested in the guideline on the 
environmental risk assessment of medicinal products by the European Medicines Agency (EMA 
2006). However, to produce more realistic estimates on the environmental occurrence of 
pharmaceuticals, the total residue approach advocated by EMA was supplemented with selected 
removal processes. These removal processes included elimination in waste management, 
metabolism, wastewater treatment plant processes and environmental processes during the 
transport from emission location to the Baltic Sea. 
Using the BPL, we estimated the loads of eight APIs to the Baltic Sea as well as their concentrations 
at river mouths and in coastal waters. The loads of diclofenac, carbamazepine, tramadol, 
clarithromycin, ofloxacin and venlafaxine to the Baltic Sea were estimated to be the highest from 
Poland. Similarly, the highest metformin and ibuprofen emissions were estimated to occur from 
Russia. Despite these countries being estimated to emit the highest total loads to the Baltic Sea, there 
was a lot of variation in the estimated national per capita emissions for different APIs. 
The highest API concentrations at river mouths were estimated to occur in southern parts of the 
BSR. Rivers with relatively high API concentrations were estimated to be located e.g. in Denmark, 
where the river flow rates are low, and population living in river basins is relatively high. 
The predicted API concentrations in wastewaters and river mouths were compared to the measured 
concentrations in the same regions reported by Ek Henning et al. (2020). The predicted 
concentrations were generally within the observed range in wastewaters. However, ofloxacin 
concentrations were far below the measured range in influent and effluent wastewaters. This 
discrepancy was explained by the chemical analyses carried out by Ek Henning et al. (2020) covering 
the total concentration of the racemic mixture (ofloxacin), including also the enantiopure form 
(levofloxacin), while the sales statistics used in this calculation exercise covered only the racemic 
mixture. 
The predicted concentrations in river mouths were generally higher than those measured by Ek 
Henning et al. (2020). However, there were also locations where the concentrations were lower than 
the measured ones. As the BPL model estimates the annual average concentration in river mouths 
based on long-term average flow rates, and the weather conditions were somewhat exceptional in 
many sampling sites during the CWPharma sampling campaign (Ek Henning et al. 2020), more data 
points would be required to properly calibrate the BPL model and to assess its performance.  
The calculation approach used in the BPL model takes into account several real-life processes and 
estimates where potential hotspots may be located. This kind of visual and easy to use tool helps to 
target expensive and labor-intensive screening campaigns at areas of highest concern. Selected 




Active pharmaceutical ingredients (APIs) have been detected in environmental samples in every 
inhabited continent (aus der Beek et al. 2016). Several APIs have also been detected in wastewaters 
and environmental samples in the Baltic Sea Region (BSR) (UNESCO & HELCOM 2017, Ek Henning 
et al. 2020). However, knowledge about the extent of contamination by pharmaceuticals entering the 
Baltic Sea is inadequate.  
One of the aims in the project CWPharma was to estimate the overall loads of selected APIs to the 
Baltic Sea, and to identify potential hotspots for both emissions and occurrence. This would help to 
identify the APIs of highest concern, and the areas where monitoring should be carried out and 
emission reduction measures could have the highest overall impact. 
The most straight forward way of increasing knowledge on the environmental levels of 
pharmaceuticals would be to carry out extensive monitoring campaigns. However, the Baltic Sea 
drainage basin is vast and has regionally varying environmental conditions. Achieving a 
comprehensive overview of API concentrations in a regional scale would require numerous samples, 
resulting in high costs.  
Since pharmaceuticals are used in a very regulated manner, simulating their loads based on sales 
statistics could prove to be a more cost-efficient approach. The simplest way to achieve this would 
be to utilize the ‘total residue approach’ recommended in the European Medicines Agency’s (EMA) 
guideline on pharmaceutical risk assessment (2006). However, for most APIs this approach will 
inherently result in overestimations of the load entering the environment, as it assumes that all sold 
mass is eventually emitted into the environment.  
Therefore, the aim in this work was to produce more realistic estimates of the API load reaching the 
Baltic Sea (BS) by including several removal processes into the estimation. To do this, a calculation 
tool, Baltic Pharma Load model (BPL), was developed. This model takes into account the reductions 
in total API load due to metabolism, wastewater treatment plant (WWTP) processes and 
environmental processes. 
BPL is a GIS-based calculation tool for estimating the API load entering the BS. Since the primary 
emission source of API emissions is estimated to be consumption and subsequent excretion (e.g. EC 
2019), population and API sales information were selected as the driving parameters of the model. 
The uneven distribution of the population within the BSR (see Figure 1) was also taken into 
consideration. The approach chosen for the BPL model, some background information and selected 
results of this calculation exercise can be viewed in a web-based map application (SYKE 2020). 
The aim of the work was to  
A) estimate the loads of selected APIs to the BS,  
B) estimate their concentrations in river mouths and in coastal areas, and 
C) use these estimates to assess where the highest loads originate from, and which parts of the 
Baltic Sea receive highest API loading 
Several scenarios were developed to estimate the natural variation in loads and concentrations, 
caused by variations in e.g. temperature and water flow volumes. The model was designed to give 
rough estimates of the current API concentrations along BS coasts for later risk estimations, and to 
be easily modifiable, allowing for estimates on the effects of proposed risk mitigation measures under 










2.1. Model development & structure 
The aim of the model development was to produce a calculation tool that would enable reliable 
estimation of pharmaceutical loads reaching the environment, and the API concentrations at various 
sites in the environment and in wastewaters. To do this, three removal processes were taken into 
consideration. 
Counting from the ingestion of a pharmaceutical product to the eventual emission of its residues 
into the environment, the first removal process is metabolism in the human body. Metabolism of 
each API varies between individuals. Also, the route of administration may have a significant impact 
on how efficiently pharmaceuticals are transformed before their excretion. For instance, topically 
administered pharmaceuticals may be washed off before their absorption and metabolism. 
Therefore, the fraction of API excreted as the parent compound is not a natural constant. 
Additionally, while pharmaceuticals that are left unused never go through metabolic processes, some 
of them may be flushed into the sewer network. Emissions from unused pharmaceuticals were 
accounted for with the help of national statistics collected by Mehtonen et al. (2020). 
The second dissipation process is removal during wastewater treatment. Current WWTPs are not 
designed to remove APIs, but several APIs are biodegradable and are therefore degraded or 
transformed in WWTP processes to a varying degree. For several APIs, binding to particles and 
eventually ending up in wastewater sludge may play a more important role in overall removal at 
WWTPs than biodegradation. However, not all sewage is treated at WWTPs. Thus, a country-specific 
fraction of wastewaters, as reported by UNICEF & WHO (2019), and the pharmaceutical residues 
they contain, was assumed to not go through the removal processes at WWTPs.  
The third removal process is elimination due to degradation or sorption in the surface waters that 
receive the wastewaters. These removal processes are highly dependent on environmental 
conditions, such as temperature and light intensity. While these factors affect the degradation rate 
of APIs in the environment, the total load to the Baltic Sea depends on how long it takes for an API 
to travel from a discharge point to the sea. To account for this variability in removal rates, several 
scenarios aiming to present different seasons and annual variation were developed. Bio- and 
photodegradation were taken into consideration for the whole BSR catchment area. Sedimentation 
was only included in coastal regions.  
The loads in wastewaters (influent and effluent) were calculated for all APIs screened in the 
CWPharma screening study (Ek Henning et al. 2020) and the predicted concentrations were 
compared to the ones measured by Ek Henning et al. (2020). The loads to the BS and their 
concentrations at river mouths and coastal waters were estimated for eight APIs: carbamazepine 
(CBZ), clarithromycin (CLM), diclofenac (DCF), ibuprofen (IBU), metformin (MTF), ofloxacin (OFL), 
tramadol (TRD) and venlafaxine (VFX).  
The removal processes and assumptions on national practices contain high uncertainties. However, 
to implement them into the calculation tool, they were considered to behave as constants, and their 
values were selected based on data presented by Ek Henning et al. (2020) and Mehtonen et al. (2020), 
other data available in literature, and expert judgement. The processes included into the model are 
presented in Figure 2. Potential emissions from e.g. landfills, veterinary medication and utilization 
of sewage sludge were not included into the model. A comprehensive description of the structure of 





Figure 2. Calculation framework and removal processes included in the calculations (highlighted in green). The dotted line 
presents the situation, where unused pharmaceuticals are not treated properly, but where they are eliminated by e.g. 
incineration in municipal waste management or permanent encapsulation in landfills. 
Some calculation exercises have previously been carried out to estimate API loads and concentrations 
in the environment. Bollmann et al. (2019) estimated the loads of selected micropollutants to the 
Baltic Sea using concentrations measured in treated and untreated wastewaters and stormwaters, 
and calculating the loads based on estimated water flows. Their approach was based on a model city 
with a wide range of input parameters. These input parameters were selected to represent the 
estimated situation in the Baltic Sea area. The calculation tool was then further expanded to cover 
the Baltic Sea area by modifying relevant input parameters. On the other hand, Oldenkamp et al. 
(2018) estimated the concentrations of a wide range of APIs in surface waters across Europe using 
national sales statistics and water flow networks. The removal processes they accounted for were 
degradation in the environment, sorption to particles and eventual sedimentation, and metabolism. 
Metabolism was also included as a process that may increase the API load, i.e. as the input from 
metabolism of prodrugs. Oldenkamp et al. (2018) included the WWTPs in the calculation region into 
the calculations by inserting them into the flow network and assigning WWTP-specific removal rates 
based on the processes in those WWTPs. 
The approach selected in the BPL model contains parts of both approaches. Whereas Bollmann et al. 
(2019) used generic input parameters, and treated the BSR as one big block, and Oldenkamp et al. 
(2018) treated the area as a network, BPL-calculations are based on a grid-based approach, where 
every grid cell is an individual calculation unit containing all relevant processes, and a flow network 
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2.1.1. GIS-materials & processing 
To estimate the API load to the Baltic Sea, certain geographical and hydrographical parameters in 
different parts of Baltic Sea region had to be considered by using available data. To do this, several 
open data sources were accessed, and the data was further processed to accommodate the selected 
approach. 
Both raster and vector analyses were utilized in the GIS-based modelling to process data to be applied 
in further calculations. The coordinate system used in the modelling was ETRS_1989_LAEA, which 
HELCOM mainly uses in its own spatial datasets. ESRI’s mapping and analytics software were used 
to compile the GIS-materials for this model.  
In the calculation model, the entire BS catchment area was divided into a 1 x 1 km2 grid. Each grid 
cell contains vital information for the calculations, such as coordinates, estimated distance from the 
BS, population, elevation, lakes and rivers, country, and identifiers on several layers (grid cell-
specific, catchment area-specific, etc.). With the help of the grid cell specific identifier, the source 
data and the data produced in further calculations could be e.g. rejoined to a specific coordinate, 
while other identifiers were used e.g. in aggregating the results. Each grid cell was assigned a virtual 
WWTP, in the sense that WWTP removal processes were assumed to take place in each cell, right 
after excretion. A comprehensive description of structure of the BPL calculation grid is presented in 
Annex 1. 
The high-resolution grid (1 x 1 km2) used in the BPL model was selected after preliminary tests with 
a lower resolution (10 x 10 km2). The lower resolution would have resulted in the calculations 
requiring less computing power. However, this would have been achieved at the expense of the 
quality of the results. Using low resolution would have resulted in the input data, such as the 
distances from the BS and population, being of much lower quality, resulting in the results being of 
lower quality. 
When selecting the input data for the model, the aim was to use open source data that are available 
to everyone free of charge. HELCOM map and data service (HELCOM 2020) was identified as a good 
source for regional information on the BSR. In many cases, however, more suitable open GIS datasets 
for modelling purposes were found elsewhere. The challenge was to find data that would cover the 
entire catchment area of the Baltic Sea and be of sufficient accuracy and quality. A particular 
challenge between the different data types and their sources and formats was to fit them to 1 x 1 km 
grid cells and a common GIS-based model, due to differences in location accuracy, unit accuracy, 
scale and quality of different data sets. This was achieved by processing the GIS-materials using 
different kinds of methods such as resampling and interpolating.  
In general, EU countries usually had a common source of data of sufficient quality covering their 
regions, but certain data sets (e.g. population: Eurostat 2016b & CIESIN 2016, rivers and lakes: 
Eurographics 2018 and JRC 2007 & Vogt et al. 2007) had to be supplemented with data on non-EU-
countries, from other sources. The quality of the data from non-EU-countries was not always as good 
as the data in other parts of the Baltic Sea catchment area.  
The aim of the BPL model was to indicate areas with the highest API concentrations as well as 
possible emission hotspots. To do this the study area was classified into different region classes 
depending on the processes through which APIs reach the BS (presented in Table 1 and Figure 3). 
Within this regional division, the regions were divided further into smaller areal units (e.g. individual 




Table 1. Emission and recipient areas, explanations on different region classes and processes included in each class. 





sold &  
used 
Removal  
at virtual  
WWTP 




in the  
environment 
API load used  




Main river basins Yes Yes Yes No During transport  
• Distance estimated 
based on elevation 
model (see p. 12) 
• Flow speed varies 
with scenario (see 
chapter 0) 




Urban clusters located 
close to a large WWTP, a 
subset of inland areas 
Yes Yes Yes No 
Coastal 
land 
Land areas between main 
river basins and on islands 
Yes Yes Yes No No, wastewaters are 
assumed to be 
emitted into the 
Baltic Sea. 
In coastal waters, both as 
background concentration and 





Urban clusters located 
close to a large WWTP, 
with a high population 
density (see p. 11), a subset 
of coastal land 








Degradation in the 
environment, once recipient 
has been reached 
Water volume where the API 
load is diluted 
River 
mouth 
Mouths of the rivers included 
into the BPL 
Inland areas No No River flow 
Urban 
coast 
Coastal waters within a 
perimeter of 3 km from the 
closest coastal urban cluster 
Inland and 
coastal areas 
Yes Yes, degradation rate varies with 
depth, season and region (see 
chapter 2.2.3) 
 
Water volume in the coastal region 
Coastal 
water 
Coastal waters within a 
perimeter of 3 km of the 









Figure 3. Regional classification used in the calculations. 
The coastal urban clusters were defined as urban areas with more than 50,000 inhabitants within 5 
km from the coast and with a WWTP (distance max 5.5 km from urban cluster) that treats over 
3,650,000 m3 wastewater per year (Eurostat 2016a, HELCOM 2011). Inland urban clusters were also 
determined based on the same data on urban clusters, but using the Urban Waste Water Directive 
(UWWTD) database v7 (EEA 2019), which contains the locations and PE-values of WWTPs located 
in EU member states. Different input data on WWTPs were used in identifying coastal and inland 
urban clusters, due to UWWTD not covering Russia. Using spatial data analyses, each WWTP with 
12 
 
a PE-value higher or equal to 50,000 was joined to the closest population cluster for further API load 
calculations. 
As presented earlier in Figure 1, population is not distributed geographically uniformly within the 
BSR, and between different countries. Dividing the BSR into different region classes helps to 
highlight the differences also within countries. Within the whole BSR, 75% of the population is 
located in inland areas. However, there is high variation between countries. For instance, in Poland, 
96% of the population is located in inland areas, while the same portion for Denmark is 27%. 
Population distribution by each region class is presented in Figure 4. 
 
Figure 4. Population distribution by country and region class. Other countries include NO, SK and CZ, that have relatively 
small areas and little population within the BSR. 
The regions classified as inland areas, include the main river basins of the Baltic Sea region. The 
source data was the Baltic Sea catchment area compilation which the HELCOM member countries 
have gathered from their own catchment area data (HELCOM 2018a). Coastal areas (emissions from 
WWTPs straight into the Baltic Sea) included areas between the main river basins on the coast and 
in the archipelago, as presented by HELCOM (HELCOM 2018a, HELCOM 2017). 
The Global Multi-resolution Terrain Elevation Data 2010 (Danielson & Gesch 2011) model was used 
as the basis for modeling flow directions. To refine these estimates, known main flow paths were 
highlighted by burning in lakes and rivers into the digital elevation model. Stream burning is a flow 
enforcement technique used to correct surface drainage patterns derived from digital elevation 
models. The technique involves adjusting the elevation of grid cells that are coincident with the 
features of a vector hydrography layer. The watersheds in the Baltic Sea catchment area compiled by 
HELCOM (HELCOM 2018a) were also emphasized into the elevation model. A flow direction model, 
presenting the flow directions for each grid cell, was calculated by using the preprocessed elevation 
model. The flow direction modelling did not take into account bifurcations of streams. 
A flow accumulation grid was produced and combined with the flow direction model to determine 
the flow paths for each grid cell. These datasets were further utilized to calculate the upper 
catchment areas and downstream distances to the sea for each grid cell. Identifying the upstream 
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grid cells is especially important for identifying which cells flow through which lakes and river 
mouths. Additionally, the average flow rate (m3/s) of the annual flow data (HELCOM 2018b) for 1995–
2006 was included to the grid cells of the main river basins. The calculated flow distances to the BS 
and main flow routes are presented in Figure 5. 
 
Figure 5. Calculated distances to the Baltic Sea along the calculated flow routes. Main flow routes area presented in turquoise 
line and country borders in black line. 
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The coastal areas into which each emission cell flows were also calculated based on the flow direction 
model. This information is vital for estimating the total load reaching different sections of the BS 
coastline. On the other hand, sea depth data were interpolated by using the raster grid of the Baltic 
Sea bathymetry computed from the original Digital Topography of the Baltic Sea (HELCOM 2005). 
Volume estimates (m3) of each grid cell in the sea were derived from sea depth data. In addition, a 
three-km wide coastal zone was defined for the coastal areas and used in the concentration 
calculations. The sea depths within the calculation grid are presented in Figure 6.  
 
 
Figure 6. Sea depth in the calculation area. 
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2.2. Calculation approach & included processes 
The calculation grid contains 1.9 million cells. To make the calculation process efficient, calculations 
were carried out using the computing language and environment R (R Core Team 2020). The 
calculation process presented in chapters 2.2.1 through 2.2.4 were compiled into R scripts. Compiling 
the calculation method into scripts allowed the calculation to be repeated efficiently, while 
minimizing human error. The scripts are available in the web (http://hdl.handle.net/10138/321722). 
2.2.1. Load and concentration estimation in wastewaters 
Sales of each API were calculated for each grid cell as the national per capita sales multiplied by the 
number of inhabitants in the cell. These values were further used in estimating the load entering the 
virtual WWTP, by multiplying the cell-specific consumption by the API-specific excretion rate. This 
value was modified according to national information on the fraction of pharmaceuticals that is 
eventually left unused, which fraction of this goes through appropriate pharmaceutical waste 
management, and assumptions on which fraction of the remainder is flushed into the sewer network. 
The API-specific input values on national sales and environmental properties are presented in Tables 
2 and 6, respectively. 
The resulting influent load to virtual WWTP, in turn, was used further in estimating the effluent load 
from the virtual WWTP, with the help of the API-specific WWTP removal rate. These removal rates 
were calculated based on concentration data presented by Ek Henning et al. (2020), and accounts 
only for removal from the water phase, disregarding potential emissions from e.g. sewage sludge 
utilization.  
Loads in influent and effluent wastewaters were calculated using Eq. (1) and (2), respectively. The 
estimated loads were transformed into concentrations using an average per capita water 
consumption (𝑉𝑝𝑐) of 140 l/d/person (see Eq. (3) and (4)). Estimates on the total load eventually 
reaching the BS were calculated using the estimated loads in effluent wastewater, taking into account 
selected removal processes in the environment (see chapter 2.2.2). 
 
(1) 𝐿𝑖𝑛𝑓 = 𝐶 × (1 − 𝐹𝑢) × 𝐸 + 
              𝐶 × (𝐹𝑢 × (1 − 𝐹𝑝) × 𝐹𝑤2𝑠 
, where 
𝐿𝑖𝑛𝑓 = Load in influent wastewater [mg/a] 
𝐶 = Total annual sales in grid cell [mg/a] 
𝐹𝑢 = Fraction of sold medicines left unused [-] 
𝐸 = API-specific excretion rate [-] 
𝐹𝑝 = Fraction of unused medicines treated properly [-] 
𝐹𝑤2𝑠 = Fraction of improperly treated pharmaceutical 
waste flushed down the sewer [-] 
 
(2)  𝐿𝑒𝑓𝑓 = 𝐹𝑠 × 𝐿𝑖𝑛𝑓 × (1 − 𝑅𝑅) + 
              (1 − 𝐹𝑠) × 𝐿𝑖𝑛𝑓 
𝐿𝑒𝑓𝑓 = Load in effluent wastewater [mg/a] 
𝐹𝑠 = Fraction of wastewater connected to sewer 
network [-] 







𝐶𝑖𝑛𝑓 = API concentration in influent wastewater [mg/L] 
𝑉𝑝𝑐 = Per capita water consumption [L/d] 
 
(4)  
𝐶𝑒𝑓𝑓 =  
𝐿𝑖𝑛𝑓 × (1 − 𝑅𝑅)
𝑉𝑝𝑐 × 365 
 
𝐶𝑒𝑓𝑓 = API concentration in effluent wastewater [mg/L] 
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2.2.2. Load estimation to river mouths and to the Baltic Sea 
The cell-specific effluent load into the water environment was used in estimating the load to the river 
mouth, and subsequently to the BS, taking into account degradation and environmental conditions, 
such as water temperature and flow speed during transport. 
 
Delay estimations in river basins  
The flow route network (see p. 12) was used in estimating the time it takes for emissions originating 
in a certain grid cell to reach the BS. This network gives an estimate on the distance from each grid 
cell to the BS. To estimate how long it takes for an emission to reach the BS, the distance was divided 
with the estimated flow speed. Different scenarios (see chapter 2.3.2) were developed, with different 
flow speeds, to account for variations between seasons.  
The estimates derived based on these background data were combined with information on selected 
lakes located in the calculation area and their estimated retention times. The flow network was used 
in identifying which grid cells are located upstream from which lakes. The retention time of each 
lake was added to the flow times of each cell located upstream from the discharge point of the lake. 
If there were several consecutive lakes, the lake retentions were summed (see Figure 7). The lakes 
included into the model are presented in Annex 2. 
Lakes were selected from each country by CWPharma project partners in respective countries. Lake 
selection was carried out based on lake retention times and locations: lakes with longer retention 
times or locations downstream from significant population centers were prioritised. During this 
selection process, it was concluded that there are no lakes that would have a relevant impact on 
retention times to the BS in Denmark and Germany. 
As an example, in Finland a preliminary set of lakes was selected from a national database (WSFS-
VEMALA, e.g. Huttunen et al. 2016) by selecting the lakes with the highest retention times. Retention 
time for each lake was evaluated by dividing the volume of the lake by the outflow of the lake. This 
set was further supplemented with a set of smaller lakes located downstream from towns with 
significant population (e.g. Kuortaneenjärvi in western Finland), and some of the lakes with highest 
retention times were excluded if they were upstream from towns and cities (e.g. Kilpisjärvi in 
northern Finland). 
Information on the retention time and location of the discharge point was collected for each lake. 
Based on the coordinates, the discharge points were placed manually into grid cells best 
corresponding to the general location of the lake and the calculated flow network. 









𝑇𝑡 = Total delay from emission cell to the BS [d] 
𝐷 = Distance from emission cell to the BS [m] 
𝑉𝑓𝑙𝑜𝑤 = Flow speed [m/s] 
𝑇𝐿 = Cumulative retention time in lakes located downstream from the 
emission cell [d] 






Figure 7. An example of how lakes and distance from the BS were taken into consideration in the delay-estimates. In Point A, 
the total delay was calculated by dividing the distance to the BS (50 km) with the flow speed (0.15 m/s), resulting in a delay of 
3.86 d. However, since there is a lake below point B, the retention in this lake must be accounted for. Therefore, the delay from 
Point B is not 7.72 d, but 127.72 d. The retention times in lakes no. 10 to 7 seem to increase, due to the retention in each lake 
being added to the retentions of lakes located downstream. 
 
Estimation of removal rates in the environment 
During the transport from river basin grids cells to the BS, part of API load is dissipated due to 
photolysis and microbiological degradation. In the BPL model, these two processes were assumed to 
be the most relevant dissipation ways for most APIs in rivers and lakes. 
In the BPL model, water flow in rivers and lake is divided into photoactive layer Fphoto and non-
photoactive layer. Degradation is calculated separately in these parts (see Eq. (6)). The total loads to 
the BS, to its sub basins, and to river mouths were aggregated from the loads from individual grid 
cells.  
(6)  𝐿𝐵𝑆 = 
𝐿𝑒𝑓𝑓 × [𝐹𝑝ℎ𝑜𝑡𝑜 × 𝑒
(−𝑘𝐹×𝐷𝑡)
+ (1 − 𝐹𝑝ℎ𝑜𝑡𝑜) × 𝑒
(−𝑘𝑏𝐹×𝐷𝑡)] 
, where 
𝐿𝐵𝑆 = Load to the Baltic Sea [mg/a] 
𝐹𝑝ℎ𝑜𝑡𝑜 = Fraction of surface water, where APIs 
are exposed to photodegradation [-] 
𝑘𝐹 = Degradation rate in the photoactive water 
fraction [1/d] 
𝑘𝑏𝐹 = Degradation rate in the non-photoactive 
water fraction [1/d] 
𝐷𝑡 = Transport time from grid cell to the BS [d] 
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While photodegradation is assumed to occur only in the surface layer of the water column, 
biodegradation is assumed to occur in the whole volume (see Eq. (7) and (8)). The dissipation 
processes are described by pseudo first order kinetics, where the different processes are combined 
by summing their rates (see Eq. (8)). The impact of water temperature on biodegradation is 
calculated using a simple approximation based on Arrhenius equation (Eq. (9)). This approach is 
similar to the one suggested in the European Chemicals Agency (ECHA) guidance for biocide 
registration (2017).  
(7)  𝑘𝑏𝐹 = 𝑘𝑏𝑖𝑜𝑇 , where 











𝑘𝑝ℎ𝑜𝑡𝑜 = Photodegradation rate (direct + 
indirect) in optimum radiation conditions [1/d] 
𝐷𝑇50𝑝ℎ𝑜𝑡𝑜 = Photodegradation half-life [d] 
𝐷𝑇50𝑏𝑖𝑜𝑇 = Biodegradation half-life [d] 
 
(9)  𝐷𝑇50𝑏𝑖𝑜𝑇 = 𝐷𝑇50𝑏𝑖𝑜𝑅𝑒𝑓𝑇 × 𝑒
𝛼×(𝑇𝑟𝑒𝑓−𝑇) 𝐷𝑇50𝐵𝑖𝑜𝑅𝑒𝑓𝑇 = Biodegradation half-life in 
reference temperature d] 
𝛼 = A parameter including natural constants and 
activation energy etc. (see below) [1/°C] 
𝑇𝑟𝑒𝑓 = Reference temperature for biodegradation 
[°C] 
𝑇 = Temperature in the environment [°C] 
 
According to the opinion of European food safety authority (EFSA 2008), Arrhenius activation 
energy 65.4 kJ/mol should be used, if no substance specific information exists. Pesticides and 
pharmaceuticals are both organic synthetic compounds and the groups are not expected to differ in 
this perspective. The suggested Arrhenius activation energy corresponds to a Q10 value of 2.58 1/°C 
and thus   = (ln Q10)/10 = 0.0948 1/°C. On the other hand, in the EU biocide registration, an older 
value 0.08 1/°C is used. In this project value 0.09 1/°C is used in calculations for APIs. 
Temperatures used for different areas, and the water fraction exposed to photodegradation are 
presented in Table 4. The fraction of photoactive water volume (𝐹𝑝ℎ𝑜𝑡𝑜 in Eq. (6))  is difficult to 
determine. It sums many different processes from river geometry to radiation intensity and water 
quality (DOC and Secchi depth). On a sunny summer day (high radiation intensity) in a 20 m and 5 
m deep canal-type river profile, photoactivity can be assumed highest in a five cm surface layer of 
the water column. Similarly, light intensity can be assumed to decrease by 50% for each five cm step 
deeper into the water column. Using these assumptions, 𝐹𝑝ℎ𝑜𝑡𝑜 gets value 0.025. If the river were 
wider and shallower, 𝐹𝑝ℎ𝑜𝑡𝑜 would be higher (e.g. for a river 100 m wide and 2 m deep, 𝐹𝑝ℎ𝑜𝑡𝑜 would 
be 0.05). However, in cloudy days the value is smaller and during nights it is zero. There is also high 
seasonal variation in the radiation – and ice cover in winter in many rivers. For the calculation 
implementation, 𝐹𝑝ℎ𝑜𝑡𝑜 was treated as a constant for the whole BSR, with the value varying from 0 
to 0.045, depending on calculation scenario (see chapter 2.3.2). 
Potentially relevant removal processes, overlooked in the BPL model, are hydrolysis and 
sedimentation. The relevant part of hydrolysis is assumed to occur already before API is released to 
river water from WWTP. Therefore, it is not included as separate process in the model. Although 
sedimentation may be important for some compounds in some water bodies, it is not included into 
the model. It is assumed, that the most sorptive APIs will adsorb to particles in WWTPs. Additionally, 
while APIs from effluent may adsorb on particles, both dissolved and particle bound APIs may 
transport via river to BSE. Including sedimentation into the river processes in the model would also 
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have required river specific information on sedimentation rate. Therefore, for the very sorptive APIs 
the model is expected to give a slight overestimation on API loads and concentrations. 
 
2.2.3. Calculation of concentration in river mouths and coastal areas 
Predicted environmental concentrations (PECs) were estimated for 240 river mouths located within 
the BSR. These concentrations at river mouths were estimated based on the loads calculated for the 
cells located upstream from the river mouth cell. These cells could be identified based on the flow 
accumulation grid (see p. 12). The PECs represent average annual concentrations, and as such is 
expected to differ from individual measurement results. The river mouths covered by the BPL model 
and river-specific annual flows are presented in Annex 3.   
As the calculation grid contains the estimated total transport times from each grid cell to the BS, the 
transport times to the river mouths could be calculated as well. To estimate the loads to the river 
mouths, Eq. (6) was modified by replacing 𝐷𝑡 with 𝐷𝑡𝑅𝑀 (see (Eq. (10) and (11)). The estimated load 
was converted to annual average concentration by dividing it with the annual average river flow for 
in each respective river (Eq. (12)).  








𝐿𝑅𝑀 = Load to the river mouth [mg/a] 
𝐷𝑡𝑅𝑀(𝑖) = Transport time from emission 
cell i to the river mouth 
 
(11)  𝐷𝑡𝑅𝑀(𝑖) = 𝐷𝑡(𝑖) − 𝐷𝑡(𝑟) , where 
𝐷𝑡(𝑖) = Transport time from emission cell i 
to the BS [d] 
𝐷𝑡(𝑟) = Transport time from river mouth 
cell r to the BS [d] 
 
(12)  𝑐𝑅𝑀 =
∑ 𝐿𝑅𝑀
𝑉
× 1000  , where 
𝐶𝑅𝑀 = Concentration in river mouth [ng/L] 
𝐿𝑅𝑀 = Loads from cells located within the 
river basin [mg/a] 
𝑉 = Annual average flow in the river [m3/a] 
 
 
The API concentrations in coastal areas are approximated from the calculated annual average loads 
to the BS using two different approaches. The first approach is similar to the one used in estimating 
concentrations at river mouths (see Eq. (12)). Using this approach, 𝐶𝑟𝑎𝑤 is calculated by simply 
diluting the annual load to the coastal water volume (see Eq. (13)). The equation is especially suitable 
for areas where water changes during the year (e.g. estuaries).  
The second approach estimates a long-term plateau concentration (𝐶𝐴𝐴), assuming that APIs are not 
transported out from the recipient coastal area. However, sedimentation, photodegradation and 
biodegradation are included into the calculation. The concentration is calculated by mixing the 
calculated plateau mass to water volume (see Eq. (14), (15) and (16)).  
The input load is the sum of the loads from all cells discharging to that specific coastal area. Within 
each area, total and instant mixing of load in coastal water volume is assumed to take place. The 
concentrations in coastal waters were calculated for two different areas: urban coasts and coastal 
waters in general (see Table 1). The latter represents the background concentration, assuming the 
load to that coastal region is distributed uniformly in the area. The former, on the other hand, 
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assumes that the emission from the coastal urban cluster remains within the coastal waters within a 
3 km perimeter from the cluster. Background concentration caused by the load from areas outside 
the coastal urban cluster are taken into account as well. Discussion on different dissipation routes is 







𝐶𝐴𝐴(𝑖) = Long-term plateau concentration in coastal 
area i 
𝑀(𝑖) = Plateau mass in Baltic Sea coastal area i [kg] 


















𝑞 = Season in focus [-] 
(1=Q1 (Jan-Mar),…, 4=Q4 (Oct-Dec)) 
𝑙 = Water layer in focus [-] 
(1 = surface, 2 = mid-layer, 3 = bottom layer) 
𝐷𝑙  = Depth of layer 𝑙 [m] 
𝐷𝑡𝑜𝑡  = Total depth in the focus area [m] 
𝑚𝐴𝑃𝐼 𝑠 = Mass of sedimented API [kg/a] 
𝑘(𝑞, 𝑙) = total degradation rate in layer 𝑙 during season 
𝑞  
 






𝐷𝑇50𝑏𝑖𝑜 ×  𝑒
𝛼×(𝑇𝑟𝑒𝑓−𝑇𝑞𝑙)
 
𝑘𝑞𝑙 = Degradation rate in layer l during season q 
𝑎𝑞𝑙 = Fraction of photolysis activity in layer l in 
season q in relation to the maximum potential 
photolysis [-] 
(in June the fraction is 1,0 in layer l1; the value of 
l3 is 0 in all seasons) 
𝐷𝑇50𝑝ℎ𝑜𝑡𝑜 = Photolysis half-life [d] 
𝐷𝑇50𝑏𝑖𝑜 = Biodegradation half-life in reference 
temperature 𝑇𝑟𝑒𝑓 [d] 
𝑇𝑟𝑒𝑓 = reference temperature [°C] 
𝑇𝑞𝑙 = Temperature in layer l in season q [°C] 
𝛼 = temperature correction factor [1/°C] 
 
Dissipation processes in the BSE 
Sedimentation 
Sedimentation can be an important dissipation pathway from water phase especially for APIs having 
high adsorption affinity. The real sedimentation processes in BSE are rather complicated (e.g. 
Blomqvist & Heiskanen 2011) but a simple approach is used in the BPL model. The annual incoming 
load is divided into adsorbed phase and water phase. APIs are assumed to adsorb only on particulate 







𝐶𝑟𝑎𝑤(𝑖) = Concentration in coastal area i, estimated 
from annual load 
𝐿𝐵𝑆(𝑖) = Annual load to coastal area i [kg/a] 
𝑉(𝑖) = Water volume in the coastal area i [m3] 
21 
 
constant value for organic carbon burial rate is used for whole BS (see p. 27). Eq. (17) presents the 
equation used in estimating the mass of sedimented APIs in the BPL model, and Box 1 shows the 







𝐾𝑂𝐶 × 𝐴 × 𝑘𝑆𝐸𝐷𝑃𝑂𝐶
 , where 
𝐿𝐵𝑆(𝑖) = API load to coastal area i [kg/a] 
𝑉𝑖 = Water volume in coastal area i [m
3] 
𝜌 = water density [kg/m3] 
𝐾𝑂𝐶 = API’s partitioning factor between dissolved 
and adsorbed phases (adsorption coefficient) in 
proportion to organic carbon [l/kg] 
𝐴𝑖 = Area of coastal area i [m
2], 
𝑘𝑆𝐸𝐷𝑃𝑂𝐶 = Burial rate of particulate organic carbon 
in sediment [kg/m2/a] 
 






𝐾𝐷 = partitioning coefficient (linear adsorption) 
It is defined as the quotient of concentrations in adsorbed 
(𝑐𝑆) and in dissolved (𝑐𝐷) phases. 
𝑐𝐴𝑃𝐼 𝑠 = 𝐾𝐷 × 𝑐𝐴𝑃𝐼 𝐷 
𝑐𝐴𝑃𝐼 𝑠 = concentration of API in sediment 










Concentration is given as API mass per matrix mass:  
𝑚𝑠 is sediment mass and 𝑚𝑤 is water mass. Values of both 
sides are divided by 𝑓𝑜𝑐 (fraction of organic matter) 




𝑚𝐴𝑃𝐼 𝐿 − 𝑚𝐴𝑃𝐼 𝑠
𝑚𝑊
 
The non-adsorbed part of total API is the API in dissolved 
phase. Here, because the focus is in the API sedimentation 
during a year and its relation to one year API loading, the 
annual API load (𝑚𝐴𝑃𝐼 𝐿) is used as total API. 
Consequently, only one year sedimentation is used as 
sediment mass. Assuming adsorption occurs on organic 
carbon only, the fraction of organic carbon of the one year 
sedimented material is the mass of annually buried 
particulate organic carbon 𝑚𝑃𝑂𝐶 = 𝑚𝑠 × 𝑓𝑜𝑐.  
𝑚𝐴𝑃𝐼 𝑠 
(𝑚𝐴𝑃𝐼 𝐿 − 𝑚𝐴𝑃𝐼 𝑠)
=









𝐾𝑂𝐶 × 𝐴 × 𝑘𝑆𝐸𝐷𝑃𝑂𝐶
 After some re-organizing steps and using markings: 
𝑚𝑃𝑂𝐶= 𝑘𝑆𝐸𝐷𝑃𝑂𝐶 and 𝑚𝑊 = 𝑉 × 𝜌, the result is Eq. (17). 
 
API degradation in BSE 
When API-load and the first order degradation rates are expected to be constant, a steady state 
“plateau” concentration is going to be reached in a system. The plateau principle (steady state 
concentration = input rate/dissipation rate) was originally developed in the 1940’s in pharmacy to 
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calculate the right dose for patients and later expanded to different areas, including environmental 
modeling. The API loading into coastal areas can be seen as constant in this context, but degradation 
rates are known to vary with depth and season. Despite the varying dissipation rate, a steady state 
situation with seasonal fluctuation is expected to be reached. The plateau equation is typically used 
if dissipation processes follow first order kinetics. However, in this simplified approach 
sedimentation is assumed to occur instantly and to be a linear process. Therefore, the sedimented 
part of the annual API load is calculated first and only the rest (non-sedimented) part of annual API 
load is used for plateau calculation. This is an oversimplification of the actual process and it 
underestimates the sedimentation of persistent APIs, but given the high uncertainties in the input 
parameters, this simplification was considered to give an estimate of sufficient quality.  
The fraction of the annul load, remaining in the water phase after sedimentation is divided to daily 
loads (annual load/365) to have the same time unit as used in the dissipation. The daily load is 
instantly mixed to the water volume of the focus region at the loading day. No further mixing (e.g. 
due to changing temperature gradient) between layers is assumed to happen. This API-mass is 
assumed to undergo degradation processes through biodegradation and photolysis. 
Photodegradation and other radiation-initiated degradation processes are usually faster than 
biodegradation, but they can occur only in surface layer where enough radiation energy is available. 
In the model, the sea water profile is divided into three layers according to photoactivity capacity. In 
the surface layer the photoactivity is expected to have its full capacity in summer. In the second layer 
there is some photoactivity but radiation energy and photoactivity is only a portion of that in surface 
layer. Photoactivity is not relevant in the third layer located below the second layer. Radiation 
attenuation in sea water depends on wavelength. The UV-wave length (<400 nm), which has more 
energy than visible light and thus is more important for degradation processes, penetrate only into 
surface water while longer wavelength can reach to depths deeper than measured Secchi depth 
(Simis et al. 2017).  
Biodegradation in BSE is assumed to occur in the same way as in freshwater and the same 
temperature correction equation is used (see river processes, Eq. (9)). However, for the coastal area, 
different temperatures are used for different latitudes and depths. Temperature correction is carried 
out for different seasons. For each season, the mass is calculated and averaged to produce an annual 
average plateau mass (see Eq. (15)). Using the first order kinetics and assuming no differences in the 
load, the plateau concentration is mathematically reached within 8 times half-life since the start of 
the loading, and rather good estimate is reached within 5 half-life times. 
2.2.4. Risk identification 
The predicted concentrations in river mouths and coastal waters estimated for the eight APIs 
presented in Table 2 were compared to API-specific predicted no effect concentrations (PNEC) 
reported by Ek Henning et al. (2020), presented in Table 6. This comparison was carried out by 
dividing the PEC with the API-specific PNEC-value (see Eq. (18)). Whenever the resulting risk 









𝑅𝑄 = Risk quotient [-] 
𝑃𝐸𝐶 = Predicted environmental concentration [ng/L] 
𝑃𝑁𝐸𝐶 = Predicted no effect concentration [ng/L] 
 
Since the APIs in focus in this work represent only a very small fraction of all the APIs on the market, 
and being emitted into the environment, this exercise cannot be used in estimating the overall risk 
posed by pharmaceutical emissions to the environment. Therefore, the approach presented above 
was applied only to individual APIs.  
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2.3. Input data & scenarios 
2.3.1. National input data 
The APIs to be modelled were selected based on previous information about their occurrence and 
possible risks to the environment. Strong emphasis was given to the screening campaign carried out 
in the project CWPharma (Ek Henning et al. 2020). The APIs selected to be simulated in this work, 
as well as their national sales, are presented in Table 2. The API sales were largely combined in a 
parallel activity of the project CWPharma and reported by Ek Henning et al. (2020), and further 
supplemented with the data published by the MORPHEUS-project (Kaiser et al. 2019) and by the The 
Danish Health Data Authority (2020). Sales information for all APIs looked into in the project 
CWPharma is presented in Annex 4. 
 
Table 2. API-specific annual sales (average for the tears 2015-2017). 
API Sales Per 
capita 
avg 5) 
Sales DE1) EE1) FI1) LV1) SE1) PL2) LT2) DK3) RU 
DCF kg/a 27,000 1,500 2,500 2,000 2,800 8,000 510 910 20,0004) 
0.61 
mg/d/pers. 0.90 3.1 1.2 2.7 0.78 0.58 0.71 0.44 0.37 
CLM kg/a 11,000 410 220 450 630 8,600 130 470  
0.41 
mg/d/pers. 0.37 0.86 0.11 0.63 0.17 0.62 0.18 0.23  
MTF kg/a 1,600,000 23,000 150,000 29,000 110,000 670,000 19,000 92,000  
51 
mg/d/pers. 54 47 75 41 32 48 26 44  
IBU kg/a 340,000 15,000 120,000 20,000 120,000 8,500 3,900 64,000  
13 
mg/d/pers. 11 32 61 28 32 0.61 5.5 31  
OFL kg/a 480 3,7 11 27 0,013   0,017  





TRD kg/a 21,000 320 1,700 360 3,500   6,400  
0.87 
mg/d/pers. 0.72 0.67 0.86 0.5 0.97   3.1  
VFX kg/a 19,000 120 2,000 57 3,600   2,400  
0.70 
mg/d/pers. 0.64 0.24 0.98 0.08 0.99   1.1  
CBZ kg/a 37,000 1,000 3,000 1,400 5,900 27,000 400 1,800  
1.4 
mg/d/pers. 1.2 2.2 1.5 2.0 1.6 2.0 0.56 0.88  
1) Ek Henning et al. 2020 (data averaged over years 2015–2017) 
2) Kaiser et al. 2019 (data for year 2015) 
3) The Danish Health Data Authority 2020 (data averaged over years 2015–2017) 
4) HELCOM 2014 (data for early 2010’s, exact year unknown) 
5) Calculated as population weighted per capita consumption based on countries with sales statistics available. This value was used 
whenever no country-specific value was available. 
 
Information on pharmaceutical sales in Denmark was available in defined daily doses (DDD) and in 
sold packages. Ek Henning et al. (2020) noted that converting DDD values into mass units contains 
several uncertainties. Therefore, the Danish sales data was converted from sold packages to mass 
units. The information available on the Medstat.dk website (The Danish Health Data Authority 2020) 
made it possible to produce a seemingly good estimate of the total sales. However, it was not possible 
to validate these estimates within this project.  
The weighted per capita sales figure was calculated as the sum of the masses sales in the BSR 
countries, where sales information was available, divided by the population in those countries. For 
countries, for which no sales statistics were collected (BY, CZ, NO, SK and UA), this value was used.  
As the calculations were carried out for the whole BSR, national information on sewage treatment 
and waste management was also utilized in order to account for the regional differences. Information 
on sewer network coverage was collected for all countries with regions within the Baltic Sea 
catchment area. Information on waste management was collected in a parallel activity of project 
CWPharma (Mehtonen et al. 2020). The national input data on waste and sewage management are 
presented in Table 3. Since waste management statistics in all countries were either lacking or 
24 
 
outdated, no information on which fraction of improperly managed unused pharmaceuticals are 
eventually flushed into the sewer network. Therefore, a constant of 0.5 was applied to the whole BSR. 
 




Fraction of sold 
pharmaceuticals 









BY 0.08 0.28 0.83 
CZ 0.08 0.28 0.99 
DE 0.08 0.28 0.99 
DK 0.08 0.28 0.99 
EE 0.08 0.28 0.99 
FI 0.04 0.65 0.99 
LT 0.08 0.12 0.96 
LV 0.08 0.08 0.92 
NO 0.08 0.28 0.75 
PL 0.08 0.07 0.99 
RU 0.08 0.05 0.67 
SE 0.05 0.72 0.99 
SK 0.08 0.28 0.95 
UA 0.08 0.28 0.61 
1) Mehtonen et al. 2020. When no national value was available, an average based on available values was issued. 





2.3.2. Scenarios for API dissipation in inland and coastal waters 
 
Bio- and photodegradation were taken into consideration when estimating the removal rates in rivers 
and lakes, and in coastal waters. The seasonal differences in the rates were taken into consideration 
by carrying out the calculations with five different scenarios for the inland processes. The riverine 
dissipation processes were included into three of these (scenarios 1, 2 & 3), while scenario 0 included 
only removal due to metabolism, waste management and WWTP processes. Scenario -1 presented 
the “total residue approach” used in the environmental risk assessment of pharmaceuticals (EMA 
2006) and included no removal processes. These scenarios are presented in Table 4. The estimated 
variation in coastal temperature and light conditions were averaged to produce one estimate on 
annual the average concentration (see chapter 2.2.3 and Eq. (15)). 
 
Table 4. Scenarios for degradation in inland waters. 
Scenario Removal processes 
(biodegradation & 
photodegradation) 
River flow conditionsa) Water temperature 
in inland areas 
-1 
All sold mass is assumed 
to be discharged into 
environment 
• No removal processes 
taken into 
consideration.  
• No flow conditions 
taken into 
consideration 




Effluent mass in waste-
waters is assumed to 
reach the Baltic Sea 
• Metabolism and 
removal at WWTP 
included 
• Environmental removal 
processes not taken into 
consideration 
• Flow speed (m/s) not 
used in calculation 
• Flow rate (m3/s) at 
river mouths assumed 
to be the average of 
annual averages  




no impact on 
results 
1  
Effluent load is reduced by 
environmental processes 
before reaching the Baltic 
Sea (annual average) 
• Biodegradation rate is 
corrected to scenario 
temperature.  
• Photodegradation (incl. 
radiation initiated 
degradation) takes place 
in 1.5% of the total 
water volume.  
• Flow speed assumed 
to be annual average 
(0.15 m/s) 
• Flow rate at river 
mouths assumed to 
be the annual average 
• North from GoFb): 
7 °C 
• South from GoFb): 
9 °C 
2 
Effluent load is reduced by 
environmental processes 
before reaching the Baltic 
Sea (summer conditions) 
• Biodegradation rate is 
corrected to scenario 
temperature.  
• High radiation energy 
and long days leads to 
the best possible 
photoactivity. 
Photoactivation takes 
place in 4.5% of the 
total flow volume. 
• Flow speed assumed 
to be 80% of the 
annual average (0.12 
m/s) 
• Flow rate at river 
mouths assumed to 
be 80% of the annual 
average 
• Whole BSR: 18 °C 
3 
Effluent load is reduced by 
environmental processes 
before reaching the Baltic 
Sea (winter/spring 
conditions) 
• Biodegradation rate is 
low due to low 
temperature. 
Biodegradation rate is 
corrected with 
temperature. 
• Photolysis not included 
• Flow speed assumed 
to be 120% of the 
annual average (0.18 
m/s) 
• Flow rate at river 
mouths assumed to 
be 120% of the annual 
average 
• Whole BSR: 5 °C 
a) Annual average flow rates for each river in the BPL model are presented in Annex 3. 
b) GoF = Gulf of Finland, the threshold line was set to Y-coordinate 4 300 000 
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Water flow in inland scenarios 
Flow rate values used in the BPL model are based on the average of the annual averages as reported 
by HELCOM (HELCOM 2018b). These values were then modified for each river, using a scenario-
specific multiplier. The scenario-specific multipliers were estimated using literature data on river 
flow rates, and their variation. For example, the long-term average discharge from the area of Finland 
was 3,293 m3/s during 1912-2004 (Korhonen 2007). The annual was about 18%. In Finland the lowest 
monthly mean discharges were roughly 80% of the annual long-term average (Korhonen 2007). The 
discharge in high flow situations in spring was up to 200% of the mean. However, as the calculation 
approach in BPL aims to estimate the annual average loads and concentrations, only moderate flow 
rate values were chosen for the scenarios. In reality some of the flow peaks in different rivers may be 
much more than 120% of the mean, resulting in the calculated concentrations exceeding those 
measured in the actual environment during those flow peaks. 
Based on these considerations, in scenario 2 (low flow situation) flow rate and flow speed at river 
mouths were assumed to be 80% of the average (see Table 1). In scenario 3 (high flow situation) flow 
rate and flow speed were assumed to be 120% of the average. 
 
Water temperature in inland scenarios 
Using the equations presented in chapter 2.2, water temperature affects the degradation of 
substances in the environment. The temperatures used in inland scenarios are presented in Table 4, 
while the considerations behind those values are presented in the following paragraphs. 
 
Temperature in scenario 1 
Air temperature data from DWD (Deutcher Wettendienst) temperature maps were used to evaluate 
the mean water temperatures in the study area. South from the latitude of Gulf of Finland (Y-
coordinate <4 300 000) the annual mean air temperature for 1981–2010 was about 5–10 °C according 
to DWD maps. North from this latitude the mean air temperature was about 0–5 °C.  
However, the difference between mean air and mean water temperatures is greater in the north 
because of the longer ice-covered period. In Finland the mean annual temperatures of river waters 
are approximately 6–8 °C (Hertta database). Similar values were available also for lakes. For example, 
in lake Saimaa in Finland, the mean surface water temperature was about 8 °C in 1995–1998 while 
the water temperature was assumed to be 1 °C during the ice-covered period (Hertta database).  
A mean value of 12 °C is suggested to be used when calculating the degradation of substances in 
Europe (European Chemicals Agency, 2017). The mean annual water temperature of the River Vistula 
in Poland is 8 °C in the upper reaches and 9 °C in the middle and lower reaches. In the middle and 
lower parts of the river the water is about 2 °C warmer than the mean annual air temperature of 
Poland (Parczewski & Pruchnicki 2017). In Latvian rivers the mean water temperature for period 
2000–2019 was also about 9 °C (LEGMC 2020). 
Based on these data, 9 °C was selected as the water temperature for scenario 1 in regions south from 
the latitude of Gulf of Finland. 7 °C was selected for the area north from this latitude. The lower value 
is relevant mainly for Finland and Northern Sweden. 
 
Temperature in scenario 2 
Mean long-term surface water temperatures in some Finnish lakes (e.g. Lake Pielinen, Lake Kallavesi, 
Lake Lappajärvi) are about 18 °C in July. The mean temperature in surface waters is about 2 °C higher 
than the mean air temperature in July (Korhonen 2002). Mean river water temperatures are 18–19 °C 
in Finland in July (biggest rivers in Hertta database). 
The water temperature of River Vistula varies from 12 °C to 15 °C in summer. In river sections that 
are thermally affected by nearby industries, however, the water temperature is as much as 6 to 10 °C 
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higher (Parczewski & Pruchnicki 2017). Mean water temperatures in Latvian rivers in the Daugava, 
Gauja, Lielupe and Venta river basin districts were about 19–21 °C in July during 2000–2019 (LEGMC 
2020). 
According to DWD temperature maps the mean air temperature in July in 1981–2010 was 15–20 °C 
throughout the study area except in the northern parts of Finland and Sweden. Therefore, water 
temperature of 18 °C was used in scenario 2 in the whole study area. 
 
Temperature in scenario 3 
In River Prosna in Poland and in River Daugava in Latvia the high flow peaks occur in springtime 
(European Environmental Agency, 2016). In Finland high flow situations usually occur during the 
snow melt or afterwards from April to June (Korhonen 2007). High flow situations seem to occur 
later in northernmost parts of the study area than in the lower latitudes.  
During 1961–2000 the surface water temperature reached 5 °C in southern Finland in the beginning 
of May and in northern Finland at the end of May or in early June. In spring the average air 
temperature is a couple of degrees higher than the water temperature (Korhonen 2002). 
According to DWD temperature maps the mean air temperature reached 5–10 °C in the study area 
south from the latitude of Gulf of Finland in April and north from that latitude in May in 1891–2010. 
The timing of the high flow situations also varies spatially. Scenario 3 represents the situation during 
flow peaks. Therefore, a temperature of 5 °C was chosen for this scenario for the whole study area. 
Because the study area is large, this scenario occurs in different months in different regions. 
 
Sedimentation rate in coastal areas 
The sedimentation rate around BSE (sediment profiles accumulated after 1963- 1986 until 1995-2003) 
were 60–6,160 g/m2 per year (Mattila et al. 2006). E.g. in Gdansk bay, the annual sediment 
accumulation has shown to be 176–966 g/m2 (literature referred by Damrat et al. 2013). The organic 
carbon content of BSE sediments varies from 0.1% to 16% (Leipe et al. 2010). The burial rate of 
particulate organic carbon in mud areas around BSE was 14–35 g/m2 per year (Leipe et al. 2010). They 
also calculated that 3.5 +/- 2.9 MT of particulate organic carbon is annually buried in the whole BSE 
area (including sediment accumulation areas and areas with no sedimentation). Based on the values 
presented by Leipe et al. (2010), 𝑘𝑆𝐸𝐷𝑃𝑂𝐶 was assigned the value 20 g/m
2/a. 
 
Photoactivity – radiation penetration in coastal areas 
As was presented earlier in chapter 2.2.3 (p. 22), the water column in coastal waters was divided into 
three layers, varying on the estimated photoactivity. Layers h1 and h2 are assumed to be photoactive, 
while the bottom layer (h3) is assumed not to receive enough light to sustain photolysis in any 
meaningful extent. The proportion of the depths of photoactive layers h1 and h2 to the total depth 
are significant for photodegradable APIs.  
Although UV radiation penetrates only few centimeters, the very thin surface layer is mixed with 
waves and the depth of sea water exposed to full spectra of solar radiation is higher than that of still 
water. The first layer depth (h1) is selected to represent the significant wave height in June, when 
radiation – and photodegradation is at its highest. The monthly average of significant wave height 
has its minimum (about 0.5 m) in June (e.g. Pettersson et al. 2019) in all BSE areas.  
Secchi depth was planned to be used as the bottom depth of the second layer. The secchi depths vary 
between BSE regions (av. 4–8 m in open sea areas). However, the variation from on shore to open 
sea is even higher. In estuaries the secchi-depth may be very low (sometimes <0.5 m). Because the 
focus of the model is the coast 0–3 km from on-shore, it was decided that no regional secchi-depth 
scenarios were used but a value of 2,5 m is used for all coastal areas. Radiation and thus 
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photodegradation is significantly lower in the second layer than in the surface and thus its thickness 
(bottom depth) is not as significant as that of the surface layer.  
The radiation available for photosynthesis (for algae and aquatic plants) in different sea water depths 
is studied e.g. by Simis et al. (2017). They found that the radiation energy decreases fast with depth. 
This idea was applied to photodegradation in this model. Photoactivity factor (𝑎(𝑞, 𝑙) in Eq. (16)) was 
assumed to decrease to 1/z when moving from layer h1 to h2. The parameter z is a factor describing 
the assumed decrease in photoactivity when moving to deeper water columns. In this work, z was 
assigned a constant value of 4, corresponding to exponential decrease in radiation activity, as 
demonstrated in Figure 8.  
 
Figure 8. Radiation energy decreases with depth. According to the selected depths of layers 1 and 2, the radiation energy in 
layer 2 (0.5 m–2.5 m) is about ¼ => z=4. 
 
Seasonal variation 
Seasonal variation in photodegradation activity was estimated based on the seasonal variation of 
radiation energy. It is highest in June (mid-summer) and lowest in December, when no 
photodegradation was assumed.  Some photoactivity is assumed to take place from March to 
September. The seasonal variation of photodegradation activity, as used in the BPL model, is 
presented in Table 5. 
 
Water temperature in coastal areas 
The Baltic Sea surface water temperature has increased during the last 30 years at a rate of about 0.59 
°C/decade. During 2014–2018 the annual mean surface temperature has varied between 8.0 and 9.0 
°C (Siegel and Gerth 2019). The maximum difference in annual temperatures between areas is about 
3 degrees Botnian Bay being the coldest and southern parts of BS being the warmest. In coastal areas 
temperatures are higher than in open sea areas especially in summer time. Taking into account the 
simplifications contained in the BPL model, it was not considered worthwhile to create very detailed 
scenarios. Thus, the regional variations in temperature were simplified by dividing the BSE area into 
three temperature regimes.  
Surface temperature is measured daily – also from satellites. However, in deeper depths, the amount 
of data is lower. On average it seems that thermocline is in 30–50 m depth. Water temperature varies 
seasonally above thermocline. The annual variation of temperature and radiation causes faster 
degradation than the annual averages of the same values but the actual difference between annual 
average and seasonal variation depends on the depths. Temperatures used in the calculations are 
presented in Table 5. 
 
  













Relative radiation (proportion of energy compared to that on suraface) 
A quess: activation decreasing with depth
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Table 5. Temperatures used in the three depth-layers and different latitudes. (Q1: Jan-Mar, Q2: Apr-Jun, Q3: Jul-Sep, Q4: Oct-
Dec) 












𝑎(𝑞, 𝑙) [-] 0.05 1 0.5 0 0.0125 0.25 0.125 0 0 0 0 0 
Temperature [°C] 
Northern parts 
(Bothnia bay & 
Bothnia sea, 
North from  
Y-coordinate 
4 300 000) 
0 10 19 2 0 9 16 1.6 0.4 4.6 12 2.5 
Middle areas 
(including Gulf 
of Finland & 
Gulf of Riga, Y-
coordinates 
between 
3 700 000-4 300 
000) 







3 700 000) 
2 14 21 6 2 14 19 6 3 8 14 5 
a) Layer depths are capped at total depth. I.e., if total depth is 1.4 m, layer h1 is 0–0.5 m and layer h2 is 0.5–1.4 m. 
b) Sedimentation is assumed to take place only when the load from land areas enters the BS. Sedimentation rate is assumed not to 
vary from seasonally or regionally. 
c) Photodegradation is assumed to be similar in all regions. Values presented for layer h2 are calculated from values assigned to 




2.3.3. API-specific properties 
The APIs selected to be modeled in this work, as well as their sales data for the BSR countries are 
presented in Table 2 in chapter 2.3.1. API-specific property data required by the BPL model were 
compiled through a literature review. Various search engines were utilized (e.g. Web of Science, 
Google Scholar) and results from studies with an experimental design relevant for the BSR were 
collected. API-specific property data, such as information about degradation pathways and half-lives, 
binding to solids and excretion rate were compiled. The partitioning coefficients (Koc) and PNEC-
values collected by Ek Henning et al. (2020) were used. Properties relevant for the BPL model for the 
selected APIs are presented in Table 6. The considerations in selecting these values is presented in 
the following sub-chapter. 
 















CBZ 3 12.01) 4502) - - 3241) 128,0001) 
CLM 30 29.11) 403) - - 4571) 3.911) 
DCF 61.5b) 6.421) 2.44) 605) 31.55) 2191) 85.21) 
IBU 1 95.0 96.35) 24.85) 31.55) 2,0901) 0.121) 
MTF 100 99.81) 28.36) - - 19.11) 1,3501) 
OFL 90 86.51) 10.62) - - 2,0401) 20.41) 
TRD 10 3.101) 4.77) 1217) 237) 6171) 170,0001) 
VFX 5 19.81) 3.57) 1147) 237) 1911) 3,2201) 
a) Removal at WWTPs is defined here as removal from the water phase (influent concentration vs. effluent concentration). This 
parameter includes removal due to biodegradation and hydrolysis, as well as due to adsorption onto particles and potential 
volatilization. 
b) Excretion rate for orally administered DCF is estimated to be 1%. However, due to a high fraction of overall sales being used 
topically, the effective excretion rate is higher. In Finland it is estimated, that 65% of DCF is used topically. Only 6% is of 
topically administered DCF is estimated to be absorbed. Using these data, the excretion rate was calculated following the 
method presented by Äystö et al. 2020.
1) Ek Henning et al. 2020 
2) Andreozzi et al. 2003 
3) Vione et al. 2009 
4) Fass.se 
5) Arajuo et al. 2014 
6) Straub et al. 2019 
7) Rúa-Gómez & Püttmann 
2013 
 
Selection of API-specific input data 
Carbamazepine 
In CWPharma, CBZ removal was calculated for 21 pairs of influent and effluent wastewater samples. 
The removal rates ranged from -360% to 98% (Ek Henning et al. 2020). The median and average 
removal rates were 12% and -7.6%, respectively. The removal rate of 12% was used for the calculations. 
Björlenius et al. (2018) estimated an overall removal half-life of 1,294 d in the Baltic Sea environment. 
However, many sources report shorter half-lives, such as 37.8 d (Andreozzi et al. 2002) and 73 d 
(Álvarez-Ruiz et al. 2020). In another paper Andreozzi et al. (2003) concluded that CBZ photolysis in 
northern regions is slow, and the half-life for direct photolysis in central Europe is in the range of 
450 d in the autumn. The photolysis half-life of 450 d was used for the calculations. 
 
Clarithromycin 
In CWPharma, CLM was estimated to be removed in conventional WWTPs on average by 22.3% (Ek 
Henning et al. 2020), while the median removal rate was estimated to be 29.1%. The latter value, 
29.1%, was selected to be used here. 
Information on CLM removal in environmental processes is scarce. However, some information on 
its photodegradation is available. Vione et al. (2009) concluded that the photodegradation half-lives 
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DCF removal rates based on the samples taken in CWPharma (Ek Henning et al. 2020) ranged 
between WWTPs from -150% to 33%. The average rate was -14.6%, while the median value was 6.42%. 
There is high variability in DCF removal in WWTPs. However, the removal rates are usually slightly 
positive. Therefore, the median value, 6.42% was selected here. 
DCF has long been an API of interest, and therefore there is more information on its environmental 
properties than on many other APIs. Photodegradation half-lives for DCF in Central Europe have 
been estimated to range from <1 to 5 d. According to the Fass.se database, photolysis half-life for DCF 
is 2.4 d, while according to Arajuo et al. (2014) reported DCF photolysis half-lives to range from 5.76 
to 2.15 d, depending on whether the sample was filtered or unfiltered. The value 2.4 d was selected 
to represent the photolysis half-life. 
DCF is also known to be slowly biodegradable. According to Arajuo et al. (2014) the biodegradation 
half-life is 60 d. 
 
Ibuprofen 
IBU removal at WWTPs is high according to most literary sources. In CWPharma project the removal 
rate could only be calculated for one sampling occasion at one WWTP. The removal rate was 
estimated to be 86% (Ek Henning et al. 2020). However, the removal rates are often >90% (e.g. Miehe 
2010, Äystö et al. 2020). Therefore, a removal rate of 95% was used for the calculations. 
According to Packer et al. (2003), IBU degrades through photolysis in river water, with a half-life of 
0.11 d. This is in stark contrast with the results reported by Arajuo et al. (2014) who tested the 
persistence of four APIs in filtered and unfiltered waters using different light conditions. The half-
life they reported for IBU in filtered lake water under sunlight was 96.3 d. In addition to testing 
photodegradation of selected APIs, Arajuo et al. (2014) also tested their degradation in filtered water 
in darkness. In this test, they estimated a half-life of 248 d for IBU. However, considering the high 
degradability of IBU often demonstrated in WWTPs, this value seems very high for biodegradation. 
They also reported an overall half-life of 19.7 d in unfiltered lake water under natural sunlight (Arajuo 
et al. 2014). Using the k-values reported by Arajuo et al. (2014), a biodegradation half-life of 24.8 d 
was estimated. This value was used in combination with the photodegradation half-life of 96.3 d. 
 
Metformin 
Between 98-100% of MTF was estimated to be removed during WWTP processes (Ek Henning et al. 
2020). The value 99.8% was selected to be used here. However, there is relatively little information 
on its environmental properties. Straub et al. (2019) estimated its photolysis half-life to be 28.3 d. 
This value was used for the calculations. No information on MTF biodegradation was available. 
 
Ofloxacin 
In the project CWPharma, OFL removal values could only be estimated for two data points. The 
average removal rate was 86.5% (range: 83–90%) (Ek Henning et al. 2020). However, according to Ek 
Henning et al., the removal rates reported in literature vary a lot, ranging from -157% to 99%. 
Therefore, a removal rate of 86.5% was used for the calculations. 
Andreozzi et al. (2003) reported OFL to go through photodegradation in relatively northern areas 
(50 °N), with half-lives ranging from 1.6 to 10.6 d. As the Baltic Sea catchment area is located between 
49–70 °N, the highest reported value was used to represent photodegradation in the region. No 
information was found on biodegradation rates for OFL, but there are some indications that it is 
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biodegraded relatively efficiently (Jung et al. 2009). Nevertheless, OFL was considered to go through 
photodegradation only and no biodegradation was assumed to take place. 
 
Tramadol 
Previously TRD removal rates have been reported to range from -26% (Hörsing ym. 2014) to 50% 
(Rúa-Gómez & Püttmann 2011). In the CWPharma project, TRD removal rates in WWTPs ranged 
from -105 to 90% (Ek Henning et al. 2020) with the median removal rate of the 20 data points being 
3.1% (avg -1.5%). The range of the removal rates is wide, but the average and median values are well 
in line with the removal rates reported by Fick et al. (2011) and Verlicchi et al. (2012), -3% and 4%, 
respectively. In the calculations the median removal rate (3.1%) calculated in CWPharma was used. 
According to Rúa-Gómez & Püttmann (2013), indirect photodegradation is the dominant process for 
TRD degradation in natural waters. They tested the degradation of five APIs in different types of 
waters (ultrapure, river water, river water with no biotic processes) in different conditions. The half-
life of TRD in natural river water was reported to be 3.7 d. The values selected for the calculations for 
half-life attributed to photodegradation by sunlight was 4.7 d, and biodegradation half-life at 23 °C 
was 121 d.  
 
Venlafaxine 
VFX removal rates in WWTPs were estimated to vary between -90 and 63% (Ek Henning et al. 2020). 
The median and average removal rates were 14.5 and 19.8%, respectively. Previously reported values 
have ranged from 7.7% (Gurke et al. 2015) to 21% (Fick et al. 2011) and 49% (Rúa-Gómez & Püttmann 
2011). The removal rate selected for calculations was 19.8%. 
According to Rúa-Gómez & Püttmann (2013), indirect photodegradation is the dominant process for 
VFX degradation in natural waters. The overall half-life in natural river water was reported to be 2.4 
d. The values selected for the calculations for half-life attributed to photodegradation in sunlight was 





3. Results and discussion 
3.1. Loads to river mouths 
To identify the rivers with the highest API loads to the BS, the river-specific loads were divided with 
the load from the river with the highest load. This quotient was then used in ranking the rivers based 
on how high or low the API-specific load was compared to other rivers. These values were then 
averaged between different APIs and different calculation scenarios to produce a concise estimate 
on which rivers carry the highest API loads to the BS. The rivers with generally the highest API loads 
are presented in Figure 9 and Table 7. 
The rivers with generally the highest loads included rivers with very high population density in the 
river basin (e.g. Damhusåen, 3 100 pers./km2), but also rivers with very low population density (e.g. 
Oulujoki, 6.8 pers./km2). Based on the BPL model, loads to the mouths of rivers correlate well with 
the population in river basin. However, national and regional differences, such as differences in 
consumption patterns and environmental conditions, also have an impact on the load to the river 
mouth.  
The simulated loads in scenario -1 were higher than those in any other scenario (for scenario 
descriptions, see Table 4). The simulated loads in scenario 0 varied from 1% (IBU) to 56% (DCF) of 
those in scenario -1 depending on the API. This indicates the high importance of metabolism and 
wastewater treatment, which are included into scenario 0 but not in -1. The difference between 
simulated loads in scenario 0 and those estimated using scenarios 1, 2 and 3 was rather small in most 
cases, indicating that degradation in rivers and lakes plays a minor role in the total dissipation. The 




Figure 9. API loads from each river included into the BPL model relative to emissions from other rivers. The rivers with the 




Table 7. Estimated API Loads to the mouths of 15 rivers receiving the highest API loading within the BSR. The loads were 
generally highest to the mouth of rivers with the highest population in their river basins (see Annex 3). 
River Scna) 
Load to river mouth [kg/a] 
CBZ CLM DCF IBU MTF OFL TRD VFX 
Vistula, PL 
1 922 1,140 2,530 108 15,300 16.2 835 357 
0 923 1,150 2,770 138 15,500 16.4 919 395 
-1 16,300 5,120 4,900 13,900 411,000 114 7,380 5,920 
Oder, PL 
1 603 742 1,740 24.2 3,130 9.42 558 238 
0 604 748 1,890 29 3,160 9.55 610 261 
-1 10,700 3,360 3,350 12,100 276,000 76.9 4,910 3,950 
Neva, RU 
1 171 196 228 232 30,000 9.22 117 53.5 
0 173 198 553 425 30,200 9.29 225 104 
-1 3,020 787 966 37,200 111,000 26.3 1,810 1,520 
Nemunas, LT 
1 78.4 101 524 76.5 6,380 3.81 148 63.2 
0 78.5 102 563 87.6 6,430 3.85 160 68.4 
-1 1,490 444 999 12,900 56,800 20.5 1,320 1,060 
Daugava, LV 
1 80.8 102 773 109 5,210 4.29 66.3 19.4 
0 80.9 102 813 122 5,260 4.32 71.2 21.2 
-1 1,460 443 1,440 17,700 38,800 21.9 586 328 
Norrström,SE 
1 33.0 24.6 150 8.92 247 3.02e-04 32.6 14.4 
0 33.3 24.8 295 21.7 250 3.05e-04 65.5 29.6 
-1 1,060 119 533 22,100 21,800 0.00246 663 676 
Pregolya, RU 
1 33.1 40.3 87.3 29.3 2,240 0.970 34.3 15.1 
0 33.1 40.4 91.4 29.7 2,250 0.975 35.7 15.8 
-1 569 174 161 1,830 16,000 4.39 283 227 
Narva, RU 
1 29.6 42.6 115 8.94 2,710 1.02 11.3 3.79 
0 29.8 43.2 285 47.9 2,750 1.03 29.2 10.3 
-1 545 187 509 6,630 15,100 3.79 237 147 
Göta älv, SE 
1 23.9 18.1 109 7.99 247 0.0238 24.3 10.9 
0 24.1 18.2 212 16.3 249 0.0242 47.3 21.3 
-1 765 87.4 383 15,800 15,800 0.0815 477 485 
Kokemäenjoki, FI 
1 13.9 6.47 82.8 4.86 248 0.193 10.0 4.88 
0 14.0 6.55 199 17.4 250 0.195 24.9 12.6 
-1 445 31.2 357 17,600 21,600 1.56 250 284 
Luga, RU 
1 11.3 13.4 26.9 26.6 2,080 0.632 13.8 6.3 
0 11.3 13.5 28.2 28.8 2,090 0.639 14.4 6.63 
-1 188 53.3 48.7 1,680 6,600 1.75 113 91.0 
Lielupe, LV 
1 13.5 16.9 147 11.0 390 0.781 12.7 3.77 
0 13.5 17.2 181 17.3 395 0.792 15.9 4.81 
-1 237 75.3 319 3,150 6,260 4.70 128 72.9 
Vantaanjoki, FI 
1 7.83 3.65 104 8.86 140 0.109 13.0 6.54 
0 7.84 3.66 111 9.7 140 0.109 13.9 7.01 
-1 248 17.4 199 9,820 12,100 0.870 139 159 
Kymijoki, FI 
1 9.48 4.42 41.8 3.42 169 0.131 5.18 2.59 
0 9.58 4.47 136 11.9 171 0.133 17.0 8.57 
-1 304 21.3 243 12,000 14,800 1.06 170 194 
Venta, LV 
1 7.63 9.72 98.6 8.85 227 0.450 10.7 3.59 
0 7.63 9.74 102 9.24 228 0.452 11.1 3.74 
-1 134 42.8 180 1,730 3,890 2.74 89.4 56.8 




3.2. Loads to the Baltic Sea 
3.2.1. Carbamazepine 
Annual CBZ sales within the Baltic Sea drainage basin were estimated to be 50 tonnes. CBZ loads 
were estimated to originate mainly from inland areas. Inland areas and inland urban clusters 
accounted for 80% of the load reaching the BS, while coastal cities (i.e. coastal urban clusters) 
accounted for 15% of the total annual load of 2.6 tonnes. Most of the emissions reaching the BS (61%) 
were estimated to originate from Poland (Figure 10). 
 
Figure 10. Carbamazepine loads reaching the Baltic Sea from each country and region, estimated according to scenario 1. 
Circa 47% of the CBZ emissions within the Baltic Sea drainage area were estimated to originate from 
its use, while the rest was estimated to originate from the improper treatment of unused 
pharmaceuticals (Figure 11). However, due to poor data on pharmaceutical wastage and treatment of 
that waste, this estimate contains large uncertainties. Estimates on the mass of pharmaceuticals 
flushed into the sewer network are uncertain. Here it was assumed, that 50% of the pharmaceutical 
waste that is not treated properly, is flushed into the sewer network. Changing this fraction would 





Figure 11. Carbamazepine flows according to scenario 1. Green boxes present end-points/processes, where the load is destroyed 
before reaching the environment. Orange boxes present suboptimal management practices, while yellow boxes present 
emissions into the water environment. 
 
The total CBZ loads reaching the Baltic Sea from each grid cell are presented in Figure 12. The load 
estimates are highly dependent on the sales information. When looking at sales figures presented in 
Table 2, or the cell-specific loads presented in Figure 12, Lithuanian consumption and subsequent 
emissions seem rather low compared to other countries. The Lithuanian consumption information 
used in the calculations was compiled by the project MORPHEUS for a smaller part of Lithuania, and 
it is unclear how well this information presents the situation in the whole country. 
National per capita loads to the BS ranged from 11 mg/a in Lithuania to 39 mg/a in Estonia and 41 
mg/a in Poland and Latvia. When calculating per capita loads by calculation areas, the highest 
emissions were estimated to originate from coastal Latvia (see Figure 13). When looking at the 
calculation area-specific per capita emissions, it must be noted that the calculation areas mainly 
follow the outlines of river basins, giving no regard to country borders. For instance, despite the 
national per capita emissions being the lowest in Lithuania, the per capita emissions within the 
calculation areas covering large parts of Lithuania are much higher. This is caused by those 
calculation areas also covering regions in other countries, with higher per capita CBZ consumption 









Figure 13. Mean per capita CBZ load reaching the Baltic Sea, aggregated by calculation areas. The dashed area shows the 
countries for which no national sales data was available, but a population weighted average value was used. 
 
When looking at individual urban clusters emitting wastewaters into the Baltic sea, the highest 
emissions are estimated to originate from St. Petersburg. Although the assumed per capita 
consumption of CBZ does not differ greatly between Russia and other countries (see Table 2), the 
estimated CBZ emissions from other coastal cities are generally less than one fifth of the emissions 
originating from St. Petersburg (Figure 14). However, since the consumption value is an average 





Figure 14. Ten coastal urban clusters with the highest CBZ emission reaching the Baltic Sea. The green bars present the cities 
in countries with sales statistics available, while orange bars represent cities in countries where an average per capita sales 
value was used. The numerical value presents the calculated load in kilograms, using two significant numbers. 
The coastal areas with the highest incoming CBZ loads were estimated to be located in Poland, in 
the Gdansk and Bornholm basins, as well as on the coast of St. Petersburg, in eastern Gulf of Finland 











The overall sales of CLM in the Baltic Sea drainage area were estimated to be 14 tonnes, resulting in 
a total load of 3.1 tonnes being emitted into the aquatic environment. The annual load eventually 
reaching the Baltic Sea was estimated to range from 3 to 3.1 tonnes. This high portion of effluent load 
estimated to reach the Baltic Sea reflects the fact, that no biodegradation was taken into 
consideration for CLM, but that it was assumed to only degrade through photolysis. Circa 63% of the 
load reaching the Baltic Sea was estimated to originate from Poland, followed by emissions from 
Russia (12%) and Sweden (4%). The emissions were estimated to originate mainly from inland areas 
and inland urban clusters (circa 81%), while coastal cities accounted for 14%. National loads are 
presented in Figure 16. 
 
Figure 16. Clarithromycin loads reaching the Baltic Sea from each country and region class, estimated according to scenario 
1.  
CLM was estimated to originate mainly from consumption and subsequent excretion in areas 
connected to centralized wastewater treatment (Figure 17). The load to surface waters from areas 




Figure 17. Clarithromycin flows according to scenario 1. Green boxes present end-points/processes, where the load is destroyed 
before reaching the environment. Orange boxes present suboptimal management practices, while yellow boxes present 
emissions into the water environment. 
As no biodegradation was taken into consideration, the overall degradation rate was rather low. 
Therefore, the regional distribution of the emissions reaching the Baltic Sea, presented in Figure 18 
are rather similar as those estimated for CBZ (Figure 12), but differ from those of e.g. DCF (Figure 
24). As the degradation rate decreases, the significance of flow time from emission source to the 
Baltic sea decreases. This makes emissions from e.g. inland urban clusters more important. 
The national per capita loads to the Baltic Sea from coastal countries ranged from 8.2 mg/a in Finland 
to 68 mg/a in Estonia. This difference is in line with national per capita sales presented in Table 2. 
Regionally the highest per capita emissions were estimated to originate from coastal areas in Estonia 









Figure 19. Mean per capita clarithromycin load reaching the Baltic Sea, aggregated by calculation areas. The dashed area 
shows the countries for which no national sales data was available, but a population weighted average value was used. 
 
The ten coastal cities estimated to emit the highest load or CLM into the Baltic Sea are presented in 
Figure 20. The city emitting the highest CLM load to the Baltic Sea was estimated to be St. Petersburg. 
However, as there is no information available on actual sales of CLM in Russia, but an average has 
been used, the results are very uncertain. Replacing the average per capita sales used for Russia (0.41 
mg/d/person) with the minimum and maximum per capita sales values reported from other 
countries, 0.11 mg/d/person and 0.86 mg/d/person (see Table 2), can help us estimate the range of 
emissions from St. Petersburg. Thus, the emissions would likely range from 46 kg/a to 370 kg/a. In 




Figure 20. Ten coastal urban clusters with the highest clarithromycin emission reaching the Baltic Sea. The green bars present 
the cities in countries with sales statistics available, while orange bars represent cities in countries where an average per capita 
sales value was used. The numerical value presents the calculated load in kilograms, using two significant numbers. 
The load reaching coastal waters in different areas is presented in Figure 21. CLM was estimated to 
be emitted in highest total quantities to the coastal areas in Poland, in the Gdansk basin (1,200 kg) 










Annual DCF sales within the Baltic Sea drainage basin were estimated to be 22 tonnes. The total loads 
to the Baltic Sea, estimated for DCF varied from 9.6 tonnes/a to 12 tonnes/a, estimated using 
scenarios 2 and 0, respectively, while the emission estimated using the whole residue approach 
suggested by EMA (2006) reached 22 tonnes. The Country emitting the highest DCF loads was 
estimated to be Poland, in all scenarios (Figure 22). Circa 20% - 25% of the DCF load reaching the BS 
was estimated to be emitted from coastal cities (coastal urban clusters), while the majority (64–69%) 
was estimated to originate from inland areas. The overall high emissions from inland areas are largely 
due to Poland, where inland emissions accounted for 96% of the total load to the BS. Coastal cities 
had a much higher impact on the total load e.g. in Denmark (45%), Finland (42%), Sweden (41%) 
and Latvia (38%).  
 
 
Figure 22. Diclofenac loads to the Baltic Sea from each country and region class, estimated according to scenario 1.  
 
DCF emissions reaching the Baltic Sea were estimated to originate mainly from the use of DCF within 
regions connected to centralized sewage treatment (Figure 23). Estimating the importance of waste 
management is much more uncertain, due to poor waste statistics. However, only a relatively small 







Figure 23. Diclofenac flows according to scenario 1. Green boxes present end-points/processes, where the load is destroyed 
before reaching the environment. Orange boxes present suboptimal management practices, while yellow boxes present 
emissions into the water environment. 
 
The grid cell-specific estimated DCF loads to the BS are presented in Figure 24. The emissions from 
areas with high travel times (see Figure 5) and significant lakes, in e.g. Central Finland, southern 
parts of Sweden, and areas in Russia, upstream from lakes Ladoga and Onega were estimated to be 
relatively low.  
The national per capita emissions reaching the Baltic Sea ranged from 15 mg/a (Norway) and 58 mg/a 
(Russia), to 520 mg/a (Latvia) and 540 mg/a (Estonia). When looking at individual calculation areas 
(Figure 25), the highest per capita DCF emissions reaching the Baltic Sea (640 mg/person/a) were 
estimated to originate in coastal areas in Estonia. The relatively high per capita emissions from 









Figure 25. Mean per capita diclofenac load reaching the Baltic Sea, aggregated by calculation areas (AlueId). The dashed area 
shows the countries for which no national sales data was available, but a population weighted average value was used. 
 
The cities with the highest total load to the Baltic Sea were estimated to be Riga and St. Petersburg 
with the annual emissions reaching 380 kg and 370 kg, respectively. Ten coastal cities with the 
highest emission to the Baltic Sea are presented in Figure 26. As the calculation scenarios assumed 
that coastal cities emit their treated wastewaters directly into the BS, these emissions do not undergo 




Figure 26. Ten coastal urban clusters with the highest diclofenac emission to the Baltic Sea. The numerical value presents the 
calculated load in kilograms/a, using two significant numbers. 
 
The coastal areas receiving the highest loads were estimated to be located in Poland. The DCF load 
to the coastal waters in the Gdansk basin were estimated to be 2,300–2,800 kg/a, depending on the 
calculation scenario. For reference, the DCF load to the coastal waters of the Gulf of Riga was 
estimated to range from 1,000 to 1,100 kg/a, and from 440 to 450 kg/a for the Finnish coast on the 









The annual sales within the Baltic Sea drainage area was estimated to be 420 tonnes. The estimated 
load to the BS was 1.6 tonnes/a. This is a small fraction of the load (420 tonnes) estimated using the 
total residue approach (EMA 2006). The total IBU load reaching the Baltic Sea, estimated using 
scenarios 1-3 (see Table 4), ranged from 1,100 to 1,300 kg/a. The emissions were estimated to originate 
mainly from coastal urban clusters, this region accounting for 48–53% of the load to the BS.  National 
loads are presented in Figure 28. Russia was estimated to account for 43–47% of the total load 
reaching the Baltic Sea.  
 
Figure 28. Ibuprofen loads reaching the Baltic Sea from each country and region, estimated according to scenario 1. 
 
Circa 66% of the IBU load in wastewaters within the Baltic Sea drainage basin was estimated to 
originate from improper treatment of unused medicines (see Figure 29). This is due to the very low 
fraction of IBU excreted unchanged (1%, see Table 6). Although the mass of consumed IBU is several 
times higher than the mass estimated to be left unused, wastage was estimated to be a significant 
emission source since that mass will never undergo metabolic processes. However, the mass of 
pharmaceuticals flushed into the sewer network contains large uncertainties. To allow for more 
elaborate estimates, more comprehensive statistics on pharmaceutical wastage and waste 
management would be required. 
Similarly, circa two thirds (1,100 kg) of the IBU mass emitted into the water environment was 
estimated to originate from untreated wastewaters. Although the load in influent wastewater at 
WWTPs is ten-fold (11,000 kg) compared to the one in wastewater generated outside sewer network 




Figure 29. Ibuprofen flows according to scenario 1. Green boxes present end-points/processes, where the load is destroyed 
before reaching the environment. Orange boxes present suboptimal management practices, while yellow boxes present 
emissions into the water environment. 
 
Regional distribution of the emissions reaching the Baltic Sea is presented in Figure 30. Emissions 
from coastal Russia were estimated to be relatively high, due to a high fraction of wastewater being 
left untreated (see Table 3). 
The national per capita emissions reaching the Baltic Sea ranged from coastal countries ranged from 
0.5 mg/a in Poland to 8.8 mg/a in Sweden, 16 mg/a in Finland, and 58 mg/a in Russia. When looking 
at individual calculation areas, the highest per capita emissions were estimated to originate from 
coastal cities in Russia (Figure 31). The high emissions from Russia, Belarus and Ukraine are in line 
with low sewer network coverage (see Table 3). As IBU is removed efficiently in conventional 









Figure 31. Mean per capita ibuprofen load reaching the Baltic Sea, aggregated by calculation areas. The dashed area shows the 
countries for which no national sales data was available, but a population weighted average value was used. 
 
The highest load originating from individual cities varied drastically, with St. Petersburg being the 
city emitting the highest load of IBU into the Baltic Sea. The city-specific IBU loads are presented in 
Figure 32. The country with the highest per capita IBU consumption in the region is Finland. The 
mass of sales were estimated to be 24 tonnes in Helsinki, and 22 tonnes in St. Petersburg. However, 
due to more pharmaceuticals being left unused, a smaller fraction of pharmaceutical waste being 
managed properly (see assumptions in Table 3), and a lower fraction of wastewater being treated, the 




Figure 32. Ten coastal urban clusters with the highest ibuprofen emission reaching the Baltic Sea. The green bars present the 
cities in countries with sales statistics available, while orange bars represent cities in countries where an average per capita 
sales value was used. The numerical value presents the calculated load in kilograms, using two significant numbers. 
 
IBU was estimated to be emitted in highest quantities to the coastal waters outside St. Petersburg, in 
eastern Gulf of Finland. These emissions were estimated to reach 450 kg/a. Other areas with high 
IBU loads were e.g. coastal waters outside Riga and Gdansk, with loads of 140 kg and 110, respectively. 









Annual MTF sales within the Baltic Sea drainage basin were estimated to be 1,400 tonnes. The overall 
annual MTF load estimated to reach the Baltic Sea was estimated to be 91 tonnes. This estimated 
load is significantly lower than the one (1,400 tonnes) suggested by the whole residue approach (EMA 
2006). The highest annual emissions (54–55 tonnes) were evaluated to originate from Russia, 
followed by emissions from Belarus and Ukraine (Figure 34).  
Circa 36% of the load to the BS were estimated to originate from coastal urban clusters. There were 
large differences between countries. For instance, in Poland, emissions coastal cities were estimated 
to account for only 2% of the load reaching the Baltic Sea. 
 
Figure 34. Metformin loads reaching the Baltic Sea from each country and region, estimated according to scenario 1. 
The load to the BS was estimated to originate largely from its use in areas not connected to 
centralized wastewater treatment (Figure 35). This is in line with results presented in Figure 34, 
which clearly reflect the coverage of sewer network in these countries. In the three countries 
accounting for the highest loads to the BS (RU, BY, UA), the fraction of population connected to 
wastewater treatment is less than 85%. This has a high impact on estimated MTF emissions, due to 
the API being efficiently removed in conventional WWTP processes (removal rate >99%). Emissions 
from WWTPs were estimated to account for only circa 3% of the load to the water environment, 
while the remaining 97% is emitted in wastewaters that are left untreated. This result is in line with 
those published by Bollmann et al. (2019), who identified untreated wastewaters to be significant 




Figure 35. Metformin flows according to scenario 1. Green boxes present end-points/processes, where the load is destroyed 
before reaching the environment. Orange boxes present suboptimal management practices, while yellow boxes present 
emissions into the water environment. 
 
The grid cell-specific MTF loads to the BS are presented in Figure 36. The areas in countries with 
relatively low fraction of wastewater is treated are highlighted as important emissions sources. On 
the other hand, areas with high population density are also shown as emission hotspots.  
The national per capita load reaching the Baltic Sea ranged from 130 mg/a in Sweden to 6,600–6,800 
mg/a in Ukraine. The per capita emission was highly dependent on the fraction of sewage that is lead 
to proper wastewater treatment. The highest per capita emissions in individual calculation areas 
(5,800 mg/a) reaching the Baltic Sea were estimated to be in coastal Russia (Gulf of Finland & 
Kaliningrad). However, as no actual sales figures are available for e.g. Russia or Ukraine (see Table 
2), these results rely strongly on the assumption, that the per capita consumption of MTF in these 









Figure 37. Mean per capita metformin load reaching the Baltic Sea, aggregated by calculation areas (AlueId). The dashed area 
shows the countries for which no national sales data was available, but a population weighted average value was used. 
 
The coastal cities with the highest MTF load reaching the Baltic Sea were estimated to be St. 
Petersburg and Kaliningrad. However, emissions from Russia are based on uncertain assumptions. 
For instance, as presented in Figure 1, the information on population density available in areas in 
Russia, and other areas outside the EU is very much less exact than for EU-member states. This may 
result in inaccurate estimations on spatial emissions. Ten coastal cities with the highest emission 





Figure 38. Ten coastal urban clusters with the highest metformin emission reaching the Baltic Sea. The green bars present the 
cities in countries with sales statistics available, while orange bars represent cities in countries where an average per capita 
sales value was used. The numerical value presents the calculated load in kilograms, using two significant numbers. 
 
The coastal areas with the highest incoming MTF load were estimated to be in the eastern Gulf of 
Finland, off the coast of St. Petersburg. The MTF load entering this coastal area was estimated to 
reach 46 tonnes annually. For reference, the MTF load entering the coastal waters in the Swedish 
coastal waters in the northern Baltic Proper off the coast of Stockholm were estimated to be around 
390 kg/a.  
The estimated loads to coastal waters in different parts of the Baltic Sea are presented in Figure 39. 
These estimated loads varied only slightly between scenarios. This is likely due to no biodegradation 










The total mass of annual sales of OFL within the Baltic Sea drainage area was estimated to be 340 kg. 
This would result in 58 kg being emitted into the water environment, assuming that the removal rate 
at MWWTPs is 86.5%. The total load reaching the Baltic Sea was estimated to range from 57 to 59 
kg/a, depending on the calculation scenario. This estimate covers only the emissions from the use of 
the racemic mixture (ofloxacin), and not those from the use of the enantiopure form levofloxacin. 
More discussion on this is presented in chapter 4.2 The high portion of emission to the surface waters 
eventually reaching the BS reflects the slow photodegradation and no biodegradation being 
incorporated into the calculations.  
The emissions reaching the Baltic Sea from individual countries is presented in Figure 40. Emissions 
were estimated to originate mainly from Poland and Russia, these countries accounting for 44% and 
32%, respectively. According to the calculations, coastal cities accounted for 20% of the load, while 
inland areas (including inland urban clusters) accounted for 76%. 
 
Figure 40. Ofloxacin loads reaching the Baltic Sea from each country and region class, estimated according to scenario 1.  
The majority of OFL emitted into water environment was estimated to originate from usage within 
sewer network coverage (Figure 41). However, circa 37% was estimated to originate from areas 
outside sewer network coverage. Improper management of pharmaceutical waste was estimated to 




Figure 41. Ofloxacin flows according to scenario 1. Green boxes present end-points/processes, where the load is destroyed 
before reaching the environment. Orange boxes present suboptimal management practices, while yellow boxes present 
emissions into the water environment. 
The estimated emissions from each grid cell are presented in Figure 42. The per capita load to be 
Baltic Sea varied between countries from 0.16 µg/person/a in Sweden and 0.37 µg/person/a in 
Denmark to circa 2.0 mg/person/a in Ukraine and 2.4 mg/person/a in Latvia. The relatively high 
emissions from Latvia are in line with consumption information (see Table 2). However, Ukrainian 
emissions are very uncertain due to no sales statistics being compiled for Ukraine. A population 
weighted average per capita consumption (0.013 mg/person/d) was used for Ukraine. However, the 
estimated high emissions from Ukraine reflect the relatively low level of sewer network coverage. As 
over 85% of OFL is removed in WWTPs, but removal in the environment is slow, the level of sewer 
network coverage has a direct impact on overall load to the Baltic Sea.  
When looking at regional emissions the highest per capita loads to the Baltic Sea (2.4 mg/person/a) 
were estimated to originate from coastal regions in Latvia (see Figure 43). Areas with the lowest per 








Figure 43. Mean per capita ofloxacin load reaching the Baltic Sea, aggregated by calculation areas. The dashed area shows the 
countries for which no national sales data was available, but a population weighted average value was used. 
 
Figure 44 presents the ten coastal cities with the highest OFL loads to the Baltic Sea. The highest 
load to the Baltic Sea was estimated to originate from St. Petersburg. It is noteworthy, that the OFL 
load estimated to originate from St. Petersburg accounts for roughly 49% of the total load originating 
from Russia. However, the absolute load from Russia, and its relation to emissions from other 




Figure 44. Ten coastal urban clusters with the highest ofloxacin emission reaching the Baltic Sea. The green bars present the 
cities in countries with sales statistics available, while orange bars represent cities in countries where an average per capita 
sales value was used. The numerical value presents the calculated load in kilograms, using two significant numbers. 
 
The highest OFL load was estimated to be emitted to the coasts off the cities of Gdansk and St. 
Petersburg, 170 kg/a and 140 kg/a, respectively. However, as these estimates are highly dependent on 
the sales data, which we do not have for Poland or Russia, the loads should be further investigated. 
To produce more elaborate estimates, better sales statistics would be required. When looking at loads 
to coastal areas in countries where sales statistics were collected, the highest load was estimated to 










The annual total TRD sales within the Baltic Sea catchment area were estimated to be 30 tonnes. The 
load estimated to be emitted to waters receiving sewage, was 3.6 tonnes. Load reaching the Baltic 
Sea was estimated to range from 2.9 to 3.3 tonnes, with emission from Poland accounting for 42-45% 
of this mass. Coastal cities (i.e. coastal urban clusters) were estimated to account for 23% of the total 
load reaching the Baltic Sea. According to the calculations, 63-67% of TRD loads originate from 
inland areas. National emissions are presented in Figure 46. 
 
Figure 46. Tramadol loads reaching the Baltic Sea from each country and region, estimated according to scenario 1. 
TRD emissions were estimated to originate to a large extent from the usage and excretion of the API 
(Figure 47). Circa 24% of the load to wastewaters was estimated to originate from improper 
management of unused pharmaceuticals. Due to the poor removal at conventional WWTPs (3.1%, 
see Table 6), a vast majority of the load in influent wastewaters was estimated to reach the water 





Figure 47. Tramadol flows according to scenario 1. Green boxes present end-points/processes, where the load is destroyed 
before reaching the environment. Orange boxes present suboptimal management practices, while yellow boxes present 
emissions into the water environment. 
The national per capita emission reaching the Baltic Sea from coastal countries ranged from 21 mg/a 
in Latvia, to 130 mg/a in Denmark. The Danish per capita emission is roughly 3.6 times higher than 
the second highest per capita emission (Lithuania, 37 mg/a). The relatively high emissions are in line 
with the high per capita consumption in Denmark, presented in Table 2. 
The grid cell-specific emissions are presented in Figure 48 and calculation area-specific per capita 
loads are presented in Figure 49. The emissions were estimated to be much lower in areas, that flow 
through big lakes. These areas include e.g. Central Finland, Russian areas flowing though the lake 
Ladoga, and Swedish areas flowing though the lakes Vänern and Vättern. The highest regional per 










Figure 49. Mean per capita tramadol load reaching the Baltic Sea, aggregated by calculation areas. The dashed area shows the 
countries for which no national sales data was available, but a population weighted average value was used. 
The highest load originating from individual cities was estimated to come from Copenhagen, 
followed closely by emissions from St. Petersburg. The mass of sales was estimated to be 1,600 kg in 
Copenhagen, and 1,500 kg in St. Petersburg. Due to a large difference in per capita sales, the emissions 




Figure 50. Ten coastal urban clusters with the highest tramadol emission reaching the Baltic Sea. The green bars present the 
cities in countries with sales statistics available, while orange bars represent cities in countries where an average per capita 
sales value was used. The numerical value presents the calculated load in kilograms, using two significant numbers. 
Despite the largest per capita emissions, and highest city-specific emissions being emitted in 
Denmark, the coastal areas receiving the highest TRD loads were estimated to be located in Poland. 
The estimates of the load reaching the coastal waters in the Gdansk basin ranged from 770 to 940 
kg/a, using scenarios 2 and 3, respectively. This high load is well in line with the high number of 
people (25 million), whose emissions flow into that coastal area. For comparison, the emissions 
reaching the coastal areas outside the city of Copenhagen were estimated to be 400 kg/a, while these 









The total annual sales of VFX were estimated to be 23 tonnes. However, due to no national 
information being available from Poland, Lithuania and Russia, the estimate is uncertain. The 
national per capita sales range from 0.08 mg/d/person in Latvia to 1.1 mg/d/person in Denmark, 
resulting in an overall population weighted average of 0.70 mg/d/person. If minimum national sales 
were assumed to be applicable for the countries with no sales data, the total sales in the BSR would 
decrease to 9.8 tonnes/a. Similarly, assuming the maximum national sales would be applicable for 
the countries with no sales data, the total sales would reach 32 tonnes/a.  
The load reaching the recipient waters was estimated to reach 1.4 tonnes/a, using the average sales 
value when no data was available. The load would range from 520 kg to 2,000 kg/a, using the 
assumptions presented above. The load reaching the Baltic Sea was estimated to range from 1,100 kg 
to 1,200 kg/a, using scenarios 2 and 3, respectively. The national loads to the Baltic Sea are presented 
in Figure 52. Poland accounted for circa 50% of the total load reaching the Baltic Sea. However, if we 
assume that the Latvian low sales best reflect the sales in Poland, the total load reaching the Baltic 
Sea would be 440 kg. In this case, the emissions from Poland would decrease to 67 kg, resulting in 
Denmark being the country with the highest national emissions to the Baltic Sea. 
 
Figure 52. Venlafaxine loads reaching the Baltic Sea from each country and region, estimated according to scenario 1. 
As the population weighted average per capita sales value is considered the best estimate, when no 
national data is available, further discussion will concentrate on results obtained using that value. 
VFX was estimated to originate mainly from consumption of the API (Figure 53). However, flushing 





Figure 53. Venlafaxine flows according to scenario 1. Green boxes present end-points/processes, where the load is destroyed 
before reaching the environment. Orange boxes present suboptimal management practices, while yellow boxes present 
emissions into the water environment. 
 
The total estimated VFX loads reaching the Baltic Sea from each grid cell are presented in Figure 54, 
and calculation area-specific per capita emissions are presented in Figure 55. The national per capita 
load reaching the Baltic Sea ranged from 1.8 mg/a in Latvia to 25 mg/a in Denmark. Highest regional 









Figure 55. Mean per capita venlafaxine load reaching the Baltic Sea, aggregated by calculation areas. The dashed area shows 
the countries for which no national sales data was available, but a population weighted average value was used.  
Loads from individual cities are presented in Figure 56. The highest load originating from individual 
cities was estimated to come from St. Petersburg. However, the loads from Copenhagen, Stockholm 





Figure 56. Ten coastal urban clusters with the highest venlafaxine emission reaching the Baltic Sea. The green bars present 
the cities in countries with sales statistics available, while orange bars represent cities in countries where an average per capita 
sales value was used. The numerical value presents the calculated load in kilograms, using two significant numbers. 
The loads to coastal waters in different parts of the Baltic Sea are presented in Figure 57. The coastal 
areas estimated to receive the highest loads were located in Poland and Russia. The Polish coastal 
waters in Gdansk and Bornholm basins, and Russian coastal waters in eastern Gulf of Finland were 
the only coastal waters receiving more than 100 kg VFX annually. Outside Russia and Poland, the 
coastal area with highest incoming load was located in Denmark (The Belts). The strait between 










3.2.9. Summary of loads to the Baltic Sea 
The national loads to the BS were estimated to be highest from Poland for DCF, CBZ, TRD, CLM, 
OFL and VFX. Similarly highest emissions were estimated to occur from Russia for MTF and IBU. 
However, there was more variation in the national per capita loads for each API (see Table 8). The 
highest per capita emissions were estimated to occur from Denmark for TRD and VFX, from Estonia 
for DCF and CLM, from Latvia for OFL and from Russia for IBU and MTF. Per capita emissions for 
CBZ were estimated to similar in Latvia and Poland, and only slightly lower in Estonia.  
 





Per capita emission reaching the Baltic Sea (mg/a/person) 
CBZ CLM DCF IBU MTF OFL TRD VFX 
DE 2 945 092 22 29 180 9.2 220 0.72 30 14 
DK 4 879 992 16 18 89 25 180 3.7e-04 130 25 
EE 1 290 739 39 68 540 20 200 0.34 24 4.4 
FI 5 313 289 18 8.2 180 15 310 0.24 22 11 
LT 3 026 584 11 15 140 7.0 380 0.71 37 16 
LV 2 079 911 41 52 520 53 1,200 2.4 21 1.8 
PL 38 431 200 41 50 110 0.52 200 0.60 36 16 
RU 9 443 010 32 37 58 58 5,800 1.8 30 14 
SE 9 349 371 18 13 120 8.8 130 1.6e-04 28 12 
a) Population aggregated from the calculation grid. The data used in the grid (Eurostat 2016b) refers to year 2011. 
The API with the highest variation in country-specific per capita emissions was MTF. However, the 
highest MTF emissions were estimated to originate from Russia, where no sales statistics were 
available. On the other hand, relatively high per capita emissions of TRD were estimated to originate 
from Denmark. A similar difference is present in the national consumption statistics (Table 2).  
The coastal waters with highest API loading were estimated to be on the northern coast of Poland 
(Gdansk basin and Bornholm basin). For instance, the DCF load to Polish coastal waters in the 
Gdansk basin ranged from 2,300 kg/a to 2,800 kg/a, using scenarios 2 and 3, respectively. On the 
other hand, the MTF load to the Russian coastal waters in the Gulf of Finland was several times 
higher than the loads to any other coastal area within the BSR. The coastal waters with the highest 









Table 9. Estimated API loads to coastal waters in different parts of the BSR receiving the highest API loading. 
Coastal area 
scna) 
Load to coastal waters [kg/a] 
CBZ CLM DCF IBU MTF OFL TRD VFX 
Gdansk Basin, PL Coastal waters 
1–3 989–993 1,200–1,230 2,340–2,850 70.3–121 15,200–15,800 16.8–17.5 770–943 326–404 
-1 17,500 5,500 5,260 14,300 441,000 123 7,920 6,350 
Bornholm Basin, PL Coastal waters 
1–3 645–647 781–801 1,620–1,940 18.5–26.7 3,270–3,380 9.79–10.2 519–625 220–267 
-1 11,500 3,600 3,570 12,400 295,000 82.1 5,240 4,220 
Gulf of Finland, RU Coastal waters 
1–3 258–262 299–303 451–457 451–457 45,900–46,600 14.1–14.3 228–231 105–106 
-1 4,510 1,210 1,360 51,000 163,000 40.1 2,710 2,240 
Eastern Gotland Basin, RU Coastal waters 
1–3 115 143–146 554–639 95.6–119 9,150–9,360 4.86–5.03 167–193 71.4–82.8 
-1 2,120 635 1,170 15,300 75,000 25.4 1,640 1,320 
Gulf of Riga, LV Coastal waters 
1–3 108 135–137 1,020–1,130 119–146 5,870–6,030 5.75–5.9 75.9–89.9 19.9–25.1 
-1 1,940 595 2090 24300 50,000 31 776 411 
Gulf of Finland, FI coastal waters 
1–3 39.2–39.5 18.2–18.4 436–450 37.7–38.5 698–706 0.542–0.549 54.6–56.1 27.4–28.2 
-1 1,250 87.9 1000 49,600 60,900 4.39 703 800 
Gulf of Finland, EE Coastal waters 
1–3 56.3–57.1 88.8–90.5 502–593 24.3–30.6 2,780–2,890 1.23–1.27 25.4–34.7 5.49–8.69 
-1 1,090 406 1310 14,700 27,100 5.74 407 208 
Belts, DK Coastal waters 
1–3 27.6 30.9 153–154 43.5–43.7 317–318 6.0e-04 228–229 42.9–43.1 
-1 555 143 277 19,300 27,900 0.00517 1950 717 
Northern Baltic Proper, SE Coastal waters 
1–3 50.8–51.6 37.8–38.5 285–334 20.6–21.4 381–387 5.0e-04 63.1–73.2 28.4–32.7 
-1 1,650 185 827 34,300 33,800 0.00382 1030 1,050 
Kattegat, DK Coastal waters 
1–3 24.3 27.3 134–136 38.1–38.5 280 6.0e-04 199–202 37.5–38 
-1 490 126 245 17,100 24,700 0.00457 1720 633 
Kattegat, SE Coastal waters 
1–3 41.7–42.3 31.3–31.8 264–273 19.4–19.8 378–386 0.02 58.9–60.5 26.5–27.3 
-1 1,350 153 675 27,900 27,700 0.0828 839 854 
The Sound, DK Coastal waters 
1–3 135 15.1 75.5 21.4 155 3.0e-04 112 21.1–21.1 
-1 272 69.8 136 9,460 13,700 0.00253 956 351 
Mecklenburg Bight, DE Coastal waters 
1–3 24 31.4–31.5 194–197 10–10.1 242 0.779–0.781 32.7–33.1 14.9–15.1 
-1 483 145 354 4,480 21,300 6.35 283 251 
Bothnian Bay, FI Coastal waters 
1–3 15.4–15.5 7.5–7.57 186–198 16.1–17 302–307 0.212–0.215 23.9–25.5 11.9–12.7 
-1 487 35.9 382 18,700 23,000 1.65 275 310 
Bothnian Sea, FI Coastal waters 
1–3 16.7–17.1 7.72–7.96 92.9–135 7.68–8.75 295–304 0.229–0.237 11.5–16.4 5.77–8.1 
-1 540 37.9 433 21,400 26,300 1.89 303 345 
a) The load estimated with the total residue approach (scn -1) is equal to the estimated consumption in the area discharging to each coastal area.
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The simulated API-specific end-points presented in figures 11, 17, 23, 29, 35, 41, 47 and 53, are 
summarized in Table 10 as fractions of the total sales within the BSR. Degradation during transport 
to the BS was most important for DCF. However, DCF was also estimated to be the API with the 
highest fraction of sales reaching the BS.  
The most relevant removal processes from ingestion of API to reaching the BS were estimated to be 
metabolism and removal in WWTPs. Elimination during transport had a minor impact on the 
selected APIs. 
 
Table 10.Overview on API-specific end-points according to scenarios 1–3. 
End-point [%] 
API 
CBZ CLM DCF IBU MTF OFL TRD VFX 
Eliminated in 
waste management 
4.3 4.4 4.4 4.2 4.3 4.4 4.5 4.4 
Metabolized 89.8 64.5 35.7 93 0 9.2 83.3 88.1 
Eliminated in 
WWTP 
0.7 8.5 3.7 2.4 89.3 69.1 0.4 1.4 
Eliminated during 
transport to the BS 
0 0-0.5 5.7–11.7 0.1 0–0.1 0–0.5 1.0–2.2 0.6–1.3 





3.3. Concentrations in wastewater and surface water 
3.3.1. Predicted influent and effluent concentrations 
Calculated national average concentrations in influent and effluent wastewaters for all APIs analysed 
in CWPharma WP2 are presented in Annexes 5 and 6, respectively. The PECs for the selected 8 APIs 
for influent and effluent wastewaters are presented in tables 11 and 12, respectively. The tables also 
present the range of concentrations detected in the sampling campaigns carried out in CWPharma 
(Ek Henning et al. 2020). During the screening campaign samples were collected from Estonian, 
Finnish, German, Latvian, Polish and Swedish wastewaters. 
The concentrations in influent and effluent wastewaters were calculated assuming, that the water 
flow at WWTPs is 140 L/person/day. This approach will overestimate concentration in situations 
where the water flow is higher, e.g. due to higher per capita water usage or when a significant sewage 
volume originates from industrial activities or stormwaters. 
All PECs for CBZ, CLM, DCF and VFX in influent wastewater were within the range of detected 
concentrations. Similarly, PECs in influent wastewaters for MTF and TRD were within the range of 
detected concentrations, except in Finland and Denmark, respectively. However, the screening 
campaigns carried out by Ek Henning et al. (2020) did not cover Denmark. Concentration data from 
Denmark would be required to estimate whether the concentrations are actually higher in Denmark 
than in other BSR countries, as could be assumed based on our calculations. 
 
Table 11. Predicted average influent concentrations of modeled substances for each country and the range, median and number 
of measured influent concentrations reported by Ek Henning et al. (2020). The green background color tells that predicted 
value is within the observed range.  
 
Predicted influent concentration (ng/L) 
 
CBZ CLM DCF IBU MTF OFL TRD VFX 
FI 390 230 5,200 7,200 520,000 33 630 380 
SE 390 360 3,300 3,800 220,000 0.022 710 380 
DE 490 800 3,800 3,100 370,000 98 620 340 
LV 910 1,400 12,000 9,300 280,000 230 460 47 
EE 870 1,900 13,000 8,600 320,000 47 580 130 
PL 910 1,400 2,500 200 330,000 83a) 800a) 410a) 
LT 250 400 3,000 1,700 180,000 83a) 790a) 400a) 
DK 350 490 1,900 8,300 300,000 0.050 2,700 600 
RU 670a) 920a) 1,600 4,300a) 350,000a) 83a) 810a) 420a)  



















Median 720 330 4,500 3,600 100,000 710 600 600 
N 28 31 36 6 36 20 27 30 
a) Based on the weighted average per capita sales, presented in Table 2.  
b) Results above the limit of quantification, as reported by Ek Henning et al. (2020) 
All PECs in effluent wastewaters, except those for IBU and OFL in all countries and TRD in Denmark, 
were within the range of detected concentrations (Table 12). PECs for DCF matched relatively well 
with the detected concentrations, being 0.34 (Russia) to 2.8 (Estonia) -fold compared to the median 




Table 12. Predicted average effluent concentrations of modeled substances for each country and the range, median and number 
of measured effluent concentrations reported by Ek Henning et al. (2020). The results falling within the range of detected 
concentrations is presented in green background.  
 Predicted effluent concentration (ng/L) 
 CBZ CLM DCF IBU MTF OFL TRD VFX 
FI 350 160 4,900 360 1,000 4.5 610 310 
SE 350 260 3,700 190 430 0.003 680 310 
DE 430 570 3,600 150 730 13 600 270 
LV 800 990 11,000 470 560 31 450 37 
EE 760 1,300 12,000 420 640 6.3 560 100 
PL 800 980 2,300 10 660 11a) 780a) 330a) 
LT 220 290 2,800 87 360 11a) 770a) 320a) 
DK 310 350 1,700 410 600 0.007 2,600 480 
RU 590a) 650a) 1,500 220a) 700a) 11a) 780a) 340a) 
 Measured effluent concentration (ng/L)



















Median 670 220 4,500 14,000 820 550 520 420 
n 33 32 34 8 6 3 33 29 
a) Based on the weighted average per capita sales, presented in Table 2.  
b) Results above the limit of quantification, as reported by Ek Henning et al. (2020) 
 
3.3.2. Predicted surface water concentrations 
River mouths 
The estimated API-specific annual concentrations, averaged across all rivers in the BPL model from 
the results from scenarios 1-3, ranged from 48–72 pg/L for OFL to 82–120 ng/l for MTF. The scenario 
3 predicted lowest and the scenario 2 highest concentrations for all APIs in estuarian river waters in 
all countries (for scenario descriptions, see Table 4). The rivers with generally the highest overall API 
concentrations are presented in Figure 59 and Table 13. 
While the loads to the BS through each river (see chapter 3.1) correlated strongly with population in 
the river basin and national sales statistics, concentrations at river mouths were strongly linked to 
flow rates in the rivers, and flow rate modifiers used in scenarios 2 and 3. The highest API 
concentrations were estimated to occur in southern parts of the BSR. 
The rivers with the generally the highest concentrations in Estonia, Finland, Latvia, Lithuania and 
Sweden were estimated to be Pühajõgi, Vantaanjoki, Lielupe, Akmena-Dane and Råån, respectively. 
Many of the rivers estimated to have highest concentrations were different from the rivers estimated 
to carry the highest loads (see chapter 3.1.) For instance, although the river with the highest flow rate, 
Neva, was estimated to carry the fifth highest DCF load to the BS (230 kg/a), the predicted 






Figure 59. API concentrations at each river mouth included into the BPL model relative to concentrations at other river 




Table 13. Estimated API concentrations at the mouths of 15 rivers with the highest predicted concentrations within the BSR. 
River Scn 
Concentration at river mouth (ng/L) 
CBZ CLM DCF IBU MTF OFL TRD VFX 
Damhusåen, DK 
1-3 230–340 260–380 1,300–1,900 360–540 2,600–3,900 0,0053–0,0079 1,900–2,800 360–530 
-1 5,500 1,400 2,700 190,000 280,000 0,051 19,000 7,100 
Kighanerenden, DK 
1-3 110–170 130–190 620–940 180–270 1,300–1,900 0,0026–0,0039 920–1,400 170–260 
-1 2,700 690 1,300 94,000 140,000 0,025 9,500 3,500 
Mølle å, DK 
1-3 94–140 100–160 520–780 150–220 1,100–1,600 0,0022–0,0032 780–1,200 150–220 
-1 2,300 580 1,100 79,000 110,000 0,021 8,000 2,900 
St. Vejle å, DK 
1-3 87–130 97–150 490–730 140–210 1,000–1,500 0,002–0,003 720–1,100 140–200 
-1 2,100 540 1,000 73,000 110,000 0,02 7,400 2,700 
Værebro å, DK 
1-3 52–78 58–87 290–440 82–120 600–900 0,0012–0,0018 430–650 81–120 
-1 1,300 320 630 44,000 63,000 0,012 4,400 1,600 
Duvenbäk, DE 
1-3 18–27 24–36 150–220 7,7–11 180–280 0,6–0,89 25–37 12–17 
-1 440 130 320 4,100 19,000 5,8 260 230 
Oder, PL 
1-3 30–45 37–54 89–110 1,3–1,3 160–230 0,47–0,68 29–35 12–15 
-1 630 200 200 720 16,000 4,6 290 230 
Oldenburger graben, DE 
1-3 16–23 20–31 130–190 6,6–9,8 160–240 0,51–0,76 21–32 9,8–14 
-1 380 110 280 3500 17,000 4,9 220 200 
Aalbek, DE 
1-3 15–22 19–29 120–180 6,2–9,3 150–220 0,48–0,72 20–31 9,3–14 
-1 360 110 260 3,300 16,000 4,7 210 190 
Reda, PL 
1-3 28–42 35–52 81–120 0,42–0,63 140–210 0,42–0,63 27–40 12–17 
-1 590 190 170 180 15,000 4 260 210 
Vistula, PL 
1-3 23–34 28–41 65–79 2,9–2,6 380–550 0,4–0,58 21–26 9,2–11 
-1 480 150 140 410 12,000 3,4 220 170 
Pregolya, RU 
1-3 12–18 14–21 32–44 10–15 800–1200 0,35–0,51 12–17 5,5–7,6 
-1 240 74 68 780 6,800 1,9 120 97 
Schwentine, DE 
1-3 12–17 15–23 95–140 4,9–7,2 120–180 0,38–0,56 16–24 7,3–11 
-1 280 84 210 2,600 12,000 3,7 160 150 
Usserød å, DK 
1-3 27–41 31–46 150–230 43–65 310–470 6.3e-04–9.5e-04 230–340 43–64 
-1 660 170 330 23,000 33,000 0,0061 2,300 850 
Trave, DE 
1 11–16 14–21 86–120 4,4–6,4 110–160 0,34–0,51 14–21 6,6–9,6 
-1 250 76 190 2,400 11,000 3,3 150 130 
Median 
1 2,9 3,3 20 2,8 35 2.0e-04 10 3 
-1 65 15 37 1,300 2,800 0,0016 90 52 
Average 
1 7,9 9,1 50 9,6 98 0,058 47 9,6 
-1 160 42 92 4,400 7,200 0,43 400 160 
90% of all results 
1 0,11–23 0,057–30 1–150 0,079–28 0,96–320 1.6e-06–0,33 0,17–150 0,05–28 
-1 3,2–480 0,27–140 1,9–270 43–13,000 83–20,000 1.2e-05–2,3 1,7–1,300 1,2–470 
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PECs for coastal waters were compared to the concentrations measured during the sampling 
campaign carried out as a part of the project CWPharma (Ek Henning et al. 2020). The MECs for the 
estuaries of rivers covered by the BPL model were compared to respective PECs. This comparison is 
presented in Figure 60. 
All PECs for CBZ in Peene and Vistula and for MTF and VFX in Motala ström were within the range 
of detected estuarian concentrations of those same rivers. On the other hand, the concentrations 
were generally overestimated to a varying extent. On average, the calculated concentrations were 11–
15 times higher than the measured values. However, this error was highly variable between APIs and 
rivers. For instance, the average error for CBZ ranged from 2.3 to 4.3-fold, while the error ranged 
from 28 to 41-fold for CLM. The PECs were occasionally lower than the ones detected in the rivers 
Motala Ström, Peene and Vistula.  
Due to the variability of the error-quotients and low number of measured concentrations in the 
simulated areas, the available dataset does not allow for proper calibration of the BPL model. 




Figure 60. Predicted concentrations (scenarios 1–3), average concentrations (MEC) and the range of measured concentrations 




The estimated background concentrations in coastal waters in different parts of the BS ranged from 
the median concentration of 0.3 pg/L estimated for OFL to 16 ng/L estimated for MTF. The estimated 
median concentrations at urban coasts for these APIs were 12 pg/L and 220 ng/L, respectively.  
The concentrations at urban coasts were several times higher than the estimated background 
concentrations. As in case of estuarian concentrations, the scenario 2 (winter/sping) predicted 
highest concentrations for all APIs, while scenario 3 predicted the lowest. 
The PECs for coastal waters were compared to the concentrations measured during the CWPharma 
sampling campaign (Ek Henning et al. 2020) and those presented by HELCOM (UNESCO & 
HELCOM 2017). PECs for scenarios 1–3 in both background areas and urban coasts, as well as the 
MEC values are presented in the Table 14. The city-specific PEC values for urban coasts are presented 
in Figures 61 and 62. 
Median PECs in background areas for DCF, TRD, VFX and IBU were within or almost in the range of 
MECs. Median PECs for TRD and VFX corresponded very well with the median of their measured 
concentrations. The Craw concentrations were generally closer to the MECs than the CAA. The 
predicted concentrations for the urban coasts were generally higher than the MEC-values. 
 
Table 14. Predicted and measured environmental concentrations in the BS coastal waters. 
API 
PEC (Scn. 1–3) [ng/L] a) 
MEC [ng/L] a), b) 
Background  
conc. 






Min Craw: 0.0091 Craw: 1.1 
CWPharma: 0.6 (n=13) 
HELCOM: 0.25 (n=132) 
Med. Craw: 0.69 Craw: 8.1 
CWPharma: 1.5 (n=13) 
HELCOM: 3.4 (n=132) 
Max Craw: 60–61 Craw: 100 
CWPharma: 6.3 (n=13) 





Min Craw: 0.014 Craw: 1.1 
CWPharma: 0.59 (n=5) 
HELCOM: 0.27 (n=2) 
Med. Craw: 0.43 Craw: 6.5 
CWPharma: 1.2 (n=5) 
HELCOM: 0.27 (n=2) 
Max Craw: 63–65 Craw: 100 
CWPharma: 1.6 (n=5) 






Craw: 0.17,  
CAA: 0.36 
Craw: 7–7.1,  
CAA: 13 
CWPharma: 0.43 (n=11) 
HELCOM: 0.1 (n=61) 
Med. 
Craw: 5.2–5.3,  
CAA: 8.8–9.3 
Craw: 92–93,  
CAA: 140 
CWPharma: 2.8 (n=11) 
HELCOM: 0.2 (n=61) 
Max 
Craw: 160–200,  
CAA: 300–370 
Craw: 1100,  
CAA: 1700 
CWPharma: 22 (n=11) 





Craw: 0.0019,  
CAA: 0.0018 
Craw: 0.39,  
CAA: 0.3 
HELCOM: 0.25 (n=17) 
Med. 
Craw: 0.14,  
CAA: 0.12 
Craw: 1.8–1.9,  
CAA: 1.6–1.8 
HELCOM: 3.4 (n=17) 
Max 
Craw: 4.2–4.3,  
CAA: 4.2–4.3 
Craw: 38,  
CAA: 33 




PEC (Scn. 1–3) [ng/L] a) 
MEC [ng/L] a), b) 
Background  
conc. 






Min Craw: 0.073 Craw: 20 CWPharma: 3.4 (n=10) 
Med. Craw: 16 Craw: 220 CWPharma: 17 (n=10) 





Min Craw: 8.4e-08 Craw: 8.5e-06 CWPharma: 15 (n=1) 
Med. Craw: 3.3e-04–3.4e-04 Craw: 0.012 CWPharma: 15 (n=1) 






Craw: 0.0049,  
CAA: 0.0097 
Craw: 2.6–2.7,  
CAA: 3.8 
CWPharma: 0.12 (n=12) 
HELCOM: 0.69 (n=2) 
Med. 
Craw: 0.89–0.94,  
CAA: 1.5–1.6 
Craw: 12,  
CAA: 20 
CWPharma: 1.0 (n=12) 
HELCOM: 0.69 (n=2) 
Max 
Craw: 35–43,  
CAA: 62–76 
Craw: 200,  
CAA: 160 
CWPharma: 5.5 (n=12) 






Craw: 0.0015,  
CAA: 0.0028 
Craw: 0.79–0.84,  
CAA: 1.4–1.5 
CWPharma: 0.14 (n=12) 
HELCOM: 1.0 (n=2) 
Med. 
Craw: 0.56–0.6,  
CAA: 0.93–0.98 
Craw: 8.1, CAA: 12 
CWPharma: 0.9 (n=12) 
HELCOM: 1.0 (n=2) 
Max 
Craw: 24–29,  
CAA: 39–48 
Craw: 110,  
CAA: 81 
CWPharma: 4.8 (n=12) 
HELCOM: 1.0 (n=2) 
a) Only PEC-values higher than zero, and MEC-values higher than the LOQ were taken into consideration. 








Figure 62. Predicted concentrations at urban coasts for CBZ, CLM, MTF and OFL. The whiskers present the variation between different scenarios (1-3).
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3.3.3. Predicted concentrations in surface waters vs. PNEC 
CLM, DCF, IBU and MTF were estimated to 
exceed their PNEC-values in river waters and 
coastal waters within the BSR. The risk quotients 
are presented in Figure 63. Additionally, with 
scenario -1, CBZ and VFX exceeded their 
concentrations in individual rivers in Denmark 
(Damhusåen, Kighanerenden, Mølle å and St. 
Vejle å). PNEC-exceedances were more common 
in southern parts of the BSR than in the northern 
parts. 
The API with the highest PNEC-exceedances was 
IBU. However, the PNEC-values presented in 
literature for IBU contain a lot of variation. The 
PNEC-value used here, 0.12 ng/L (Ek Henning et 
al. 2020), is somewhat lower than those 
commonly presented. For instance, Orias & 
Perrodin (2013) used a PNEC-value 200 ng/L, and 
Korkaric et al. (2019) presented a revised EQS of 1 
ng/L. If those PNEC-values were to be used, the 
RQ-values would be significantly lower. However, 
the estimated IBU concentrations in two rivers 
would still exceed even the value presented by 
Orias & Perrodin (2013).  
As the RQ-value is highly dependent on the 
PNEC-value, the high RQs for this API should be 
considered a signal that IBU ecotoxicity should be 
further investigated to help derive a robust PNEC.  
At least one API was estimated to exceeded its 
PNEC-value in each of the urban coasts covered 
by the BPL model. However, there were many 
wider coastal areas, where the dilution factor was 





Figure 63. Risk quotients for the eight APIs in river mouths 
and coastal waters according to scenario 1. The whiskers 
present the range of concentrations in 90% of river mouths. 
Note that the risk quotients for ibuprofen exceed the y-scale. 
The RQs for coastal waters were calculated using 𝐶𝑟𝑎𝑤. 
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4. Model evaluation 
4.1. Critical overview of the model processes  
The model calculates API emissions originating from approximately 1.9 million 1 km2 grid cells 
representing the BSR catchment area, dissipation of APIs during the transport from the emission 
source to the BS coast, and the eventual loads to the BS. The driving parameter was API consumption 
which was based on national sales and divided into grid cells according to population. The estimated 
API loads emitted in wastewater effluents were based on coefficients (e.g. API-specific excretion rate 
and removal rate at WWTP). A pseudo first order equation was used to estimate dissipation during 
transport to the BS in inland surface waters. The time available for transport was calculated using 
simulated flow-path model created in this project for the whole BSR from elevation and other open 
source data. The model itself is not dynamic, but seasonal changes were taken into account by 
running different simulation scenarios. The outputs are annual loads and annual average 
concentrations (during a typical year) in selected areas. Loads were transformed into concentrations 
by using typical water volumes e.g. in river mouths. In coastal areas two approaches were used to 
estimate concentrations, as presented in chapter 2.2.3. 
During the last decade several similar models and their applications have been published. Some of 
them are more specific but may require external hydrological model to obtain good results e.g. 
STREAM-EU (Lindim et al. 2016, Lindim et al. 2019, van Gils et al. 2020). Some of the models have 
incorporated catchment data but they do not cover the whole BSR like ePiE (Oldenkamp et al. 2018). 
On the other hand, e.g. GLOBAL-FATE (Font et al. 2019, Acuña et al. 2020) calculates concentrations 
in the whole world but process description is more simple than in the BPL model presented here. 
The inbuilt GIS-model makes BPL a stand-alone model and independent of external hydrological 
models. The transport time calculations are based on the calculated flow-path lengths. The estimated 
transport time combined with the simple approach used in estimating the dissipation during 
transport, together with the WWTP processes incorporated into each grid cell, create the basis for 
the calculation approach. It is relatively simple and efficient compared e.g. to those approaches 
where mass is routed over the whole chain from one node to the next.  
The main known limitations in the process description of the current model are related to the 
definition of the fraction of water where photodegradation occurs, the dissipation processes and 
dilution of APIs in coastal areas, and to sedimentation. Photodegradation is the most important 
process for the degradation of many APIs (e.g. Oldenkamp et al. 2019). In the BPL model, a scenario-
specific constant (𝐹𝑝ℎ𝑜𝑡𝑜) describes the portion of water flow where photodegradation takes place in 
inland waters. In coastal waters corresponding value (𝑎(𝑞, 𝑙)) is depth and season specific portion of 
photoactivity compared to optimal conditions. The impact of parameters affecting photodegradation 
is higher for the APIs that are easily degraded by sunlight, as highlighted by the univariate sensitivity 
analysis carried out for the BPL model (see Annex 7). Consequently, the impacts of 𝐹𝑝ℎ𝑜𝑡𝑜 and 𝑎(𝑞, 𝑙) 
would increase with decreasing 𝐷𝑇50𝑝ℎ𝑜𝑡𝑜 values. Thus, the shorter the photolysis half-life, the more 
sensitive the model is to changes in parameters related to photodegradation. Therefore, more studies 
are needed on the photodegradation of APIs in natural conditions in different depths of the water 
column, and during different seasons.  
API concentrations in coastal areas were calculated using two approaches. In the first approach, 
coastal area was considered as a continuum of a river: annual API load was divided by the water 
volume of the area. This estimation assumed uniform mixing and dissipation of an API in the coastal 
area during the loading year. In the second approach sedimentation, biodegradation and 
photodegradation were included (using simple process descriptions), but API transport from the 
recipient area was not taken into account. To improve these estimates, and to possibly merge the 
two approaches, more MEC data would be required, including well described, representative 
sampling points and depths, frequent sampling for at least two years, and comprehensive 
information on the API loading to the area.  
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Sedimentation was not considered in inland waters. This may cause overestimation of the loads of 
APIs with high sorption affinity, especially in sites of high sediment deposition on the flow-path. The 
steady state concentration in coastal water was calculated using the plateau principle. We found no 
good examples on how to apply pseudo first order kinetics (combined temperature related 
biodegradation and depth related photodegradation) and zero-order sedimentation with the plateau 
concentration calculation. To keep the calculation simple, the API-specific fraction estimated to be 
eliminated from the water phase due to sedimentation was deducted already from the annual load. 
The sedimentation rate is assumed to be constant throughout the BS coast. This is a simplification 
of the sedimentation process, and it does not take into account the continuous nature of the process, 
or its variations due to regional conditions. The approach might underestimate the sedimentation of 
persistent APIs and lead to overestimation of their concentration in coastal water. On the other hand, 
even higher error may be caused by using the constant sedimentation rate along BS coastline. It is 
clear that the simulation of API sedimentation is not site specific using this approach.  
In addition to how sedimentation was incorporated into the coastal calculations, the scenarios used 
in the calculations and the degradation calculation approach may need re-evaluation. For instance, 
the current approach does not allow the water to mix in coastal areas after initial emission. As the 
lower parts of the water column are assumed to have no photoactivity, the plateau-principle is 
applicable only to biodegradable APIs. Therefore, if the BPL model is used in estimating not only the 
locations of hotspots but also the actual concentrations, the calculation approach should be 
modified. 
 
Considerations for persistent APIs  
A numerical degradation rate coefficient is needed to simulate the loading scenarios 1-3 (see Table 
4) and to calculate plateau concentration in coastal waters. For very persistent APIs there might be 
no degradation rate value available in literature. For these compounds, the calculation can 
technically be carried out using a very long half-life, or the loading can be simulated using scenario 
0, which excludes the riverine processes.  
According to the plateau principle, the steady state concentration will be reached after around five 
half-life times since the start of the loading. If a persistent API has been on the market for less than 
five times its pseudo first order degradation half-life, the steady state concentration is not yet reached 
and comparison to measured values is not relevant. Additionally, the approach assumes API-specific 
consumption to remain constant from year to year. Despite its shortcomings, the steady state 
simulation gives valuable information. It may highlight the need for mitigation measures not only to 
those APIs having concentrations above PNEC values now, but also to apply them to persistent APIs 
whose concentrations are increasing and may exceed the PNEC in the future. The long-term 
accumulation of CBZ and its slow recovery in BS coastal areas after a hypothetical end of loading was 
well demonstrated by Björlenius et al. (2018).  
 
4.2. Model performance and suggestions for future work 
The model performance was studied stepwise, first comparing the predicted and measured 
concentrations in WWTP influent, then in effluent, and finally in the surface waters (river mouths 
and estuaries). The main results are presented in chapter 3.3. and some comparison is presented 
already there.  
When comparing the PEC-values with MEC-values, it must be taken into account that while the PECs 
represent annual national averages, the MEC-values are always bound to a certain time and location. 
Thus, the representativeness of measured data is limited. Moreover, the transformation from load to 




In this calculation exercise, the per capita wastewater flow was assumed to be 140 L/d/person. The 
estimated water volume was based on the number of inhabitants, and therefore the industrial 
wastewaters and urban storm water which may dilute the API concentrations at WWTPs were not 
taken into account. 
The predicted influent concentrations of the five (CBZ, CLM, DCF and VFX) out of the eight selected 
test APIs fitted well into the range of measured concentrations in all countries (Table 11). Also, the 
predicted influent concentrations of TRD and MTF fitted within the range of detected concentrations 
with individual exceptions. The rather good overall performance of most APIs in influent simulation 
indicates that the API consumption was well estimated in the project. However, when comparing the 
PECs and MECs for individual countries, there was more variation. For instance, MTF PECs in 
influent water (520 µg/L) were about five times higher than the observed range (43–110 µg/L) in two 
Finnish WWTPs (Ek Henning et al. 2020). Therefore, it is possible that MTF load in Finland was 
overestimated. On the other hand, TRD consumption was estimated to be relatively high in Denmark 
compared to any other BSR country (Table 2). However, the sampling campaign carried out in 
CWPharma (Ek Henning et al. 2020) did not cover Denmark, and the MEC-dataset contained no 
data from Denmark. Thus, more information would be required to assess whether the concentrations 
in Danish wastewaters are higher than in other BSR countries.  
Despite the rather good overall performance, PECs for two APIs did not fit within the MEC range 
(OFL and IBU). Predicted IBU concentrations in influent were out of the observed range in several 
countries (higher in LV, EE, DK; lower in PL, see Table 11). Predicted OFL concentrations in influent 
water were underestimated by several orders of magnitude. The lower level of the measured OFL 
concentration range in influent was barely reachable by changing the parameters describing portion 
of non-used OFL or human excreted factor, without modifying OFL sales. This exercise prompted a 
further study on OFL use. It was found out that while the usage of OFL itself is rather small, the use 
of its s-enantiomer levofloxacin is much higher (e.g. in Finland OFL usage was about 11 kg/a while 
that of levofloxacin varied from 270 to 303 kg/a during 2015-2017). The excreted factor in humans is 
about the same for the two enantiomers. In the laboratory analysis, the method does not separate 
between different enantiomers but measures the concentration of the racemic mixture. Thus, the 
OFL loads into the environment presented in this report are inherently underestimates, due to the 
sales data covering only the racemic mixture, and not the enantiopure forms. If we were to include 
the Finnish levofloxacin sales into the OFL sales value, the PEC value for influent wastewaters would 
be 940 ng/L, falling well within the Finnish MEC values (430–970 ng/L, Ek Henning et al. 2020). 
However, compiling further sales statistics on levofloxacin for all BSR-countries was not within the 
scope of this work. Nevertheless, this observation highlights the importance accessibility of 
comprehensive sales statistics.  
The predicted effluent concentrations of six out of eight APIs were within the MEC-ranges (See Table 
12). As presented above, OFL loads to WWTPs were underestimated due to incomprehensive sales 
statistics, resulting in underestimated effluent concentration as well. The IBU concentration in 
effluent was underestimated in all countries although its estimated influent concentration was in the 
range of measured concentration in half of the countries. However, the measurement data reported 
by Ek Henning et al. (2020) covered only six data points for influent and eight data points for effluent 
wastewaters. According to the few data points presented in the study, concentrations were higher in 
effluent wastewaters than in influent wastewaters, which is in stark contrast with previous results 
presented in the literature. As a result, a reliable removal rate could not be calculated from this data. 
Thus, the removal rate (95%) used in the calculations was derived as expert judgement based on 
literature sources. To better assess the performance of the BPL in estimating IBU loads and 
concentrations, more measurement data points would be required.  
In addition to the eight selected APIs, the predicted effluent concentrations of 25 other APIs were 
compared to the country-specific measured effluent concentrations presented by Ek Henning et al. 
(2020). The APIs were set in order according to their performance. The 16 best performing APIs were 
gabapentin, venlafaxine, tramadol, losartan, carbamazepine, hydrochlorothiazide, telmisartan, 
clarithromycin, mesalazine, diclofenac, citalopram, bisoprolol, naproxen, valsartan, progesterone 
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and metformin, for which the average concentration ranged from 50% to 200% of the measured 
concentration in at least half of the countries included. This criterion is rather tight due to the limited 
data and the high variation of measured concentrations in effluent waters. This API ranking indicates 
that the substances selected for simulations were not the ones performing best or worst but represent 
a somewhat random sample of all the APIs investigated in the project CWPharma.  
Surface water 
As shown in chapter 3.3.2, concentrations in river mouths and coastal waters were usually 
overestimated to a varying extent. Estimating river mouth concentrations contains more 
uncertainties than estimating effluent concentrations. However, any errors in effluent estimations 
may be multiplied when estimating environmental concentrations.  
The predicted concentrations in river mouths were typically 11–15 times higher than measured ones. 
The medians of predicted coastal concentrations fitted in the range of measured concentrations for 
all tested APIs except OFL, due to problems in sales statistics, as discussed on p. 101. However, the 
site-specific API concentrations were often overestimated but usually less than 10-fold.  
On average, a good fit between a predicted and measured environmental micropollutant 
concentration is within an order of magnitude. For example, van Gils et al. (2020) noticed that 65% 
of the concentrations predicted using the model STREAM-EU were within one order of magnitude 
of the measured concentrations, but in 10% cases the difference was higher than 100-fold. 
Summary of performance and suggestions to future work 
In model assessment attention should be given to the question: How well does the model suit its 
purpose? This includes not only the accuracy of simulated outputs, but the whole chain. Are the 
simulation results useful? Does the use of the model have any advantages over other methods?   
The current model approach was created to (1) estimate pharmaceutical load from BS catchment area 
to the BS, (2) find areas with high loadings and (3) identify potential hotspots for API occurrence. 
We think that the goals of the model are met. The model estimates the current annual loadings of 
selected APIs to the BS. Additionally, it identifies the most important source areas as well as areas 
where API concentrations can be assumed to be highest. Moreover, in a parallel activity of the project 
CWPharma, the model has been utilized in estimating the load reduction potential of selected 
scenarios (Äystö et al. 2020). Comparison between predicted and measured values indicated that 
predicted values are realistic and do not differ many orders of magnitudes from the measured ones. 
Taking into account the high uncertainties in input data and the limitations in measured comparison 
data, the model results can be assessed as good enough for its purpose.  
The predicted loads and concentrations presented in this report are obtained without any 
calibration. More realistic surface water concentrations could be achieved by calibrating the model. 
A univariate sensitivity analysis (Annex 7) gives a good starting point to select parameters for 
calibration. The parameters having the highest linear impact on predicted concentrations were sales 
modifier (tested in the sensitivity analysis, not included in the process description), excretion rate, 
removal rate at WWTP and sewer network coverage (see Table A7.2 in the Annex 7). These 
parameters affect API concentration in wastewater, but they are not related to environmental fate. A 
stepwise calibration approach, starting with these parameters (within their uncertainty areas) and 
using concentration in wastewater as an object function, might be the most efficient way to start. 
Pharmaceutical consumption data is the driving force of the simulations. Therefore, the extra 
parameter “sales modifier”, presented in Annex 7, should be utilized in calibration to account for the 
uncertainties and regional differences in API sales. This kind of parameter is used in other models as 
well (e.g. Acuña et al. 2020). Once the predicted concentrations in wastewater are acceptable, the 
parameters describing environmental fate can be calibrated.  
For a robust calibration of the BPL model, comprehensive and good quality measured datasets are 
required from WWTPs, river mouths and coastal waters. The corresponding water volumes should 
be defined to convert measured concentrations into mass units. The sampling frequency and the 
length of data series should be sufficient for calculating the typical annual average value, and the 
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uncertainties of these averages should be estimated. A rough first step calibration of API loads from 
wastewater treatment plants to surface waters could be carried out for some API & country - 
combinations using data already available.  
If remarkable differences between PEC and MEC were to occur after calibration, the model process 
description would require improvements. Some possible points to improve process description are 
pointed in chapter 4.1.  Further model development from reviewing the process descriptions to 
calibration and further validation may be useful in identifying knowledge gaps. Uncertainty 
assessment of predicted values might bring additional information as well (see e.g. Gimeno et al. 
2017).  
To increase the applicability of the BPL model, it should be looked into, whether additional processes 
could be incorporated into the calculation method. These processes could include e.g. emissions 
caused by veterinary medication, leaching from land areas where sewage sludge has been utilized in 
agriculture or landscaping, and elimination from the water phase due to sedimentation during 
transport from emission cell to the BS coast. 
The BPL model could also be implemented to a wider set of APIs. The mass flow simulations (e.g. 
Table 10) demonstrates that degradation in riverine system plays a minor role for the selected APIs. 
Thus, the model, using the assumptions in scenario 0, could be assumed to give relatively good 





A new GIS-based model, BPL, was created to estimate pharmaceutical loads to the Baltic sea and 
concentrations in river mouths and along the coast. The model was applied to eight APIs selected 
e.g. based on their occurrence and relatively high concentrations in the BSR.   
According to the BPL model and the input data utilized in this calculation exercise, the coastal areas 
with the highest API load are the Polish coastal waters in Gdansk and Bornholm basins. Similarly, 
the highest loads from individual countries originated most commonly from Poland and Russia. The 
high loads from Poland were caused by the high number of inhabitants in the basin area. However, 
as the sales statistics were lacking especially for Russia, the estimated high emissions from Russia are 
largely based on average consumption values, and as such contain significant uncertainties. 
The rivers with the highest predicted concentrations were in southern parts of the Baltic Sea region. 
Predicted concentrations of ibuprofen, clarithromycin and diclofenac exceeded the PNEC in many 
rivers and coastal areas. As expected, the predicted concentrations were higher in urban coasts than 
in wider coastal areas. Selected simulation results are demonstrated in a web map application (SYKE 
2020).  
The predicted influent and effluent concentrations of four out of eight APIs (carbamazepine, 
clarithromycin, diclofenac and venlafaxine) were within the range of measured concentrations. The 
discrepancies between the predicted and measured concentrations of the other four APIs can be 
explained by incomprehensive sales statistics or unrepresentative samples. The medians of predicted 
annual average surface water concentrations fit well into the range of measured concentrations for 
seven out of eight APIs. However, the site-specific surface water concentrations were usually two- to 
15-fold overestimated. Similar performance has been reported with other models (e.g. van Gils et al. 
2020). 
The predicted ofloxacin concentrations differed dramatically from those measured in wastewaters. 
The contrast between predicted and measured ofloxacin concentrations in influent wastewater was 
likely caused mainly by the input sales statistics covering only the racemic mixture (ofloxacin) but 
not its enantiopure form levofloxacin, which is used in higher quantities at least in Finland. 
Previously Oldenkamp et al. (2016) identified API consumption, along with ecotoxicological data 
(e.g. PNEC values), as the most important and uncertain parts affecting the assessment of API risks. 
Our modelling exercise supports their conclusion.  These observations highlight the importance of 
accessible and comprehensive pharmaceutical sales statistics. Such data is the prerequisite for any 
computational estimates on the environmental loads of pharmaceuticals. 
According to this calculation exercise, degradation in the environment is not a major dissipation 
process for the eight APIs looked into in this report. Its impact was very low compared to metabolism 
and removal in wastewater treatment plants. Thus, preliminary calculations could be carried out for 
a wider set of APIs without the need for extensive literary reviews on API-specific behaviour in the 
environment. 
The BPL model can be further refined by improving and supplementing the input data. These data 
should include more comprehensive statistics on pharmaceutical sales and management of unused 
medicines. Additionally, the model could be further improved by calibrating it using good quality 
datasets. However, the calibration of the parameters affecting environmental fate can be carried out 
only if the data on pharmaceutical sales is correct and there is a sufficient amount of measurement 
data available.  
Based on this work, computational approaches can help identify emission and occurrence hotspots. 
The identified sites could then be utilized when designing screening campaigns. The BPL model 
works well for demonstrating the potential emission hotspots and for identifying the parts in the 
emission chain, where emission reduction measures could have the biggest reduction potential. In 
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Annex 1 – Structure of the calculation grid 
Variable name  Content  
Id_nro Grid cell-specific identifier (running number)  
Point_x  X-coordinate (ETRS_1989_LAEA)  
Point_y  Y-coordinate (ETRS_1989_LAEA)  
AreaId  Area-specific identifier issued to each cluster, river basin 
and coastal area (running number)  
RegionId  Flag used to differentiate between different types of regions  
1 = Coastal urban cluster  
2 = Main river basins  
3 = Coastal areas & sea  
4 = Coastal sea areas, not included in the original HELCOM-
data  
5 = Inland urban clusters  
Country  Country (‘FI’, ‘LV’, ‘SE’, etc.)  
ToSea_m  Distance to the sea along the calculated flow route (unit: m)  
Elevation_m Elevation from sea level (unit: m)  
Population  Population per cell  
SourceCode  Baltic Sea river basin code (HELCOM, PLC-6 
subcatchments)  
Name  Baltic Sea river basin name (HELCOM, PLC-6 
subcatchments)  
AreaName  Area-specific name 
LakeOutlet_id  Identifier for lake discharge points  
LakeOutlet_name  Name for lake discharge points  
UpCatch_id  Flag used to identify an upper catchment areas of a lake 
(cells that flow through a specific lake. Each cell flowing 
through a lake has the “LakeOutlet_id” as its “UpCatch_id”)  
UpCatch_name  Name used to used to identify an upper catchment areas of 
a lake (cells that flow through a specific lake. Each cell 
flowing through a lake has the “LakeOutlet_name” as its 
“UpCatch_name”)  
Upcatch_km2  Value presenting the size of the upper catchment area of 
each grid cell (km2)  
Retention  Cumulative retention time from lakes (unit: d)  
Sea_Land  Flag used to differentiate cells located land areas and sea 
(Land = 1, Sea = 2)  
Coast3km  Flag to identify a 3 km sea zone from the coast for further 
calculations (values 1, NA)  
SeaDepth3p Sea depth (unit: m)  
SeaDepth3_m3  Sea volume in grid cell (unit: m3)  
ClassMax  Value given to urban clusters (RegionId 1 & 5) representing 
the highest class of the WWTPs linked to that cluster  
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SumPE Value given to urban clusters (RegionId 1 & 5) representing 
the sum of person equivalents for the WWTPs linked to the 
cluster  
WWTP_count  Value given to urban clusters (RegionId 1 & 5) representing 
the number of WWTPs linked t othe cluster  
RiverBasin  Flag used to identify calculated catchment areas of the main 
river basins. Each cell is given the “RiverBasin_outlet” value 
given for the cell discharging the water from that catchment 
area.  
RiverBasin_Flow_ka1995_2006  Average of annual average water flows in discharge cells for 
the years 1995-2006. Source: HELCOM (unit: m3/s)  
RiverBasin_outlet  Flag used to identify discharge cells for calculated 
catchment basins.   
Shape_Area Area of each grid (constant: 1e+06 m2) 
UC_Flag Flag used to identify urban coasts (1/0) 
CoastCluster Flag used to identify coastal waters of each urban cluster 
(AreaId of the nearest coastal urban cluster) 
Tot_cons  Consumption of a specific API in the grid cell (unit: mg). 
Calculated from the per capita consumption in each country 
multiplied by the population in the cell.  
Delay2Purku_d  Flow time from the cell to the discharge cell. Used in 
estimating the load reaching the discharge cell. Calculated 
as the cell-specific Delay_d  subtracted by the Delay_d 
calculated for the RiverBasin-specific discharge cell. (unit: 
d)  
SeaAreaId  Information of sea areas (AreaId) into which cell flows.  
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Annex 2 – Lakes included into the BPL model 
Lake  
ID 
Name Country Retention  
time (d)a) 
Population upstream  
(persons)b) 




1 Ladoga RU 4,015 1,057,799 88,790 5479500 4268500 
2 Ilmen RU 4,105 850,029 69,930 5541500 4131500 
3 Onega RU 9,125 363,259 55,136 5648500 4458500 
4 Kemijärvi (N43 146.50)x1 FI 40 28,417 27,572 5090500 4915500 
5 Kiantajärvi (N43 199.30) FI 1,413 4,253 3,492 5210500 4763500 
6 Lammasjärvi FI 1,209 6,242 3,470 5261500 4690500 
7 Rehja-Nuasjärvi FI 1,160 20,865 4,027 5178500 4678500 
8 Oulujärvi (N43 122.20)x3 FI 1,064 40,548 6,533 5160500 4683500 
9 Oulujärvi (N43 122.20)x2 FI 334 500 435 5143500 4690500 
10 Oulujärvi (N43 122.20)x1 FI 118 3,824 2,046 5123500 4702500 
11 Pielinen FI 11,920 33,439 13,843 5336500 4571500 
12 Hiirenvesi FI 10,747 12,258 6,712 5337500 4558500 
13 Höytiäinen FI 12,969 7,363 1,554 5317500 4537500 
14 Viinijärvi FI 14,308 8,784 869 5296500 4528500 
15 Pyhäselkä (Saimaa N60+75.80) FI 9,572 81,844 2,144 5322500 4496500 
16 Kiteenjärvi FI 4,272 6,353 344 5364500 4480500 
17 Pyhäjärvi FI 11,585 4,627 940 5352500 4446500 
18 Simpelejärvi (N60 68.80) FI 4,492 2,328 429 5349500 4420500 
19 Ylä-Enonvesi FI 9,513 2,537 319 5309500 4458500 
20 Juojärvi FI 14,624 6,489 1,839 5272500 4512500 
21 Syväri FI 13,183 7,714 2,382 5232500 4575500 
22 Nerkoonjärvi FI 15,440 39,954 4,755 5178500 4587500 
23 Onkivesi FI 15,431 7,601 827 5189500 4559500 
24 Maaninkajärvi FI 15,371 2,982 246 5190500 4552500 
25 Kallavesi (N60 81.70) FI 12,940 127,171 6,244 5228500 4498500 





Name Country Retention  
time (d)a) 
Population upstream  
(persons)b) 




27 Haukivesi (Saimaa N60+75.80) FI 11,428 53,884 5,353 5305500 4440500 
28 Pihlajavesi (Saimaa) FI 9,270 39,404 6,718 5279500 4393500 
29 Ukonvesi (Saimaa) FI 7,570 38,357 296 5233500 4383500 
30 Saimaa FI 7,412 65,355 5,569 5320500 4369500 
31 Kivijärvi FI 1,771 3,950 495 5262500 4326500 
32 Vuohijärvi FI 395 1,708 1,014 5215500 4328500 
33 Kallavesi FI 819 1,466 516 5216500 4366500 
34 Lahnavesi FI 425 5,765 505 5204500 4363500 
35 Ryökäsvesi-Liekune FI 4,271 9,566 2,138 5203500 4386500 
36 Kyyvesi FI 5,049 5,208 1,333 5206500 4421500 
37 Pieksänjärvi FI 8,589 14,067 116 5203500 4472500 
38 Suontienselkä-Paasvesi FI 8,238 4,125 441 5193500 4498500 
39 Niinivesi FI 4,072 11,062 2,263 5168500 4507500 
40 Iisvesi FI 4,703 3,331 579 5171500 4512500 
41 Pielavesi FI 5,155 4,159 1,093 5154500 4555500 
42 Pyhäjärvi FI 2,635 5,044 617 5106500 4603500 
43 Ylä-Keitele (N60 99.50) FI 4,947 8,928 2,800 5117500 4528500 
44 Ala-Keitele (N60+99.50) FI 5,451 11,398 575 5130500 4498500 
45 Keski-Keitele (N60 99.50) FI 4,653 9,086 2,911 5155500 4504500 
46 Konnevesi FI 3,932 3,219 1,286 5155500 4488500 
47 Kynsivesi-Leivonvesi FI 3,526 7,674 1,099 5152500 4460500 
48 Lievestuoreenjärvi FI 5,520 3,327 232 5150500 4451500 
49 Saraavesi FI 3,406 20,736 1,170 5141500 4456500 
50 Leppävesi FI 3,244 15,212 567 5144500 4437500 
51 Palokkajärvi FI 3,206 45,247 332 5134500 4442500 
52 Muuratjärvi FI 4,464 6,328 374 5133500 4427500 
53 Päijänne (pohj. N60+78.10) FI 3,182 79,622 666 5137500 4412500 
54 Jääsjärvi FI 3,210 6,670 1,499 5167500 4370500 
55 Konnivesi FI 36 8,343 597 5188500 4320500 





Name Country Retention  
time (d)a) 
Population upstream  
(persons)b) 




57 Vesijärvi FI 3,457 45,010 478 5152500 4322500 
58 Päijänne (etel. N60+78.10) FI 118 3,584 337 5151500 4334500 
59 Päijänne (kesk. N60+78.10) FI 2,871 34,699 4,461 5148500 4337500 
60 Pyhäjärvi FI 719 6,304 475 5188500 4277500 
61 Tuusulanjärvi FI 223 37,294 83 5146500 4238500 
62 Valkjärvi FI 1,674 18,887 137 5129500 4228500 
63 Enäjärvi FI 443 10,925 35 5112500 4221500 
64 Hiidenvesi FI 6,276 25,175 932 5096500 4217500 
65 Lohjanjärvi FI 6,144 27,633 1,011 5085500 4192500 
66 Kernaalanjärvi FI 1,458 14,737 1,018 5112500 4279500 
67 Äimäjärvi FI 1,450 2,752 83 5076500 4297500 
68 Ormajärvi FI 2,689 3,603 174 5122500 4307500 
69 Suolijärvi FI 1,547 1,518 124 5114500 4310500 
70 Iso-Roine FI 1,471 1,640 300 5097500 4314500 
71 Kukkia FI 2,391 2,512 763 5105500 4325500 
72 Vanajavesi (N60 79.40)x1 FI 1,055 124,653 2,904 5059500 4310500 
73 Mallasvesi (N60 84.20)x1 FI 1,194 24,877 886 5071500 4315500 
74 Längelmävesi FI 1,841 17,768 1,951 5072500 4332500 
75 Vesijärvi FI 3,519 11,143 219 5070500 4337500 
76 Keurusselkä (N60 105.40)x1 FI 2,350 17,627 1,672 5082500 4404500 
77 Jämsänvesi-Petäjävesi FI 3,621 4,138 670 5107500 4429500 
78 Pyhäjärvi FI 5,699 9,011 1,354 5111500 4480500 
79 Pääjärvi FI 5,787 5,561 1,222 5075500 4489500 
80 Lappajärvi FI 771 17,017 1,664 5003500 4529500 
81 Kuortaneenjärvi FI 50 15,454 1,242 5001500 4483500 
82 Ähtärinjärvi FI 3,027 1,498 486 5044500 4460500 
83 Vaskivesi-Visuvesi FI 2,200 3,244 529 5045500 4407500 
84 Näsijärvi (N60 95.40)x2 FI 1,694 14,507 2,914 5045500 4368500 
85 Näsijärvi (N60 95.40)x1 FI 1,580 57,686 956 5050500 4338500 





Name Country Retention  
time (d)a) 
Population upstream  
(persons)b) 




87 Parkanonjärvi FI 673 8,119 696 5001500 4377500 
88 Kyrösjärvi FI 609 16,877 1,959 5018500 4349500 
89 Mahnalanselkä Kirkkojärvi FI 77 8,846 490 5029500 4331500 
90 Kulovesi FI 27 15,925 540 5016500 4321500 
91 Rautavesi FI 10 13,274 381 5006500 4310500 
92 Köyliönjärvi FI 2,852 1,837 95 4986500 4278500 
93 Pyhäjärvi FI 2,433 8,434 660 4975500 4279500 
94 Toisvesi FI 2,617 10,080 1,126 5031500 4420500 
95 Valkjärvi FI 1,340 2,503 17 5143500 4286500 
96 Peipsi-Pihkva RU 730 671,238 46,706 5330500 4115500 
97 Kalli järv  EE 770 96 83 5319500 4042500 
98 Koosa EE 803 155 65 5313500 4045500 
99 Vagula EE 803 3,991 415 5317500 3980500 
100 Tamula EE 1,665 14,163 87 5319500 3979500 
101 Hino järv EE 1,200 11 4 5339500 3954500 
102 Aheru järv EE 183 25 36 5286500 3954500 
103 Pühajärv EE 1,095 2,788 71 5284500 3991500 
104 Saadjärv EE 3,530 1,441 30 5283500 4049500 
105 Soitsjärv EE 3,713 21 2 5283500 4052500 
106 Kaiavere järv EE 850 1,169 81 5282500 4057500 
107 Kuremaa  EE 2,050 390 25 5273500 4067500 
108 Endla  EE 742 143 53 5246500 4080500 
109 Võrtsjärv EE 1,095 12,638 1,546 5256500 4027500 
110 Veisjärv EE 1,460 29 27 5243500 3988500 
111 Õisu järv  EE 35 1,556 214 5225500 4000500 
112 Kahala  EE 365 207 26 5195500 4139500 
113 Soodla veehoidla EE 32 3,387 209 5194500 4127500 
114 Paunküla veehoidla EE 61 700 80 5192500 4097500 
116 Ülemiste EE 120 11,098 86 5153500 4120500 





Name Country Retention  
time (d)a) 
Population upstream  
(persons)b) 




118 Sutlepa meri / Sutlepsjön  EE 120 209 38 5096500 4067500 
119 Lavassaare järv  EE 60 0 16 5150500 4024500 
120 Tõhela EE 365 30 37 5133500 4005500 
121 Ermistu järv EE 182 54 21 5133500 3997500 
122 Karujärv EE 365 17 16 5033500 3980500 
123 Mullutu laht EE 37 2,001 262 5044500 3967500 
124 Suurlaht EE 73 19 10 5048500 3968500 
125 Kišezers LV 22 85,998 82 5173500 3854500 
126 Juglas ezers LV 28 62,524 1,574 5181500 3851500 
127 Slokas ezers LV 137 12,860 75 5143500 3838500 
128 Vecdaugava LV 429 3,198 11 5169500 3855500 
129 Limbažu Lielezers LV 515 572 46 5195500 3913500 
130 Mazais Baltezers LV 1,030 3,640 114 5184500 3857500 
131 Dunezers LV 19 8,340 24 5195500 3917500 
132 Liepa•jas ezers LV 27 68,803 2,358 4999500 3765500 
133 Lielais Ludzas ezers LV 813 5,089 254 5404500 3849500 
134 Indzeris LV 327 909 31 5333500 3929500 
135 Aluksnes ezers LV 2,750 7,383 36 5339500 3938500 
136 Balvu ezers LV 20 5,170 41 5352500 3905500 
137 Babites ezers LV 118 486,910 17,501 5157500 3842500 
138 Viesites ezers LV 746 1,443 43 5278500 3799500 
139 Cieceres  ezers LV 243 3,300 117 5086500 3796500 
140 Cirišs LV 96 4,044 492 5366500 3791500 
141 Durbes ezers LV 70 1,893 151 5014500 3780500 
142 Burtnieku ezers LV 61 17,883 2,116 5216500 3949500 
143 Raznas ezers LV 2,120 1,762 277 5392500 3823500 
144 Pitka ezers (Ozolaines dikis) LV 493 418 23 5207500 3794500 
145 Dagdas ezers LV 341 4,163 179 5403500 3795500 
146 Dunakla ezers LV 1,472 7,533 258 5398500 3850500 





Name Country Retention  
time (d)a) 
Population upstream  
(persons)b) 




148 Šunezers LV 423 27,506 22 5344500 3761500 
149 Lielais Subates ezers LV 417 718 26 5305500 3765500 
150 Perkonu ezers LV 38 4,362 264 5356500 3907500 
151 Kanieris LV 30 23,362 342 5136500 3844500 
152 Lielais  Baltezers LV 488 1,663 23 5182500 3854500 
153 Wigry PL 1,043 75,765 326 5174500 3517500 
154 Druzno PL 33 59,769 1,078 4934500 3486500 
155 Elckie PL 114 79,232 933 5129500 3477500 
156 Sniardwy PL 521 17,821 763 5093500 3462500 
157 Nidzkie PL 1,873 5,151 178 5082500 3454500 
158 Mikolajskie PL 657 16,099 765 5084500 3467500 
160 Lebsko PL 81 126,911 2,336 4805500 3541500 
161 Gardno PL 41 4,808 143 4776500 3528500 
162 Jamno PL 135 123,803 347 4719500 3479500 
164 Mamry Pólnocne PL 913 10,518 553 5081500 3516500 
165 Wdzydze Pólnocne PL 749 9,161 278 4838500 3460500 
166 Wdzydze Poludniowe PL 608 674 56 4839500 3456500 
167 Drawsko PL 2,439 9,763 213 4726500 3404500 
168 Rynskie PL 1,873 50,568 855 5079500 3471500 
169 Kisajno PL 6,127 5,226 60 5082500 3505500 
170 Råstojaure SE 453 0 266 4753500 5101500 
171 Torneträsk SE 3,103 448 3,454 4737500 5038500 
172 Kycklingvattnet SE 304 7 75 4520500 4612500 
173 Stor-Jorm and Lill-Jorm SE 565 253 1,288 4518500 4619500 
174 Grundforsdammen SE 8.3 18 190 4680500 4670500 
175 Blåviken SE 937 45 186 4705500 4660500 
176 Rusfors Dämningsområde SE 6.2 6,287 11,526 4716500 4646500 
177 Bjurfors N Dämningsomr SE 0.46 10,654 1,425 4788500 4587500 
178 Ytterkolkselet SE 0.20 526 472 4797500 4568500 





Name Country Retention  
time (d)a) 
Population upstream  
(persons)b) 




180 Hällbymagasinet SE 12 257 851 4675500 4549500 
181 Norrbyvattnet SE 44 51 259 4624500 4527500 
182 Vängelsjöns dämningso SE 21 6,732 5,829 4633500 4524500 
183 Stuguns Dämningsområde SE 1.7 88,817 19,994 4605500 4462500 
184 Bredsillret SE 0.22 2,075 3,591 4561500 4383500 
185 Bergeforsens Dämningsom SE 0.23 13,375 6,010 4702500 4400500 
186 Särnsjön SE 14 2,661 2,935 4491500 4290500 
187 Växsjön SE 2.1 33,393 14,801 4663500 4270500 
188 Stallfjärden SE 0.05 247,696 26,009 4728500 4183500 
189 Knon SE 3,902 13 108 4531500 4123500 
190 Flaxen SE 3,297 2,149 973 4568500 4095500 
191 Gunnern SE 3,581 3,227 999 4465500 4076500 
192 Stora Le/Foxen-Foxen SE 5,015 7,399 1,522 4429500 4025500 
193 Glafsfjorden SE 3,508 36,618 3,092 4481500 4031500 
194 Hjälmaren SE 2,245 187,093 3,636 4678500 4033500 
195 Mälaren SE 1,004 1,412,372 18,953 4775500 4049500 
196 Vänern SE 3,285 607,585 40,775 4459500 3920500 
197 Gesebols sjö SE 277 253 24 4478500 3848500 
198 Stråken SE 644 513 95 4598500 3782500 
199 Åsnen SE 243 105,992 3,092 4610500 3717500 
203 Tisnaren SE 792 2,674 668 4670500 3997500 
204 Långhalsen SE 57 3,547 255 4698500 4002500 
205 Nedre glottern SE 1,066 534 23 4679500 3968500 
207 Fläten SE 737 750 122 4682500 3983500 
210 Salstern SE 676 570 83 4619500 3959500 
211 Lien SE 585 672 118 4635500 3970500 
213 Ormlången SE 164 958 375 4658500 3975500 
215 Bönnern SE 132 8,418 1,065 4654500 3970500 
217 Vättern SE 21,197 204,196 6,028 4615500 3947500 





Name Country Retention  
time (d)a) 
Population upstream  
(persons)b) 




220 Sommen (East and West) SE 1,928 30,084 1,914 4618500 3904500 
224 Juttern SE 1,307 13,181 897 4665500 3875500 
228 Kisasjön SE 1,011 4,534 292 4656500 3891500 
229 Åsunden SE 1,095 4,325 694 4656500 3906500 
231 Stora rängen SE 244 3,355 330 4657500 3921500 
233 Svinstadsjön SE 752 204 35 4663500 3932500 
234 Roxen SE 168 198,651 2,662 4668500 3948500 
235 Asplången SE 98 112,257 686 4680500 3948500 
236 Hällerstadsjön SE 43 1,092 154 4679500 3942500 
238 Yxningen SE 6,131 738 310 4700500 3925500 
239 Ken SE 803 277 61 4694500 3934500 
240 Strolången SE 108 2,332 105 4698500 3936500 
241 Dabie PL 5.6 15,341,398 116,882 4629500 3389500 
a) Presented retention times are additive. If water from an lake A flows through  lake B, retention time for lake A would be the sum of retention times in lakes A and B. E.g. Lakes ID 7 – 10 are connected. As lake 7 is highest 
upstream, the additive retention time is the sum of retention times in this lake (Rehja-Nuasjärvi) and the ones downstream (1 160 d).  
b) Aggregated from the calculation grid.
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1 DE Aalbek 42 1.23E+07 9,804 4373500 3431500 
2 LT Akmena-dane 521 2.14E+08 91,938 5018500 3676500 
3 DK Alling å 236 5.86E+07 13,569 4337500 3700500 
4 SE Alsterån 1,539 3.69E+08 10,355 4712500 3775500 
5 SE Alterälven 456 1.54E+08 2,623 4855500 4744500 
6 DK Arresø kanal 261 4.52E+07 50,852 4448500 3654500 
7 FI Aurajoki 880 2.49E+08 136,820 4992500 4206500 
8 DK Bagge å 22 1.09E+07 297 4622500 3572500 
9 LV Barta 2,077 6.30E+08 31,876 4999500 3752500 
10 DE Barthe 243 4.30E+07 8,887 4498500 3469500 
11 DK Binderup å 88 5.87E+07 2,734 4301500 3765500 
12 DK Bjerge å 59 1.01E+07 3,046 4404500 3575500 
13 DK Bjørnsholm å 97 3.76E+07 2,832 4273500 3753500 
14 DK Blå å - bovrup bæk 34 8.29E+06 1,120 4295500 3544500 
15 SE Botorpsströmmen 1,003 1.98E+08 5,091 4713500 3856500 
16 DK Bredkær bæk 18 6.55E+06 172 4229500 3709500 
17 DK Brende å 104 2.99E+07 12,056 4316500 3585500 
18 DK Bygholm å 154 5.15E+07 15,734 4304500 3640500 
19 SE Dalälven 28,980 1.15E+10 254,591 4728500 4192500 
20 DK Damhusåen 58 1.04E+07 178,553 4479500 3624500 
21 LV Daugava 84,982 1.73E+10 2,354,903 5167500 3855500 
22 SE Delångersån 2,000 5.51E+08 11,877 4696500 4300500 
23 DE Duvenbäk 63 8.36E+06 8,265 4533500 3489500 
24 DK Elling å 124 4.84E+07 4,210 4348500 3818500 
25 DK Elsted bæk 22 3.93E+06 735 4285500 3556500 
26 DK Elverdamsåen 34 1.48E+07 5,573 4434500 3615500 
27 SE Emån 4,483 9.76E+08 75,931 4713500 3798500 
28 DK Esrum å 125 2.68E+07 20,784 4469500 3666500 
29 FI Eurajoki 1,354 2.84E+08 24,333 4943500 4287500 
30 DK Fald å 29 1.23E+07 1,307 4226500 3715500 
32 DK Fiskbæk 12 7.01E+06 265 4296500 3538500 
33 DK Fladmose å 14 1.95E+06 467 4411500 3570500 
34 DK Fladså 23 5.71E+06 756 4439500 3567500 
35 SE Forsmarksån 368 8.32E+07 748 4774500 4164500 
36 DK Fribrødre å 48 8.87E+06 1,932 4450500 3531500 
37 DE Füsinger au 268 8.29E+07 20,008 4297500 3492500 
38 LV Gauja 9,046 2.33E+09 164,185 5179500 3868500 
39 SE Gavleån 2,490 6.00E+08 109,144 4712500 4194500 
40 DK Geels å 44 7.05E+06 4,444 4354500 3591500 
41 DK Gerå 150 5.63E+07 9,106 4341500 3777500 
42 SE Gide älv 3,442 1.20E+09 2,843 4777500 4501500 
43 DE Godderstorfer au 60 9.40E+06 2,509 4390500 3469500 
44 PL Grabowa 552 2.19E+08 15,461 4735500 3496500 
45 DK Græse å 28 4.77E+06 7,913 4454500 3640500 
















47 DK Guden å 2,648 1.02E+09 257,351 4320500 3705500 
48 SE Göta älv 50,774 1.91E+10 1,351,256 4433500 3859500 
49 DK Haderslev 
møllestrøm 
112 5.71E+07 18,210 4288500 3571500 
50 DE Hagener au 128 2.46E+07 7,590 4350500 3467500 
51 DK Halsted å, borge 
bro 
22 5.02E+06 423 4405500 3532500 
52 DK Hansted å 141 4.74E+07 12,634 4309500 3641500 
53 DK Haslevgårds å 86 2.39E+07 2,728 4335500 3744500 
54 DK Hasseris å 46 2.22E+07 5,937 4311500 3769500 
55 DK Havelse å 99 1.83E+07 26,049 4456500 3645500 
56 SE Helge å 4,723 1.43E+09 160,316 4585500 3648500 
57 DE Hellbach 214 3.75E+07 11,446 4427500 3440500 
58 DK Herreds å 174 3.77E+07 11,947 4296500 3753500 
59 DK Hove å 72 9.72E+06 10,689 4456500 3626500 
60 DK Hovedkanal 193 3.50E+07 7,594 4398500 3513500 
61 DK Hulebæk 10 2.24E+06 1,022 4447500 3562500 
62 DK Hundstrup å 55 1.69E+07 4,091 4348500 3555500 
63 DK Hvidbjerg å 260 9.52E+07 7,676 4222500 3750500 
64 DK Hårby å 69 2.13E+07 7,045 4329500 3567500 
65 DK Højbro å 28 7.94E+06 2,584 4456500 3664500 
66 DK Højen å 19 1.37E+07 1,422 4288500 3620500 
67 FI Iijoki 14,312 5.62E+09 21,012 5038500 4772500 
68 PL Ina 2,142 8.79E+08 175,878 4638500 3394500 
69 SE Indalsälven 26,931 1.48E+10 105,197 4705500 4399500 
70 LV Irbe 1,947 1.06E+09 23,916 5042500 3898500 
71 DK Jordbro å 114 3.77E+07 4,742 4271500 3713500 
72 EE Jägala 906 3.33E+08 7,989 5188500 4120500 
73 DK Kær mølle å 3 2.51E+06 56 4290500 3586500 
74 DK Kærs mølleå 103 5.23E+07 11,663 4314500 3765500 
75 FI Kalajoki 4,218 1.45E+09 48,190 4996500 4639500 
76 SE Kalix älv 18,141 1.03E+10 33,874 4924500 4803500 
77 FI Karjaanjoki 2,040 5.56E+08 58,707 5073500 4182500 
78 DK Karup å 654 2.32E+08 19,285 4258500 3712500 
79 EE Kasari 2,658 8.10E+08 25,243 5128500 4037500 
80 DK Kastbjerg å 101 2.70E+07 2,873 4326500 3730500 
81 EE Keila 635 2.11E+08 18,120 5138500 4106500 
82 FI Kemijoki 51,670 1.82E+10 104,509 4986500 4811500 
83 DK Kighanerenden 15 1.19E+06 10,021 4481500 3639500 
84 FI Kiiminginjoki 3,813 1.54E+09 18,375 5039500 4754500 
85 FI Kiskonjoki 1,044 3.12E+08 10,639 5043500 4182500 
86 FI Kokemäenjoki 27,011 7.07E+09 794,389 4942500 4323500 
87 DK Kolding å 298 1.20E+08 26,989 4285500 3599500 
88 DK Korup å 52 3.59E+07 1,152 4325500 3734500 
89 DE Koseler au 52 1.63E+07 5,353 4303500 3489500 
90 FI Koskenkylänjoki 897 2.65E+08 10,734 5190500 4254500 
91 DE Kossau 123 3.01E+07 10,196 4360500 3466500 
92 FI Kuivajoki 1,351 6.10E+08 1,668 5019500 4796500 
















94 FI Kymijoki 36,588 9.68E+09 542,132 5241500 4265500 
95 FI Kyrönjoki 4,925 1.37E+09 109,659 4917500 4503500 
96 DK Køge å 133 2.34E+07 14,345 4452500 3598500 
97 DK Køng å 65 1.68E+07 3,315 4437500 3559500 
98 SE Lagan 6,455 2.51E+09 118,896 4502500 3719500 
99 DK Lammefjord s kanal 79 1.55E+07 6,349 4422500 3630500 
100 DE Langballigau 50 1.41E+07 3,483 4301500 3522500 
101 DK Langvad å 170 2.94E+07 19,768 4456500 3610500 
102 FI Lapuanjoki 4,126 1.04E+09 57,012 4942500 4550500 
103 FI Lapväärtinjoki 1,095 4.51E+08 5,938 4915500 4395500 
105 DK Lerkenfeld å 118 8.33E+07 3,118 4284500 3736500 
106 FI Lestijoki 1,372 4.08E+08 9,909 4985500 4616500 
107 LV Lielupe 17,674 2.03E+09 512,007 5159500 3845500 
108 DK Lillebæk 7 1.02E+06 841 4368500 3557500 
109 DK Lindenborg å 333 1.17E+08 19,378 4326500 3760500 
110 DK Lindholm å, 
voerbjerg 
156 1.03E+08 10,540 4314500 3775500 
111 DK Lindved å 62 1.58E+07 21,356 4349500 3586500 
112 DE Lippingau 53 1.54E+07 3,864 4308500 3515500 
113 SE Ljungan 12,897 4.34E+09 37,253 4704500 4374500 
114 SE Ljungbyån 773 1.38E+08 22,783 4703500 3741500 
115 SE Ljusnan 19,870 7.26E+09 70,566 4703500 4253500 
116 DK Ll. Vejle å 23 4.59E+06 2,699 4461500 3614500 
117 EE Loobu 203 8.42E+07 3,897 5221500 4139500 
118 RU Luga 13,665 3.32E+09 357,012 5337500 4174500 
119 SE Lule älv 25,464 1.70E+10 43,670 4878500 4768500 
121 DK Lyby-grønning 
grøft 
16 1.83E+06 1,511 4261500 3727500 
122 SE Lyckebyån 801 1.91E+08 16,988 4672500 3691500 
123 SE Lögde älv 1,639 6.30E+08 1,605 4788500 4526500 
124 DK Mademose å 7 5.88E+05 893 4447500 3635500 
125 DK Maglemose å 16 3.53E+06 4,103 4455500 3621500 
126 DK Marrebæksrende 20 3.50E+06 420 4398500 3533500 
127 DE Maurine 128 2.54E+07 4,879 4387500 3415500 
128 DK Mern å 38 9.35E+06 1,662 4454500 3549500 
129 SE Motala ström 15,466 3.18E+09 582,592 4669500 3949500 
130 FI Mustijoki 789 2.12E+08 24,773 5173500 4232500 
131 DK Mølle å 116 1.70E+07 120,314 4480500 3635500 
132 SE Mörrumsån 3,387 9.06E+08 114,779 4616500 3683500 
133 DK Nældevads å 30 6.69E+06 1,091 4413500 3526500 
134 RU Narva 71,822 1.30E+10 845,651 5333500 4170500 
135 DK Ndr. Halleby å 417 8.14E+07 25,335 4401500 3608500 
136 LT Nemunas 92,504 1.53E+10 4,160,035 5069500 3618500 
137 RU Neva 281,071 7.26E+10 5,707,947 5442500 4258500 
138 SE Nissan 2,705 1.40E+09 87,788 4496500 3732500 
139 DK Nive å 59 1.31E+07 7,420 4477500 3652500 
140 SE Norrström 22,634 5.28E+09 1,876,097 4779500 4050500 
152 SE Nyköpingsån 3,625 7.18E+08 84,838 4726500 3981500 
















154 DK Odense å 536 1.56E+08 91,959 4346500 3587500 
155 PL Oder 119,544 1.69E+10 15,547,872 4624500 3397500 
156 DE Oldenburger 
graben 
122 1.77E+07 14,896 4391500 3459500 
157 FI Oulujoki 2,3013 8.55E+09 156,938 5048500 4737500 
158 FI Paimionjoki 1,088 2.91E+08 25,656 5015500 4208500 
159 PL Parseta 3,084 8.45E+08 174,445 4683500 3466500 
160 PL Pasleka 2,280 5.05E+08 93,999 4956500 3519500 
161 DE Peene 5,041 5.99E+08 245,257 4563500 3423500 
162 FI Perhonjoki 2,538 7.48E+08 20,325 4966500 4591500 
163 EE Pirita 797 2.20E+08 52,200 5159500 4128500 
164 SE Pite älv 11,344 5.77E+09 10,059 4848500 4738500 
165 FI Porvoonjoki 1,291 3.66E+08 101,525 5179500 4238500 
166 RU Pregolya 14,086 2.35E+09 892,549 4993500 3573500 
167 EE Pudisoo 119 3.38E+07 861 5199500 4145500 
168 DK Pulverbæk 6 2.94E+06 151 4316500 3535500 
169 EE Purtse 787 2.15E+08 16,580 5281500 4146500 
170 EE Pühajõgi 213 5.54E+07 31,900 5306500 4157500 
171 FI Pyhäjoki 3,687 1.07E+09 29,047 5003500 4667500 
172 EE Pärnu 5,204 1.61E+09 73,076 5177500 4018500 
173 DK Rævs å 85 4.38E+07 13,900 4334500 3647500 
174 DE Recknitz 664 1.08E+08 26,621 4481500 3463500 
175 PL Reda 502 1.41E+08 116,200 4865500 3535500 
176 PL Rega 2,723 6.06E+08 132,533 4663500 3459500 
177 SE Rickleån 1,639 5.26E+08 3,797 4853500 4598500 
178 DK Ringe å 24 8.94E+06 1,372 4339500 3606500 
179 DK ROHDEN Å,  300 m 
NS Årup Mølle 
Dambrug 
99 3.65E+07 10,028 4304500 3621500 
180 DK Romdrup å 27 1.28E+07 3,531 4322500 3767500 
181 DK Ry å 302 1.09E+08 20,728 4311500 3796500 
182 DE Ryck 199 2.44E+07 11,107 4532500 3453500 
183 DK Ryde å 93 1.44E+07 3,200 4394500 3523500 
184 SE Råne älv 4,213 1.59E+09 3,842 4884500 4798500 
185 SE Råån 190 5.41E+07 23,991 4493500 3658500 
186 SE Rönne å 1,886 6.11E+08 94,360 4497500 3688500 
187 LV Saka 1,102 6.85E+08 14,277 5001500 3806500 
188 DK Sakskøbing å 37 1.37E+07 957 4429500 3512500 
189 LV Salaca 3,422 2.24E+09 27,978 5171500 3936500 
190 DK Saltø  å 154 3.10E+07 7,366 4425500 3570500 
191 DE Schwartau 227 5.79E+07 31,790 4368500 3423500 
192 DE Schwentine 753 2.00E+08 125,081 4333500 3468500 
193 DK Seerdrup å 53 1.25E+07 2,715 4404500 3580500 
194 RU Seleznevka 624 1.15E+08 26,356 5327500 4315500 
195 EE Seljajõgi 432 1.27E+08 25,082 5240500 4155500 
196 FI Siikajoki 4,332 1.38E+09 13,905 5018500 4711500 
197 DK Simested å 217 7.54E+07 9,205 4285500 3723500 
198 FI Simojoki 3,168 1.58E+09 2,748 5012500 4800500 
















200 SE Skellefte älv 11,783 5.55E+09 51,174 4851500 4665500 
201 PL Slupia 1,620 5.27E+08 192,996 4763500 3518500 
202 DK Solkær å 29 8.74E+06 2,325 4293500 3597500 
203 DK Spang å 60 2.23E+07 3,827 4297500 3603500 
204 DK St. Vejle å 58 1.21E+07 79,018 4470500 3616500 
205 DK Stavis å 83 2.01E+07 6,071 4338500 3592500 
206 DE Stepenitz 702 9.06E+07 35,893 4386500 3419500 
207 DK Stokkebækken 44 1.93E+07 2,167 4370500 3563500 
208 DK Storå, bromølle 117 5.44E+07 970 4246500 3769500 
209 DK Storå, møllebro 139 3.57E+07 9,144 4320500 3598500 
210 DK Suså 759 1.83E+08 76,835 4428500 3578500 
211 LT Sventoji 501 1.69E+08 8,325 5008500 3711500 
212 DK Søborg kanal 59 1.37E+07 8,713 4461500 3670500 
213 DK Taps å 76 2.39E+07 4,163 4289500 3581500 
214 DK Tingsted å 40 1.08E+07 1,064 4442500 3526500 
215 FI Torne älv - 
tornionjoki 
40,528 1.39E+10 71,805 4970500 4812500 
216 DK Tranegård lille å 23 5.06E+06 832 4456500 3569500 
217 DE Trave 927 2.43E+08 138,658 4363500 3416500 
218 DK Trend å 146 4.74E+07 7,769 4272500 3747500 
219 DK Tryggevaelde å 126 2.89E+07 6,248 4459500 3583500 
220 DK Tubæk 57 1.20E+07 2,184 4447500 3560500 
221 DK Tude å 260 5.78E+07 42,758 4403500 3592500 
222 DK Tuse å 104 2.25E+07 7,795 4420500 3621500 
223 SE Töre å 454 1.74E+08 1,124 4897500 4808500 
224 DE Uecker 2,477 2.21E+08 103,905 4588500 3411500 
225 SE Ume älv 27,058 1.45E+10 103,121 4830500 4554500 
226 FI Uskelanjoki 568 1.81E+08 30,102 5041500 4208500 
227 DK Usserød å 71 1.92E+07 39,535 4477500 3648500 
228 DK Værebro å 108 1.77E+07 69,542 4460500 3628500 
229 EE Valgejõgi 386 1.23E+08 4,989 5209500 4139500 
230 DE Wallensteingraben 175 4.24E+07 12,906 4418500 3421500 
231 FI Vantaanjoki 1,697 4.98E+08 443,494 5146500 4213500 
232 DE Warnow 3,111 4.51E+08 157,452 4462500 3442500 
233 DK Vejerslev bæk 19 7.53E+06 786 4241500 3737500 
234 DK Vejle å 221 1.22E+08 1,0171 4285500 3621500 
235 DK Vejstrup å 48 1.19E+07 3,254 4367500 3554500 
236 LV Venta 11,776 2.84E+09 335,509 5014500 3866500 
237 DK Viby å 29 1.43E+07 3,865 4311500 3593500 
238 PL Wieprza 2,208 5.06E+08 80,310 4734500 3499500 
239 EE Vihterpalu 471 1.37E+08 858 5108500 4093500 
240 DK Villestrup å 126 4.64E+07 5269 4320500 3731500 
241 DK Vindinge å 128 3.14E+07 11,117 4361500 3582500 
242 FI Virojoki 358 1.39E+08 1,282 5281500 4286500 
243 SE Viskan 2,222 1.33E+09 131,332 4454500 3793500 
244 PL Vistula 193,335 3.40E+10 23,232,687 4901500 3502500 
245 DK Vium mølleå 29 1.08E+07 1,350 4257500 3731500 
246 DK Voer å 244 9.64E+07 7,343 4346500 3790500 
















248 DE Zarow 756 6.44E+07 20,993 4585500 3412500 
249 SE Ångermanälven 32,123 1.66E+10 42,949 4715500 4458500 
250 DK Århus å 329 8.91E+07 156,728 4332500 3672500 
251 SE Ätran 3,331 1.75E+09 66,203 4473500 3757500 
252 SE Öre älv 3,014 1.16E+09 4,056 4806500 4525500 
253 DK Østerbæk 10 7.88E+05 399 4476500 3665500 
256 PL Leba 2,340 6.74E+08 129,977 4807500 3542500 
a) Aggregated from the calculation grid. 
b) HELCOM 2018b  
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Annex 4 – API-sales 
API Sales Average sales (kg/a) a) 
DE1) DK2) EE1) FI1) LT3) LV1) PL3) RU4) SE1) Overall5) 
Antibiotics 
Ciprofloxacin Total (kg/a) 23,400 1,160 351 290 244 659 9,530 - 2,670 38,300 
Per capita 
(mg/d/pers.) 
0.783 0.557 0.730 0.145 0.232 0.917 0.688 - 0.743 0.714 
Clarithromycin Total (kg/a) 11,000 469 412 216 192 450 8,610 - 628 22,000 
Per capita 
(mg/d/pers.) 
0.368 0.225 0.858 0.108 0.182 0.626 0.621 - 0.174 0.409 
Doxycycline Total (kg/a) 4,480 143 1,560 486 - 168 - - 466 7,300 
Per capita 
(mg/d/pers.) 
0.150 0.0687 3.24 0.243 - 0.233 - - 0.129 0.188 
Erythromycin Total (kg/a) 14,600 361 1.5 47.7 2.6 40.9 - - 545 15,600 
Per capita 
(mg/d/pers.) 
0.487 0.173 0.00312 0.0238 0.00247 0.0569 - - 0.151 0.390 
Fluconazole Total (kg/a) 433 197 15.4 123 - 23.6 - - 186 978 
Per capita 
(mg/d/pers.) 
0.0145 0.0946 0.0320 0.0612 - 0.0328 - - 0.0518 0.0252 
Lincomycin Total (kg/a) - - 197 149 - 15.1 - - 0 361 
Per capita 
(mg/d/pers.) 
- - 0.411 0.0743 - 0.0210 - - 0 0.0531 
Norfloxacin Total (kg/a) 355 - 79.7 1.8 - 100 - - 22.4 559 
Per capita 
(mg/d/pers.) 
0.0119 - 0.166 8.99e-04 - 0.140 - - 0.00623 0.0152 
Ofloxacinb) Total (kg/a) 481 0.017 3.67 10.8 - 26.6 - - 0.0129 522 
Per capita 
(mg/d/pers.) 
0.0161 8.16e-06 0.00764 0.00538 - 0.0370 - - 3.59e-06 0.0135 
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API Sales Average sales (kg/a) a) 
DE1) DK2) EE1) FI1) LT3) LV1) PL3) RU4) SE1) Overall5) 
Sulfadiazine Total (kg/a) 3,070 6.85 81.5 382 - 2.55 - - 0.477 3,540 
Per capita 
(mg/d/pers.) 
0.103 0.00329 0.170 0.191 - 0.00355 - - 1.32e-04 0.0912 
Sulfamethoxazole Total (kg/a) 16,700 349 407 389 137 1,020 5,680 - 0.000933 24,700 
Per capita 
(mg/d/pers.) 
0.560 0.168 0.847 0.194 0.130 1.43 0.410 - 2.59e-07 0.460 
Tetracycline Total (kg/a) 48,300 1,590 0.26 1,090 - 2.15 - - 270 51,300 
Per capita 
(mg/d/pers.) 
1.62 0.761 5.41e-04 0.542 - 0.00300 - - 0.075 1.32 
Trimethoprim Total (kg/a) 4,710 478 83.5 911 - 212 - - 192 6,580 
Per capita 
(mg/d/pers.) 
0.157 0.229 0.174 0.455 - 0.295 - - 0.0532 0.170 
Antiepileptics 
Carbamazepine Total (kg/a) 36,600 1,820 1,040 3,070 589 1,430 27,200 - 5,590 77,400 
Per capita 
(mg/d/pers.) 
1.22 0.875 2.16 1.53 0.559 1.98 1.96 - 1.55 1.44 
Gabapentin Total (kg/a) 82,800 12,700 797 8,210 - 2,150 - - 14,800 121,000 
Per capita 
(mg/d/pers.) 
2.77 6.08 1.66 4.10 - 2.99 - - 4.12 3.13 
Levetiracetam Total (kg/a) 126,000 5,610 278 6,760 - 263 - - 8,400 147,000 
Per capita 
(mg/d/pers.) 
4.20 2.69 0.578 3.38 - 0.366 - - 2.33 3.79 
Primidone Total (kg/a) 5,320 90.8 33.1 - - 2.54 - - 1.96 5,450 
Per capita 
(mg/d/pers.) 
0.178 0.0436 0.0689 - - 0.00353 - - 5.43e-04 0.148 
Antihypertensives 
Amlodipine Total (kg/a) 9,470 733 161 604 - 223 - - 945 12,100 
Per capita 
(mg/d/pers.) 
0.317 0.352 0.335 0.301 - 0.311 - - 0.262 0.313 
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API Sales Average sales (kg/a) a) 
DE1) DK2) EE1) FI1) LT3) LV1) PL3) RU4) SE1) Overall5) 
Candesartan Total (kg/a) 10,500 66 49 648 - 17.7 - - 1,340 12,600 
Per capita 
(mg/d/pers.) 
0.35 0.0317 0.102 0.324 - 0.0247 - - 0.372 0.324 
Enalapril Total (kg/a) 5,550 1,200 143 788 - 167 - - 1,960 9,810 
Per capita 
(mg/d/pers.) 
0.185 0.576 0.297 0.393 - 0.232 - - 0.545 0.253 
Eprosartan Total (kg/a) 7,800 - 2.39 1,040 - 2.49 - - 82.1 8,930 
Per capita 
(mg/d/pers.) 
0.261 - 0.00498 0.521 - 0.00347 - - 0.0228 0.243 
Hydrochlorothiazide Total (kg/a) 53,800 1,690 264 2,060 - 265 - - 551 58,700 
Per capita 
(mg/d/pers.) 
1.8 0.810 0.549 1.03 - 0.368 - - 0.153 1.51 
Irbesartan Total (kg/a) 19,000 179 0 - - 30.1 - - 1,140 20,300 
Per capita 
(mg/d/pers.) 
0.635 0.0859 0 - - 0.0419 - - 0.317 0.553 
Losartan Total (kg/a) 10,500 8,780 177 5,450 - 194 - - 6,700 31,800 
Per capita 
(mg/d/pers.) 
0.352 4.22 0.368 2.72 - 0.270 - - 1.86 0.821 
Ramipril Total (kg/a) 11,700 276 82.8 367 - 56.4 - - 253 12,800 
Per capita 
(mg/d/pers.) 
0.392 0.132 0.172 0.183 - 0.0784 - - 0.0702 0.329 
Telmisartan Total (kg/a) 6,900 32 1,030 1,140 - 510 - - 51.9 9,670 
Per capita 
(mg/d/pers.) 
0.231 0.0154 2.14 0.571 - 0.709 - - 0.0144 0.249 
Valsartan Total (kg/a) 87,500 150 331 4,560 - 336 - - 1,380 94,200 
Per capita 
(mg/d/pers.) 
2.92 0.0722 0.690 2.28 - 0.467 - - 0.382 2.43 
Asthma and allergy medications 
Cetirizine c) Total (kg/a) 143 382 34 645 - 20.2 - - 718 1,940 
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API Sales Average sales (kg/a) a) 
DE1) DK2) EE1) FI1) LT3) LV1) PL3) RU4) SE1) Overall5) 
Per capita 
(mg/d/pers.) 
0.00477 0.184 0.0708 0.322 - 0.0281 - - 0.199 0.0501 
Fexofenadine Total (kg/a) 2,420 1,660 - 639 - 0.123 - - 535 5,260 
Per capita 
(mg/d/pers.) 
0.0809 0.800 - 0.319 - 1.72e-04 - - 0.149 0.137 
Fluticasone Total (kg/a) - 13.9 0.332 14.4 - 1.31 - - 3.28 33.3 
Per capita 
(mg/d/pers.) 
- 0.00669 6.91e-04 0.00721 - 0.00183 - - 9.12e-04 0.00375 
Mometasone Total (kg/a) 75 10.9 - 10.8 - 1.7 - - 34.6 133 
Per capita 
(mg/d/pers.) 
0.00251 0.00523 - 0.00539 - 0.00237 - - 0.00962 0.00347 
Xylometazoline Total (kg/a) 108 25.1 13.3 14.9 - 9.9 - - 77.1 249 
Per capita 
(mg/d/pers.) 
0.00362 0.0120 0.0277 0.00746 - 0.0138 - - 0.0214 0.00641 
Gastrointestinal disease medications 
Omeprazole/esomeprazole Total (kg/a) 16,100 942 260 1,340 - 455 - - 6,050 25,100 
Per capita 
(mg/d/pers.) 
0.538 0.452 0.541 0.667 - 0.633 - - 1.68 0.648 
Mesalazine Total (kg/a) 108,000 17,600 762 19,100 - 459 - - 30,800 177,000 
Per capita 
(mg/d/pers.) 
3.62 8.47 1.59 9.54 - 0.638 - - 8.56 4.56 
Pantoprazole Total (kg/a) 54,100 2,370 170 2,450 - 219 - - 326 59,600 
Per capita 
(mg/d/pers.) 
1.81 1.14 0.354 1.22 - 0.304 - - 0.0905 1.54 
Hormones 
Estriol (E3) Total (kg/a) 478 0.678 30.5 2.63 - 0.0276 - - 8.05 520 
Per capita 
(mg/d/pers.) 
0.0160 3.25e-04 0.0634 0.00131 - 3.85e-05 - - 0.00224 0.0134 
Estrone (E1) Total (kg/a) 0 - - - - - - - 0 0 
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API Sales Average sales (kg/a) a) 
DE1) DK2) EE1) FI1) LT3) LV1) PL3) RU4) SE1) Overall5) 
Per capita 
(mg/d/pers.) 
0 - - - - - - - 0 0 
Norethisterone Total (kg/a) 97.8 3.88 0.476 15 - 1.15 - - 14.8 133 
Per capita 
(mg/d/pers.) 
0.00327 0.00186 9.92e-04 0.00747 - 0.00160 - - 0.00412 0.00343 
Progesterone Total (kg/a) 2,250 76.1 25.8 119 - 116 - - 127 2,710 
Per capita 
(mg/d/pers.) 
0.0751 0.0366 0.0536 0.0593 - 0.161 - - 0.0354 0.0698 
Testosterone Total (kg/a) 2,360 75.2 1.81 117 - 4.14 - - 277 2,840 
Per capita 
(mg/d/pers.) 
0.0789 0.0361 0.00377 0.0586 - 0.00576 - - 0.0770 0.0731 
Metabolic disease medications 
Allopurinol Total (kg/a) 132,000 3,400 872 2,810 - 705 - - 4,720 145,000 
Per capita 
(mg/d/pers.) 
4.41 1.63 1.82 1.40 - 0.982 - - 1.31 3.73 
Atorvastatin Total (kg/a) 12,200 2,750 174 1,620 - 655 - - 4,020 21,500 
Per capita 
(mg/d/pers.) 
0.409 1.32 0.362 0.806 - 0.911 - - 1.12 0.553 
Bezafibrate Total (kg/a) 8,140 - - 79.3 - - - - 316 8,530 
Per capita 
(mg/d/pers.) 
0.272 - - 0.0396 - - - - 0.0877 0.240 
Gemfibrozil Total (kg/a) 0 1350 - 76.2 - - - - 830 2,260 
Per capita 
(mg/d/pers.) 
0 0.650 - 0.0380 - - - - 0.230 0.0601 
Metformin Total (kg/a) 1,620,000 91,800 22,800 149,000 27,700 29,200 669,000 - 115,000 2,720,000 
Per capita 
(mg/d/pers.) 
54.0 44.1 47.5 74.6 26.3 40.7 48.2 - 31.8 50.6 
Simvastatin Total (kg/a) 40,600 4,010 88.5 2,480 - 8.76 - - 4,090 51,200 
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API Sales Average sales (kg/a) a) 
DE1) DK2) EE1) FI1) LT3) LV1) PL3) RU4) SE1) Overall5) 
Per capita 
(mg/d/pers.) 
1.36 1.93 0.184 1.24 - 0.0122 - - 1.14 1.32 
NSAIDs and analgesics 
Codeine Total (kg/a) 653 1,170 148 1,640 - 60.6 - - 1,630 5,300 
Per capita 
(mg/d/pers.) 
0.0218 0.560 0.307 0.818 - 0.0844 - - 0.453 0.137 
Diclofenac Total (kg/a) 26,900 910 1,510 2,460 744 1,950 7,980 20,000 2,800 65,200 
Per capita 
(mg/d/pers.) 
0.898 0.437 3.14 1.23 0.706 2.72 0.576 0.374 0.779 0.608 
Ibuprofen Total (kg/a) 340,000 6,3500 15,200 122,000 5,780 20,400 8,490 - 116,000 691,000 
Per capita 
(mg/d/pers.) 
11.4 30.5 31.6 60.7 5.48 28.3 0.613 - 32.3 12.9 
Ketoprofen Total (kg/a) 205 1.74 227 381 - 84.5 - - 1,800 2,700 
Per capita 
(mg/d/pers.) 
0.00687 8.36e-04 0.472 0.190 - 0.118 - - 0.500 0.0696 
Naproxen Total (kg/a) 17,200 2,360 1,900 7,730 391 762 29,600 - 21,800 81,700 
Per capita 
(mg/d/pers.) 
0.574 1.13 3.95 3.86 0.371 1.06 2.14 - 6.05 1.52 
Oxycodone Total (kg/a) - 341 11.5 255 - 0.0074 - - 625 1,230 
Per capita 
(mg/d/pers.) 
- 0.164 0.0239 0.127 - 1.03e-05 - - 0.173 0.139 
Paracetamol Total (kg/a) 32,400 422,000 18,700 205,000 2,800 14,900 - - 547,000 1,240,000 
Per capita 
(mg/d/pers.) 
1.08 202 38.8 102 2.65 20.7 - - 152 31.2 
Tramadol Total (kg/a) 21,400 6,420 322 1,720 - 360 - - 3,490 33,800 
Per capita 
(mg/d/pers.) 
0.717 3.08 0.670 0.861 - 0.501 - - 0.968 0.870 
Other 
Caffeine Total (kg/a) 492 1,780 125 59.4 - 736 - - 148 3,340 
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API Sales Average sales (kg/a) a) 
DE1) DK2) EE1) FI1) LT3) LV1) PL3) RU4) SE1) Overall5) 
Per capita 
(mg/d/pers.) 
0.0164 0.857 0.260 0.0297 - 1.02 - - 0.0412 0.0862 
Other cardiovascular medicines 
Atenolol Total (kg/a) 3,500 412 28.4 348 12.1 24.3 733 - 2,460 7,520 
Per capita 
(mg/d/pers.) 
0.117 0.198 0.0592 0.174 0.0115 0.0338 0.0529 - 0.683 0.140 
Bisoprolol Total (kg/a) 9,010 50.3 8.61 788 - 151 - - 305 10,300 
Per capita 
(mg/d/pers.) 
0.301 0.0241 0.0179 0.394 - 0.211 - - 0.0848 0.266 
Dipyridamole Total (kg/a) 680 2,530 0.0300 3,930 - 0.211 - - 1,700 8,840 
Per capita 
(mg/d/pers.) 
0.0227 1.22 6.25e-05 1.96 - 2.93e-04 - - 0.472 0.228 
Metoprolol Total (kg/a) 143,000 7,220 1,720 3,900 1,790 1,390 3,120 - 11,200 173,000 
Per capita 
(mg/d/pers.) 
4.78 3.47 3.59 1.95 1.70 1.94 0.225 - 3.11 3.22 
Nebivolol Total (kg/a) 920 7.94 48.6 16.3 - 53.3 - - 0.00854 1,050 
Per capita 
(mg/d/pers.) 
0.0307 0.00382 0.101 0.00814 - 0.0742 - - 2.37e-06 0.0269 
Sotalol Total (kg/a) 2,240 64.9 110 169 - 57.7 - - 336 2,980 
Per capita 
(mg/d/pers.) 
0.0749 0.0312 0.228 0.0842 - 0.0803 - - 0.0932 0.0767 
Warfarin Total (kg/a) 25 122 25.2 243 - 30.1 - - 234 679 
Per capita 
(mg/d/pers.) 
8.36e-04 0.0585 0.0524 0.122 - 0.0419 - - 0.0649 0.0175 
Psycopharmaceuticals 
Citalopram (Escitalopram) Total (kg/a) 6,840 876 14.1 729 - 10 - - 1,620 10,100 
Per capita 
(mg/d/pers.) 
0.229 0.421 0.0295 0.364 - 0.0140 - - 0.450 0.260 
Olanzapine Total (kg/a) 419 66.9 8.99 119 - 9.77 - - 768 1,390 
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API Sales Average sales (kg/a) a) 
DE1) DK2) EE1) FI1) LT3) LV1) PL3) RU4) SE1) Overall5) 
Per capita 
(mg/d/pers.) 
0.014 0.0321 0.0187 0.0596 - 0.0136 - - 0.213 0.0359 
Oxazepam Total (kg/a) - 213 1.12 538 4.04 20.8 - - 0.567 777 
Per capita 
(mg/d/pers.) 
- 0.102 0.00233 0.268 0.00384 0.0289 - - 0.000157 0.0782 
Quetiapine Total (kg/a) 23,400 2,610 438 4,250 - 462 - - 4,150 35,300 
Per capita 
(mg/d/pers.) 
0.783 1.25 0.912 2.12 - 0.643 - - 1.15 0.911 
Risperidone Total (kg/a) 185 10.3 1.51 18.3 3.46 3.32 45.6 - 15 283 
Per capita 
(mg/d/pers.) 
0.00619 0.00496 0.00315 0.00912 0.00329 0.00463 0.00329 - 0.00418 0.00526 
Sertraline Total (kg/a) 6,710 1,990 84.6 744 - 35.5 - - 4,990 14,600 
Per capita 
(mg/d/pers.) 
0.224 0.956 0.176 0.371 - 0.0494 - - 1.39 0.375 
Temazepam Total (kg/a) - - - 308 - - - - - 308 
Per capita 
(mg/d/pers.) 
- - - 0.154 - - - - - 0.154 
Venlafaxine Total (kg/a) 19,000 2,360 116 1,960 - 56.5 - - 3,550 27,100 
Per capita 
(mg/d/pers.) 
0.636 1.13 0.241 0.980 - 0.0787 - - 0.986 0.698 
1) Ek Henning et al. 2020 
2) The Danish Health Data Authority 2020  
3) Kaiser et al. 2019 
4) HELCOM 2014 
5) Calculated from countries for which information was available 
a) The years covered by the data vary 
b) Ofloxacin sales presented here cover only sales as the racemic mixture ofloxacin. I.e. the figure does not include enantiopure forms. 
c) Sales of levocetirizine and 45% of the sales of hydroxyzine have been included into cetirizine sales, due to levocetirizine being an enantiopure form of cetirizine, and 45% of hydroxyzine being metabolized into cetirizine.
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Annex 5 – Calculated concentrations in influent wastewater 
API Excra) 
PECinf [ng/L] 
FI SE DE LV EE PL LT DK RU 
Allopurinol 0.15 1,510 1,400 5,260 1,230 2,160 4,660b) 4,610 b) 1,950 4,680 b) 
Amlodipine 0.2 428 369 481 491 509 494 b) 490 b) 535 496 b) 
Atenolol 1 1,200 4,670 793 231 401 362 78.5 1,340 958 b) 
Atorvastatin 0.01 95.6 132 111 299 98.2 183 b) 175 b) 359 186 b) 
Bezafibrate 0.5 138 302 950 853 b) 839 b) 853 b) 850 b) 839 b) 855 b) 
Bisoprolol 0.5 1,370 292 1,050 748 62.6 944 b) 940 b) 84.3 945 b) 
Candesartan 0.8 1,790 2,040 1,910 136 557 1,790 b) 1,790 b) 173 1,790 b) 
Carbamazepine 0.03 392 394 493 913 869 908 251 353 675 b) 
Cetirizine 0.6 1,340 822 19.8 118 294 211 b) 210 b) 762 211 b) 
Ciprofloxacin 1 1,000 5,080 5,310 6,260 4,950 4,700 1,580 3,770 4,880 b) 
Citalopram (Escitalopram) 0.15 393 480 272 17.4 35.1 325 b) 322 b) 501 327 b) 
Clarithromycin 0.3 227 364 800 1,400 1,870 1,390 404 490 918 b) 
Diclofenac 0.615 5,250 3,290 3,810 11,700 13,400 2,480 3,030 1,860 1,610 
Dipyridamole 0.01 233 55.7 6.17 0.0964 0.017 75.5 b) 72.2 b) 330 76.8 b) 
Doxycycline 0.45 761 402 473 751 10,300 606 b) 603 b) 217 607 b) 
Enalapril 0.2 559 767 282 366 452 399 b) 396 b) 875 401 b) 
Eprosartan 0.9 3240 140 1,600 21.4 30.5 1,500 b) 1,500 b) 1,490 b) 1,500 b) 
Erythromycin 0.1 17.5 110 420 52.3 2.7 360 b) 2.24 150 362 b) 
Estriol (E3) 0.05 0.517 0.87 8.54 0.0227 33.9 7.96 b) 7.77 b) 0.174 8.04 b) 
Fexofenadine 0.8 1770 814 442 0.948 750 b) 758 b) 756 b) 4,370 759 b) 
Fluconazole 0.8 339 284 79.1 181 175 139 b) 139 b) 517 139 b) 
Fluticasone 0.01 0.854 0.107 1.02 b) 0.6 0.188 1.24 b) 1.19 b) 1.81 1.26 b) 
Gabapentin 1 28,300 28,200 18,800 20,500 11,300 21,400 b) 21,400 b) 41,200 21,400 b) 
Gemfibrozil 0.06 17.5 105 0 39.5 b) 36.1 b) 39.7 b) 38.8 b) 390 40 b) 
Hydrochlorothiazide 1 7,100 1,050 12,200 2,520 3,720 10,300 b) 10,300 b) 5,490 10,300 b) 





FI SE DE LV EE PL LT DK RU 
Irbesartan 0.05 217 b) 123 339 24.8 0 328 b) 321 b) 45.9 332 b) 
Ketoprofen 0.01 22.5 58.9 1.86 38.6 128 23.1 b) 22.1 b) 0.227 23.5 b) 
Levetiracetam 0.7 16,400 11,200 20,200 1,780 2,780 18,400 b) 18,400 b) 12,900 18,500 b) 
Losartan 0.04 882 598 165 142 172 434 b) 422 b) 1,980 438 b) 
Mesalazine 0.8 52,800 46,900 19,800 3,520 8,670 25,200 b) 25,100 b) 46,200 25,200 b) 
Metformin 1 515,000 217,000 366,000 278,000 322,000 330,000 180,000 299,000 346,000 b) 
Metoprolol 0.05 766 1,210 2,550 1,150 1,920 134 983 1,850 1,930 b) 
Mometasone 0.5 18.8 33.1 8.75 8.41 12.1 b) 12.3 b) 12.3 b) 18.3 12.3 b) 
Naproxen 0.5 13,400 20,800 2,000 3,760 13,800 7,590 1,310 3,960 5,410 b) 
Nebivolol 0.05 3.2 9.23e-04 16.4 43.9 54.1 16 b) 15.6 b) 2.04 16.2 b) 
Norethisterone 0.05 2.94 1.6 1.75 0.948 0.53 2.04 b) 1.99 b) 0.996 2.06 b) 
Norfloxacin 0.35 2.2 15.1 29.7 358 416 39.1 b) 38.8 b) 38.2 b) 39.2 b) 
Ofloxacin 0.9 33.4 0.0221 98.5 228 46.8 83.2 83 0.05 83.3 b) 
Olanzapine 0.07 31.6 112 9.32 9.83 12.5 26 b) 25.5 b) 21.4 26.2 b) 
Omeprazole/esomeprazole 0.01 79.1 198 146 208 147 215 b) 205 b) 123 218 b) 
Paracetamol 0.03 26,200 38,500 436 9,540 15,600 14,400 b) 1,190 81,600 14,600 b) 
Progesterone 0.05 23.3 13.8 40.1 95.4 28.7 41.5 b) 40.5 b) 19.5 41.9 b) 
Quetiapine 0.05 834 449 418 380 488 541 b) 528 b) 669 547 b) 
Risperidone 0.15 9.84 4.46 7.37 5.78 3.76 4.11 4.07 5.91 6.62 b) 
Sertraline 0.01 44 163 60.9 16.2 47.8 124 b) 119 b) 260 127 b) 
Simvastatin 0.05 486 443 724 7.21 98.5 785 b) 766 b) 1030 792 b) 
Sotalol 1 582 637 507 549 1,550 524 b) 523 b) 211 525 b) 
Sulfadiazine 0.8 1,060 0.725 560 19.6 928 504 b) 503 b) 18 504 b) 
Sulfamethoxazole 0.2 276 3.65e-04 851 2,250 1,290 648 203 255 730 b) 
Telmisartan 0.5 1,990 49.6 806 2,520 7470 885 b) 881 b) 53.7 886 b) 
Testosterone 0.1 43.1 56.1 68.1 5.3 3.25 67.5 b) 66.4 31.2 67.9 b) 
Tetracycline 0.6 2,260 309 6,700 12.6 2.25 5,560 b) 5,540 b) 3,160 5,570 b) 
Tramadol 0.1 634 705 618 461 578 803 790 2,660 808 b) 
Trimethoprim 0.5 1,580 183 549 1,050 608 602 b) 600 b) 801 603 b) 





FI SE DE LV EE PL LT DK RU 
Warfarin 0.01 14.4 7.65 0.227 13.8 14.2 5.8 b) 5.55 b) 15.9 5.9 b) 
Venlafaxine 0.05 385 384 340 46.5 129 415 405 604 419 b) 
a) Excretion rate used in the calculation. 
b) No national sales data available. Average value used.  
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Annex 6 – Calculated concentrations in effluent wastewater 
API 
RRa) PECeff [ng/L] 
FI SE DE LV EE PL LT DK RU 
Allopurinol 0.998 2.63 2.43 9.14 2.13 3.76 8.1 b) 8.01 b) 3.38 8.14 b) 
Atenolol 0.758 291 1,130 192 55.9 97.2 87.6 b) 19 b) 325 232 b) 
Bezafibrate 0.589 56.6 124 391 351 345 351 349 345 351 b) 
Bisoprolol 0.184 1,120 238 858 610 51.1 770 b) 767 b) 68.8 772 b) 




298 365 207 13.2 26.7 247 b) 244 b) 381 248 b) 
Clarithromycin 0.291 161 258 567 991 1,320 985 b) 287 b) 347 650 b) 
Diclofenac 0.0640 4,910 3,080 3,570 11,000 12,500 2,320 b) 2,840 b) 1,740 1,510 b) 
Dipyridamole 0.888 25.9 6.21 0.688 0.0107 0.00189 8.42 8.06 36.8 8.57 
Doxycycline c) 0.888 85.2 44.9 52.9 b) 84 b) 1150 67.8 b) 67.5 b) 24.3 b) 67.9 b) 
Eprosartan 0.958 135 5.83 66.2 0.889 1.26 62.4 b) 62.2 b) 61.8 62.4 b) 
Erythromycin 0.549 7.9 49.7 189 23.6 1.22 162 1.01 67.5 163 b) 
Fluconazole 0.362 216 181 50.5 116 112 88.9 b) 88.7 b) 330 89 b) 
Gabapentin 0.778 6,290 6,260 4,170 4,550 2,500 4,750 4,740 9,160 4,760 b) 




4,590 677 7,890 1,630 2,410 6,680 6,670 3,550 6,690 
Ibuprofen 0.950 360 190 154 466 429 10.2 b) 87 b) 414 217 b) 
Irbesartan 0.301 152 86.3 237 17.3 0 230 b) 224 b) 32.1 232 b) 
Ketoprofen 0.673 7.38 19.3 0.61 b) 12.6 b) 42 7.55 b) 7.23 b) 0.0743 b) 7.68 b) 
Levetiracetam 0.952 784 536 966 85.2 133 882 b) 879 b) 619 883 b) 
Losartan -0.105 974 661 182 157 190 479 b) 466 b) 2180 b) 484 b) 
Mesalazine 0.976 1,290 1,150 483 86.2 212 616 b) 615 1,130 617 b) 
Metformin 0.998 1,030 435 732 556 643 659 b) 359 b) 597 693 b) 




RRa) PECeff [ng/L] 
FI SE DE LV EE PL LT DK RU 
Naproxen 0.954 615 954 91.8 b) 173 b) 632 348 b) 60.1 b) 181 b) 248 b) 
Nebivolol 0.989 0.0353 1.02e-05 0.181 0.484 0.597 b) 0.177 b) 0.172 b) 0.0225 0.178 b) 
Norethisterone 0.976 0.0697 0.0381 0.0415 b) 0.0225 0.0126 0.0484 b) 0.0472 b) 0.0237 0.0489 b) 
Ofloxacin 0.865 4.5 0.00298 13.3 30.8 6.3 11.2 b) 11.2 b) 0.00673 11.2 b) 
Olanzapine 0.913 2.73 9.69 0.807 b) 0.851 1.08 2.25 b) 2.21 b) 1.85 2.27 b) 
Paracetamol 0.987 347 511 5.79 127 208 191 b) 15.8 b) 1,080 194 b) 
Progesterone 0.830 3.96 2.34 6.82 16.2 b) 4.87 b) 7.05 b) 6.88 b) 3.32 7.12 b) 
Quetiapine 0.831 141 75.9 70.7 64.3 82.4 91.5 b) 89.3 b) 113 92.3 b) 
Sertraline 0.913 3.84 14.2 5.31 1.42 4.17 10.8 10.4 22.6 11 b) 
Simvastatin 0.975 12.1 b) 11 18 0.179 2.44 19.5 b) 19 b) 25.5 19.6 b) 
Sotalol -0.0640 619 678 540 584 1,650 b) 558 b) 557 b) 225 559 b) 
Sulfamethoxazole 0.955 12.5 1.65e-05 38.4 102 58.2 29.3 b) 9.17 b) 11.5 33 b) 
Telmisartan 0.620 756 18.9 306 958 2,840 337 b) 335 b) 20.4 337 b) 
Testosterone 0.855 6.27 8.16 9.9 b) 0.771 0.473 9.81 b) 9.66 b) 4.53 b) 9.87 b) 
Tetracycline c) 0.888 253 34.6 750 1.41 0.251 622 b) 620 b) 353 623 b) 
Tramadol 0.0310 614 683 599 447 560 778 b) 766 b) 2,580 783 b) 
Trimethoprim 0.313 1,090 126 377 719 417 414 412 551 415 b) 
Valsartan 0.708 3,680 613 4670 754 1,100 3,920 3,910 115 3,930 b) 
Venlafaxine 0.198 309 308 273 37.3 103 b) 333 b) 325 b) 485 336 b) 
a) Removal rate used in the calculations. 
b) No sales data available. Average value used. 




Annex 7 –Univariate sensitivity analysis 
Univariate sensitivity analysis 
A univariate sensitivity analysis was carried out to estimate the sensitivity of the calculation results 
to changes in individual parameters. This analysis was carried out by making incremental changes 
to the values of 24 variables identified to affect the result. Changes in the total load to the Baltic Sea, 
mean concentration at river mouth locations and mean concentrations at coastal areas were selected 
as the end-points, for which results were compared between test-parameters. 
To carry out the sensitivity analysis, a calculation loop was created, where each variable was assigned 
either the default value, or a variable-specific test-value. Each variable was tested using 11 different 
values. The sensitivity analysis was carried out for a generic dummy-substance. The country-specific 
sales of this dummy substance were taken as the average of the eight substances presented in Table 
2 of this report. The parameters and the range of values used in the sensitivity analysis are presented 
in Table A7.1 
 
Table A7.1. Test-variables in the univariate sensitivity analysis 
Variable Min Default Max Unit 
A  
Parameter describing 
temperature effect on 
degradation (α in Eq. 
(9)) 








20 200 2,000 d 
Excr 
Excreted fraction (E in 
Eg. (1)) 
0.01 0.5 1 - 
Fphoto 
Fraction of water where 
photolysis occurs in 
inland waters 
0.0015 0.015 0.15 - 
Flow-mod 
Modifier for river flow 
volume 
0.5 1 2 - 
h1 
Depth of the surface 
layer in coastal waters 
0.05 0,5 1 m 
h2 
Depth of the middle 
layer in surface waters 
1 2,5 5 m 




150 1500 15,000 L/kg 
PT 
Fraction of unused 
medicines delivered to 
proper treatment, varies 
with country 
0.05 See Table 3 1 - 
rhow Density of marine water 901.8 1 002 1,102.2 kg/L 
RR 
Removed fraction at 
WWTP 
0.01 0.5 1 - 
Sales 
Modifier for national 
sales 0.1 1 10 - 
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Variable Min Default Max Unit 
SNC 
The fraction of domestic 
wastewaters that is 
treated, varies with 
country 
0.05 See Table 3 1 - 
T 
Average temperature in 
inland waters 
4.1 8.3 16.5 °C 
Tdivline 
Division line above 
which T=7 °C, and below 
T=9 °C 




12.5 25 50 °C 
Coastdivline1 
Northern division line 
for coastal waters 
3 700 500 4 300 000 5 172 500 - 
Coastdivline2 
Southern division line 
for coastal waters 
2 945 500 3 700 000 4 200 500 - 
Unused 
Fraction of medicines 
left unused 
0.05 0.5 1 - 
V_flow River flow speed 0.015 0.15 1.5 m/s 
Waste2Sewer 
Fraction of unused 
medicines flushed to the 
sewer network 
0,01 0,5 1 - 
Z 
Radiation decreasing 
from surface layer to the 
next (1/z) in the coastal 
areas  
1 4 10 - 
 
Variables with linear impact on results  
There were nine variables which had a linear impact on the value of at least one of the selected end-
points. Three of these parameters (Excr, Sales, Waste2Sewer) resulted in a parallel impact on all of 
the end-points. The impact of variables Excr and Sales are presented in Figure A7.1. On the other 
hand, changes in SNC, PT, Unused and Fphoto resulted in opposite impacts on all the end-points. 
Additionally, h1 had an opposite impact on the plateau concentration in coastal waters (AA_conc). 





Figure A7.1. The impacts of API-specific excretion rate and sales on the load to the Baltic Sea (BSL), mean concentration at 




Figure A7.2. The impacts of removal rate at WWTP and sewer network coverage on the load to the Baltic Sea (BSL), mean 
concentration at river mouths, and mean concentrations at coastal areas. The red point presents the default value. 
The variables with the greatest impacts on the outcomes were Excr, RR, Sales and SNC. Each variable 
with a linear impact on the outcomes is presented with the slope of the change in Table A7.2. 
 
Table A7.2. Variables with a linear impact on the outcome. 
Variable Slope 






Excr 110,000 720 110 55 
RR -100,000 -750 -100 -53 
Sales 56,000 380 58 29 
SNC -53,000 -380 -55 -28 
Unused -14,000 -120 -13 -6.5 
Waste2Sewer 6,600 43 3.6 7.2 
F_photo -4,900 -2.6 -5.2 -2.7 
PT -4,100 -30 -4.4 -2.2 




Variables with a nonlinear impact on results 
The majority of the variables had a nonlinear impact on the calculation outcomes. The fraction of 
medicines that gets flushed into the sewer network, i.e. does not go through metabolic processes, 
was the variable with the highest nonlinear impact on the load of the dummy substance to the Baltic 
Sea. On the other hand, there were some parameters, to which the calculation method was especially 
sensitive, when the parameter approached the extreme values in the tested range. For instance, the 
impact of flow speed increased with decreasing values. A similar impact would be seen if degradation 
half-lives were to be decreased. The impacts of these variables are presented in figures Figure A7.4 
and Figure A7.3. The peculiar impact Tdivline and Coastdivline had on the results is explained by the 
distribution of population and consequent emissions on both the northern and southern sides of 








Figure A7.4. The impacts of different variables on the calculation outcomes. 
